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Regulation of expression of three genes in the polyhedron
envelope protein (PEP) gene region of the Orgyia pseudotsugata
multinucleocapsid nuclear polyhedrosis virus (OpMNPV) was
examined. These genes include open reading frame (ORF) 1 (encoding
p21), ORF 2 (encoding gp16), and ORF 3 (encoding the polyhedron
envelope protein). The effect of elimination of the late promoter
elements of each ORF or both ORFs 1 and 2 on ORF 3 expression was
examined by using an ORF 3 promoter-CAT gene fusion. The data
indicated that the ORF 3 promoter was essential for the expression of
the PEP. Destruction of ORF 1 caused no effect whereas destruction of
ORF 2 promoter resulted in a 29% increase in CAT activity.
To characterize the role of ORF 1 and 2 in the viral life cycle and
the location of the proteins in virions and infected cells, antisera were
produced against these proteins. The 21 kDa protein was present in
both purified budded and occluded virions as demonstrated by
Western blot analysis. Immunoelectron microscopy showed that the
21 kDa protein was a capsid-associated protein in both phenotypes.
The ORF 2 gene encodes a 12 kDa protein that is N-glycosylated,
migrates at a MW of 16 kDa, and is not present in budded or occluded
virions. Immunoelectron microscopy indicated that gp16 is associated
with lamellar-like membranous structures in close association with the
Redacted for Privacynuclear membrane. It was also found associated with envelopes of
virions that had budded from the nucleus into the cytoplasm.
A gene that reportedly has a similar role to ORF 3 (polyhedron
envelope protein) has been described in Autographa californica
MNPV. This gene encodes a protein called the spheroidin-like protein
(SLP) because of its sequence similarity to the spheroidin inclusion
protein of the Choristoneura biennis entomopox virus. The gene was
located, sequenced, transcriptionally mapped in OpMNPV and an
antiserum was produced against a fusion protein containing most of
the SLP ORF. Immunoelectron microscopy showed that the protein
was concentrated in cytoplasmic inclusion bodiesand was not
associated with the polyhedron envelope structure in OpMNPV. It was
found to be associated with polyhedra of AcMNPV, but no specific
association with the polyhedron envelope was found.
The role of the PEP and the p10 protein in polyhedron
morphogenesis was examined using deletion mutants of OpMNPV
and immunoelectron microscopy. The p10 deletion mutant produced
polyhedra with patchy and poorly attached polyhedron envelopes,
suggesting p10 has a direct or indirect role in the proper formation of
the polyhedron envelope. The PEP deletion mutant showed that PEP
was an essential component in the formation of thepolyhedron
envelope. The mutant with both p10 and PEP deleted had polyhedra
that showed a distinct cubic morphology. These data suggest that these
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CHAPTER 1
Introduction
History and Taxonomy of Baculoviridae
The earliest European scientific description of a baculovirus
infection was described as silkworm jaundice disease in 1808 (Nysten,
1808). In 1856, Maestri and Cornalia examined jaundiced silkworms
under a microscope and observed strongly refractile crystal-like
corpuscles in blood and tissues (Maestri, 1856) (Cornalia, 1856). In 1873,
Bo lle named these crystal-like corpuscles "polyhedrische Kornchen" or
polyhedral granules. Polyhedral granules were heavier than water and
insoluble in cold or boiling water, glycerol, ethanol, weak acids and
other organic solvents. However, they did dissolve in dilute alkaline
solutions (Bo lle, 1874). In 1906, Bo lle's experiments had clearly shown
that the polyhedral bodies of silkworm were the infective agent of
jaundice (Bo lle, 1906). This disease was later referred to as polyhedral
disease. The etiological agent of polyhedral disease was not identified
as a virus until over a decade later.
In 1918-1919, Acqua provided convincing proof that the cause of
polyhedral disease was a filterable virus (Acqua, 1918-1919). These
results were not generally accepted for another decade. In 1934,
cytoplasmic produced polyhedra were discovered in midgut cells of
silkworms. The significance of this was not realized until 1950 when
two separate and distinct virus types characterized by nuclear or
cytoplasmic polyhedra were demonstrated (Smith and Wyckoff 1950).
The cytoplasmic polyhedrosis viruses were later found to have double
stranded, segmented RNA genomes and placed in the Reoviridae
family. In the same year, dissolution of polyhedra on an electron2
microscope grid revealed the rod-like shape of the nuclear polyhedrosis
virus (Hughes, 1950). Therefore, they were called baculoviruses which
is derived from the Greek word baculum meaning stick or rod.
Baculovirus research gained momentum when the first insect
cell line was establilshed by Grace (1962). In 1970, the first replication of
a nuclear polyhedrosis in an established cell line was acheived
(Goodwin et al., 1970). During this period virus purification and cell
culture techniques improved and prepared the way for investigations
into the molecular biology of baculoviruses. Today we know that
Baculoviridae is a large family of viruses, with over 600 identified
(Martignoni and Iwai, 1986). The viruses are pathogenic
predominantly for the insect order Lepidoptera (butterflies and moths),
but have also been identified in the orders Diptera, Hymenoptera,
Trichoptera, and Coleoptera (Adams and Bonami, 1992). Baculoviruses
have also been identified in the order Crustacea. Members of the
Baculoviridae are characterized by enveloped, rod-shaped virions
(approximately 40 X 400 nm) that contain a circular double-stranded
DNA genome ranging from 88 to 165 kb. The Baculoviridae has only
one genus called baculovirus. The baculovirus genus is subdivided
into two subgenera based morphological properties. Subgenus A, the
nuclear polyhedrosis viruses (NPVs), usually have many virions
occluded in a polyhedral occlusion body. There are two NPV
morphotypes. The single-nucleocapsid NPVs (SNPV) have onlyone
nucleocapsid in each envelope while the multinucleocapsids NPV
(MNPV) have several. NPV occlusion bodiesrange in size from 1 to 15
mM and are predominantly composed of a single protein named
polyhedrin (Rohrmann, 1986). Subgenus B, the granulosis viruses,
consist of occlusion bodies between 0.25 to 0.5 mM in size, thatare
predominantly composed of a single protein called granulin which is
related to polyhedrin (Rohrmann, 1986). A single nucleocapsid is
enveloped and packaged in each occlusion body.3
Baculovirus Infection Cycle
My thesis research has focused on increasing our knowledge of
the regulation and immunocytochemical localization of nuclear
polyhedrosis virus (NPV) structural proteins. Therefore, the
introduction will now focus on NPV's. The molecular biology of two
related NPVs, Orgyia pseudotsugata multicapsid nuclear polyhedrosis
virus (OpMNPV) and Autographa californica (AcMNPV) have been
studied in most detail.The OpMNPV is pathogenic for larvae of the
Douglas-fir tussock moth and AcMNPV is pathogenic for larvae of the
Alfalfa looper moth. These viruses have recently received
considerable attention because of their potential for use as insecticides.
In addition, AcMNPV is widely used as a vector for the introduction
and expression of foreign genes in insects and insect cell lines (Luckow
and Summers, 1988; Miller, 1988).
The infection cycle of the NPV's is complex and involves the
production of two structurally distinct virion phenotypes. The
polyhedra-derived virus phenotype (PDV) is the occluded form of the
virus and is responsible for the spread of the virus between insects. The
second phenotype is the nonocduded budded virus (BV) which spreads
the infection systemically to other cells within the insect host. The
infection cycle begins with the ingestion of polyhedra that dissolve and
release the PDV when they encounter the alkaline environment of the
insect midgut (see Fig. 1.1). The PDV then fuse with both the columnar
epithelial cells and regenerative cells of the insect midgut (Keddie et al.,
1989) and travel to the nucleus. During this time, the insect cells
undergo considerable morphological changes. The cells become
rounded and the nuclei enlarge, appearing to encompass most of the
cellular space. In the nucleus, the host chromatin seems to be moved
to the margins, making room for the virogenic stroma which is the
location of viral DNA replication. In the periphery of the virogenic
stroma, nucleocapsid assembly takes place. These nucleocapsids are
destined for either BV or PDV phenotype. Early in infection, BV is
produced (Bradford et al., 1990) that spreads the virus infection to other
cells in the insect. In the insect, infected hemocytes (blood cells) also4
appear to aid in the spread of the virus to other tissues by an unknown
mechanism (Keddie et al., 1989). Keddie et al. hypothesized that
adsorption of infected hemocytes to the basal lamina of various organs
facilitates virus penetration.
Nucleocapsids destined to become budded virus bud through the
nuclear membrane and temporarily acquire both the inner and outer
nuclear envelope. In Chapter 4, we show that a virally encoded 16 kDa
glycoprotein is associated with the nuclear membrane and with the
budded virus as it emerges from the nuclear membrane. This double-
membrane is then apparently lost from the nucleocapsids as they are
transported through the cytoplasm to the plasma membrane (Granados
and Lawler, 1981). The nucleocapsids then acquire a permanent
envelope when they bud through the cytoplasmic membrane that has
been modified by at least one viral encoded glycoprotein, termed gp64.
The budded virus is produced after DNA replication and late in the
infection cycle (Bradford et al., 1990).
The PDV phenotype is produced in the nucleus late in infection.
Nucleocapsids destined to become PDV are enveloped presumably by a
de novo synthesis of the envelope. After envelopment, PDV are
occluded in the polyhedrin matrix. Very late in infection a structure,
called the polyhedron envelope, forms around the mature polyhedra.
Upon death and decomposition of the insect, the polyhedra are
released to the environment.
Before I the discuss structural proteins of the two viral
phenotypes, I will define certain terms associated with these virions.
Capsid refers to the structure that forms the rod-like structure that
surrounds DNA and its associated proteins. Nucleocapsid refers to
capsids that contain the nucleoprotein components. Polyhedron-
derived virus (PDV) refers to the enveloped nudeocapsids of the
occluded virus (Fig. 2) (Rohrmann et al., 1992).Polyhedrin matrix
refers to the protein crystal that surround the PDV and is composed
primarily of the protein polyhedrin. Polyhedron envelope refers to the
envelope that surrounds the polyhedrin matrix. Polyhedrin matrix5
and polyhedron envelope protein are referred to separately as the
polyhedron specific components. Occluded virus refers to PDV and
polyhedron specific components.
Structural Proteins of the Budded and Occluded Virus Phenotypes
Baculovirus structural proteins are implicated in the virus
infection cycle, host specificity, virulence, and environmental stability
of the virus (Kuzio, 1990; Kuzio et al., 1989; William et al., 1989).
Studying baculovirus structural proteins will broaden our
understanding of viral-host relationships and will also contribute to
the development of safer and more effective viral insecticides.
To understand the structural complexity and genetic
relationship between baculoviruses, we have undertakena systematic
approach to identify and characterize baculovirus structural proteins.
To date, only eight proteins associated with nuclear polyhedrosis virus
have been well-characterized in terms of both their genetic location,
(Fig. 1.4) expression and the proteins physical location (Fig. 1.2). They
are: the fibrillar-structure-forming protein, p10 (Leisy et a1.,1986b;
Quant-Russell et al., 1987; Kuzio et al., 1984); the arginine-rich DNA
binding protein, p6.9 (Wilson et al., 1987; Russell and Rohrmann 1990b;
Maeda et al., 1991); a capsid protein, p39 (Blissard et al., 1989; Pearson et
al., 1988; Thiem and Miller, 1989; Bjornson and Rohrmann, 1992)a
second capsid protein, p87 (Muller et al., 1989); an envelope protein of
budded virus, gp64 (Vo lkman 1986; Whitford et al., 1989; Blissard and
Rohrmann, 1989); the occlusion protein, polyhedrin (Leisy et al., 1986a;
Hooft van Iddekinge et al., 1983); a polyhedra specific protein,p74
(Kuzio et al., 1989); and the polyhedron envelope protein, p32-34
(Gombart et al., 1989a; Gombart et al., 1989b; Whitt and Manning, 1988;
Bjornson and Rohrmann, 1992b).
Common Structural Proteins.
Presently there are three structural proteins common to the BV
and PDV phenotypes: the p39 and p87 capsid proteins, and the p6.96
DNA binding protein (Fig. 1.2). On Western blots, p39 and p87 antisera
react with BV and PDV. (Pearson et al., 1988; Muller et al., 1990).
Immunoelectron microscopy showed that p39 is a component of the
nucleocapsid. The random distribution of immunogold staining over
the surface of the nucleocapsid indicates that p39 is a major component
of the capsid rather than a specialized end structure (Russell et al.,
1991). p39 genes from AcMNPV (Thiem and Miller, 1989), OpMNPV
(Pearson et al., 1988; Blissard et al., 1989), and LdMNPV (Bjornson and
Rohrmann, 1992a) have been sequenced. The AcMNPV and OpMNPV
p39 amino add sequences are 59% identical, and 39% and 47% identical
to the LdMNPV p39 sequence, respectively (Rohrmann, 1992). All
eight cysteines are conserved among the three p39 sequences suggesting
they have a structural role (Rohrmann, 1992).
The p87 reading frame encodes a protein of predicted MW of 71
kDa, which has been shown by Western blot analysis to be a
component of the capsid (Muller et al., 1990). Although Western blot
analysis indicates the protein has a MW of 87 kDa, neither N or 0-
linked glycosylation accounts for the MW difference (Muller et al.,
1990). A similar gene was found on the AcMNPV genome (Lu and
Carstens, 1991). Immunofluorescence microscopy showed that p87
(like p39) was concentrated in the nucleus late in OpMNPV infection
(Muller et al., 1990).
The nucleocapsids of baculoviruses are rod-like in shape and are
composed of rings of subunits in a stacked series, with the rings aligned
perpendicular to the longitudinal axis (Burley, 1982). The
nucleocapsids have unique asymmetric caps as determined by electron
microscopy (Teak le, 1969; Kawamoto et al., 1977a; Fraser, 1986). Because
of these differences and unique staining properties, it was suggested
that the cap structures are composed of different proteins than the rods
(Teakle, 1969). Due to the nucleocapsid complexity, there may be
several proteins involved in the formation of the structure. In Chapter
3, using immunocytochemistry we have identified a third capsid
protein associated with the BV and PDV phenotypes.7
In cells, histones neutralize the electrostatic repulsions of DNA
allowing packaging of the DNA into highly condensed structures. In
baculoviruses, histones do not appear associated with DNA in
nudeocapsids (Wilson and Miller, 1986). Instead, the viral encoded
p6.9 DNA binding protein may function to neutralize the
phosphodiester backbone of the viral DNA, allowing the viral genome
to be packaged into the nudeocapsid (reviewed in Rohrmann, 1992).
Budded Virus Structural Proteins.
To date, the glycoprotein of 64 kDa (gp64) is the only BV specific
structural protein identified. gp64 has been characterized in AcMNPV
(Whitford et al., 1989) and in OpMNPV (Blissard and Rohrmann, 1989)
and has 78% amino acid identity (Blissard and Rohrmann, 1989). The
gp64 gene has both early and late promoters that allow continued
production of the protein throughout infection (Blissard and
Rohrmann, 1989). By using immunoelectron and
immunofluorescence microscopy gp64 was found to localize to the
cytoplasmic membrane (Volkman et al., 1984; Blissard and Rohrmann,
1989). As the BV nucleocapsid buds through and aquires the plasma
membrane, gp64 becomes associated with BV as a component of its
envelope. BV are thought to enter the cell by adsorptive endocytosis, a
process normally involved in the uptake of molecules used in
metabolism. BV are believed to bind to the cell surface, gathered into
invaginations of the plasma membrane called clathrin coated pits, and
which then pinch off from the membrane. As the clathrin dissociates
from these vesicles, two or more may fuse forming larger sructures
called endosomes. Endosomes become acidic, presumably by an ATP-
driven pump, that is thought to induce the viral envelope to fuse with
endosomal membrane, releasing the nucleocapsid into the cytoplasm
(Volkman and Goldsmith, 1985). gp64 has a signal sequence at the N-
terminus that is not present in the mature protein (Sivasubramanian,
1988). The protein is N-glycosylated (Roberts, 1989) and studies with
inhibitors of N-glycosylation have shown glycoslation is required for
incorporation of gp64 into virions (Roberts, 1989). Presumably,
glycosylation allows gp64 to be transported to the plasma membrane.8
gp64 also is acylated with palmitic acid. Acylation may function in
anchoring the protein to the membranes or be responsible for
membrane fusion (Roberts and Faulkner, 1989).
Occluded Virus Structural Proteins.
Polyhedrin and the polyhedron envelope protein (PEP) are two
well defined structural proteins specific to the occlusion bodies. There
are also three other proteins which appear to beassociated with the
occluded virus; p10, p74, and in Bombyx mori a 40 kDa protein.
Polyhedrin is produced in large amounts, comprising up to 18% or
more of the total alkali-soluble cellular protein ininfected insects
(Quant et al., 1984). Polyhedrin shows the highest conservation among
the baculovirus proteins with over 80% amino acid identity among
lepidopteran polyhedrins (Rohrmann, 1986). The lepidopteran
polyhedrins have 50% and 40% homology to granulins and NPV
hymenopteran polyhedrins, respectively (Rohrmann, 1992). The
conservation of the polyhedrins and granulins indicates that they
evolved from a common ancestor.
Baculoviruses are not the only viruses that embed their virions
in a protein matrix. Cytoplasmic polyhedrosis viruses (Reovirdae) and
entomopoxviruses are also occluded (Payne and Mertens, 1983; Arif,
1984; Goodwin et al., 1991). The virions of Entomopoxviruses become
occluded in spherical-shaped occlusion bodies called spherules that are
composed of a protein called spheroidin. Spheroidin genes have been
sequenced, from Choristoneura bennis EPV(Yuen et al., 1990) and
Amsacta moorei EPV (Banville et al., 1992; Hall and Moyer, 1991).
These gene products show no sequence homology to each other or to
baculovirus polyhedrins. These results indicate that the two
spheroidin proteins and the polyhedrins may have evolved
independently from each other. Recently, Via lard et al. described a
AcMNPV gene product called the spheroidin-like protein (SLP) that
has 39% amino acid similarity to the CbEPV spheroidin protein. The
CbEPV antiserum localized the SLP to the occlusion bodies but not to
PDV indicating that it is a polyhedron specific component (Via lard et9
al., 1990). Via lard et al. (1990) also demonstrated by
immunofluorescence microscopy that the SLP appeared to be associated
with the polyhedron envelope. In Chapter 5, I determined the
location, sequence, and the transcriptional map of the OpMNPV SLP
gene. I also examined the location of the OpMNPV SLP and the
AcMNPV SLP in the virus phenotypes and infected cells.
In baculoviruses, occlusion bodies (polyhedra) are surrounded by
an electron-dense amorphous polyhedron envelope. A gene encoding
a protein component of this envelope has recently been identified in
OpMNPV (Gombart et al., 1989 a,b). The polyhedron envelope protein
(PEP) (Fig. 1.2) was discovered by screening a X gt11 expression library
with a polyclonal antiserum produced against purified dilute alkaline
solubilized PDV components of OpMNPV. Two X clones that
contained nonoverlapping insert DNAs were identified. These clones
mapped to a single 32.4 kDa open reading frame (ORF) in the HindIII-
M fragment (Gombart et al., 1989b). The HindIII-M fragment of
OpMNPV was sequenced and contains five ORF's oriented in the same
direction and expressed late in infection (Fig. 1.3) (Gombart et al.,
1989a). Transcriptional mapping indicated that mRNAs from the five
ORFs coterminate at a single site downstream of ORF 5 (Fig. 1.3)
(Gombart et al., 1989a). The conserved late gene
promoter/transcriptional start sequence (A/GTAAG) was present
upstream of each ORF. The late promoter element will be discussed in
greater detail in the next section. Primer extension analysis showed
that the late promoter upstream of ORF 3 (the polyhedron envelope
protein (PEP) gene) was not the major site of mRNA initiation for the
gene (Gombart et al., 1989a). This data indicated that the use of late
promoter signal (A/GTAAG) for transcriptional initiation may vary
between different ORFs. In Chapter 2 of this thesis, I investigate the
role of the ATAAG and the upstream ORFs in expression of the PEP
gene.
A trpE-PEP gene fusion containing the entire PEP ORF was
constructed and a monospecific antiserum was produced (Gombart et
al., 1989b). Western blot analysis and immunofluorescence microscopy10
demonstrated that the protein was present in the cytoplasm and the
nucleus at 24 hr p.i. (Gombart et al., 1989b). Studies with polyhedra
solubilized under various conditions indicated that PEP is associated
with the polyhedron envelope (Gombart et al., 1989b).
Immunoelectron microscopy has confirmed that the PEP is an integral
component of the polyhedron envelope (Russell and Rohrmann,
1990a). The addition of a reducing agent like 2-mercaptoethanol along
with SDS was required to solubilize PEP from the polyhedron
envelope. The PEP solubility properties are unique from other virion
proteins such as polyhedrin and p39 that are found in the supernatant
when polyhedra are treated with dilute alkaline saline (DAS) and SDS.
This unique solubility indicated a possible thiol linkage through
cysteine residue(s) with the polyhedron envelope. The solubility
properties of the PEP and reciprocal immunoblotting experiments
indicated that the OpMNPV PEP gene encodes a protein which is
homologous to the polyhedron envelope phosphoprotein of
AcMNPV, pp34 (Gombart et al.,1989b; Whitt and Manning, 1988; van
Lent et al., 1990).
In AcMNPV, the PEP gene region has been sequenced and
transcriptionally mapped (Oel lig et al., 1987) and shares 58% amino acid
identity with OpMNPV PEP (Gombart et al., 1989a). The AcMNPV PEP
has a large hydrophilic region created by 16 arginine-serine repeats, not
present in OpMNPV. Arginine-serine repeats may have a significant
effect on the structure of the protein. The clustering of cysteine
residues in each of the hydrophilic regions in both proteins may be
important in the thiol linkages of these proteins to the polyhedron
envelope. The large hydrophilic region found in AcMNPV may make
the cysteines more available for linkage to the polyhedron envelope.
One report suggested that the polyhedron envelope was composed
predominantly of carbohydrate (Minion et al., 1979). However, others
have shown that a protein is also a component of the polyhedron
envelope (Gombart et al., 1989a,b; Whitt and Manning, 1988). The
solubility properties of PEP suggest that the protein may be covalently
attached to the carbohydrate of the polyhedron envelope via a thiol-
glycosidic linkage. Linkages of this type have been observed before.11
For example, the erythrocyte membrane glycopeptide has a
triglucosylcyteine bond (Weiss et al., 1971) and in a glycopeptide
isolated from human urine, a digalactosylcysteine bond exists (Lote and
Weiss, 1971). It is possible that there are additional proteins associated
with the polyhedron envelope.
The precise function of the polyhedron envelope is unknown.
Experimental evidence indicates that it contributes to the stability of
the occlusion bodies; in a recombinant AcMNPV with the p10 gene
deleted, the polyhedron envelope did not form properly. These
polyhedra were more fragile to physical treatments than the wild type
polyhedra (Williams et al., 1989). An association between the PEP and
p10 has been demonstrated using two different size gold particles in
immunoelectron microscopy (Russell et al., 1991). PEP associates on
the edges of fibrillar structures that are composed of p10 (Russell et al.,
1991). The role of PEP and p10 in the formation of polyhedron
envelope was examined by constructing three recombinant viruses: a
p10 gene deleted virus, a PEP gene deleted virus, and a virus where
both genes are deleted. The effects of deleting the PEP and p10 genes
were examined using immunoelectron microscopy. The results are
presented in detail in Chapter 6.
p10 is one of two known very late hyperexpressed genes. The
p10 genes have been characterized in AcMNPV (Kuzio et al., 1984) and
in OpMNPV and have 41% amino acid identity (Leisy et al., 1986b).
The p10 protein is a component of fibrillar structures that form both in
the cytoplasm and in the nucleus (van der Wilk et al., 1987; Williams
et al., 1989; Russell et al., 1991). Although p10 is commonly found
associated with polyhedra (Quant-Russell et al., 1987), it is not clear if
p10 has a structural role in the polyhedra or if p10 is simply trapped
during occlusion.
The association of p74 with polyhedra is based on the
observation that an AcMNPV p74 mutant in which p74 is inactivated
is capable of replicating in cell culture, but occluded virus produced in
cell culture are not infectious when ingested by insects (Kuzio et12
al.,1989). In cell culture, this mutant produced occlusion bodies that
contained nucleocapsids but had a poorly defined polyhedron envelope
(Kuzio et al., 1989). This result is reminscent of the virulent p10
deletion mutant of Williams et al. (1989) where the polyhedron
envelope was not properly attached to the polyhedra. Kuzio et al.
(1989) speculate that the p74 protein processes and/or modifies viral
proteins which are not required for permissive growth in cell culture
but which are essential for pathogenesis in larvae. The p74 genes have
been located downstream of the p10 gene in both AcMNPV (Kuzio et
al., 1989) and OpMNPV (Leisy et al., 1986b). The p74 is not N-
glycosylated (Roberts, 1989). Transcription of the p74 gene occurs late
and has been mapped to the sequence TATTG that is different from the
consensus late promoter ATAAG (Kuzio et al., 1989).
Nagamine et al., (1991b) have sequenced a gene that encodes a 40
kDa structural protein of the nuclear polyhedrosis virus of Bombyx
mori (BmMNPV). A monoclonal antibody specific to the protein has
been shown it to be associated only with the polyhedron derived
virions by Western blot analysis (Nagamine et al., 1991a). A cellular
location of the protein has not yet been determined. Because the 40
kDa protein is only present in the PDV, it may be a PDV specific
component like the PDV envelope.
Regulation of Baculovirus Gene Expression
Transcriptional Classes and Levels of Regulation
There are currently three transcriptional classes defined in
nuclear polyhedrosis viruses: early, late, and very late genes
(Rohrmann, 1992). The NPV early genes have promoters that are
recognized by host cell RNA polymerase II and require no viral factors
for basal levels of transcription (Hoopes and Rohrmann, 1990; Huh and
Weaver, 1990). The NPV genes transcribed after the initiation of DNA
replication are classed as late genes. Late genes normally have a five
base pair late promoter/transcriptional start sequence: A/G/TTAAG.
These late promoters are found at variable distances upstream (15 to13
174 nucleotides) from the translational start codon. The late mRNAs
normally initiate at the T or A, positions 1 or 2, of the TAAG sequence.
Late genes are transcribed by an a-amanitin resistant RNA polymerase
(Grula et al., 1981; Fuchs et al., 1983; Huh and Weaver, 1990). The RNA
polymerase may be virally encoded or a modified cellular RNA
polymerase.Between the two very late hyperexpressed genes
(polyhedrin and p10) and the other late genes there appears to be no
difference in promoter structure although there is a higher rate of
transcription initiation from these promoters, and their mRNAs are
stable very late in infection. The reason(s) for these differences are
unknown. The transcriptional organization of NPVs has been
examined by many researchers and they have found no pattern in early
and late gene distribution.
Theoretically, genes can be regulated at the level of transcription
initiation or elongation, or post-transcriptionally during maturation
events such as 5' cap addition, addition of 3' poly (A) residues, or
splicing of the message. Post-transcriptional regulation of the genes
could also be influenced by mRNA transport from the nucleus to the
cytoplasm or by differential stability of mature mRNA. The expression
of genes can also be regulated at the level of translation or bya post-
translational mechanism.
Regulation at the transcriptional level ( i.e. initiation) has been
proposed to play a critical role in NPV gene expression (reviewed,
Friesen and Miller, 1986). The evidence for transcriptional regulation
include the following: 1) Various temporal classes of viral RNA have
been identified during viral infection. 2) The rapid synthesis ofvery
late proteins closely parallels the transcription of their RNAsover a
short period late in infection. This has been interpreted tomean that
transcription is the limiting factor. 3) Multiple overlapping transcripts
with common 3' termini have been shown to be sequentially
expressed. For example, in the multiple overlapping transcription
units, the shorter transcripts are expressed early and may be turned off
by the longer transcripts that are expressed late in infection. Multiple14
overlapping transcription units are common in NPVs and will be
discussed in the next section.
Splicing does not appear to play a critical role in the regulation of
NPV genes. Only one early gene (IE-1) in NPVs is known to undergo
splicing (Chisholm and Henner, 1988; Kovacs et al., 1991). To date,
little is known about other regulatory mechanisms thatmay be used by
NPVs. In Chapter 2 we have examined the overlapping transcriptional
unit of the PEP gene, and show that the long 3' flanking sequence may
play a role in mRNA stability.
Overlapping Transcription, Promoter Occlusion, and
Polycistronic mRNA's
A common transcriptional motif in nuclear polyhedrosis
viruses are overlapping transcriptional units (Gombart et al.,1989a;
Russell and Rohrmann, 1990b; Oellig et al., 1987; Friesen and Miller,
1987; Mainprize et al., 1986; Friesen and Miller, 1986; Friesen and
Miller, 1985; Lubbert and Doerfler, 1984). Two types have been
identified. The p10 and polyhedrin RNAs expressedvery late in
infection have their 3' ends of the RNAs extended (reviewed, Friesen
and Miller, 1986). The functional significance of the extended 3' ends is
not clear. An untested hypothesis is that the 3' extended ends may
increase the stability of the RNAs. A second type, involves multiple
RNA transcripts starting from several ORFs upstream havinga
common 3' termination site. For example, a series of ORFs in the PEP
gene region and p6.9 DNA binding protein gene region coterminate
(Gombart et al., 1989a; Russell and Rohrmann,1990b). The regulation
and functional significance of thecommon 3' cotermination in the
PEP gene region is the subject of Chapter 2. In the PEPgene region, I
also examined a possible transcriptional regulatory mechanism called
promoter occlusion.
Promoter occlusion and transcriptional interference describea
situation where RNA polymerases initiating at upstream promoters
interfere with the establishment and initiation of RNA polymeraseson15
downstream promoters. An analogy would be a car attempting to get
on a busy highway. Here the strength of the downstream promoter is
influenced by the upstream promoter. To determine whether
promoter occlusion takes place, the upstream promoter could be
destroyed by a mutation, allowing the full expression of the
downstream promoter. If there is an increased rate of transcription of
the mutant construct over the wild type, then promoter occlusion may
play a regulatory role on the downstream promoter. Overlapping
transcriptional units, in which multiple promoters transcribe in the
same direction, the upstream promoters could potentially regulate
downstream promoters by promoter occlusion. Promoter occlusion
has been documented in other systems, the human a-globin gene
(Proudfoot, 1986); Drosophila melanogaster alcohol dehydrogenase
gene (Corbin and Maniatis, 1989); ribosomal RNA transcription
(Bateman and Pau le, 1988); E. coli (Gay et al., 1986; Haus ler and
Somerville, 1979) and bacteriophage lambda (Adhya and Gottesman,
1982). In Chapter 2, I examine whether promoter occlusion has a
regulatory role in the polyhedron envelope protein gene region.
In NPVs, overlapping mRNAs having 3' coterminal ends have
the potential to encode more than one protein since each mRNA
commonly contains several open reading frames. mRNAs that
contain two or more translatable open reading frames are called
polycistronic mRNAs. Bacteria commonly produce polycistronic
mRNAs from which multiple gene products are translated. Bacterial
translational initiation takes place when the 30S ribosomal subunit
binds at the AUG start codon followed by the binding of the 50S
ribosomal subunit to form the translation complex. Recognition of the
start codon is facilitated by the upstream Shine-Dalgarno sequence that
is complementary to the 16S RNA. Bacteria are capable of translational
initiation at multiple sites on a polycistronic message because the
ribosomes can bind to internal sites on the mRNA.
In eukaryotes, translational initiation takes place when the 40S
ribosomal subunit binds at the capped 5' end of the mRNA. The 40S
ribosomal subunit requires interaction with 5' cap structure to bind16
efficiently (Shatkin, 1976). The 40S subunit is unable to bind circular
mRNAs (Kozak, 1979a; Konarska et al., 1981). After binding, the 40S
subunit translocates to the AUG start site where the 60S ribosomal
subunit joins to begin translation (Kozak 1979b; Kozak, 1980). Because
the 40S subunit depends on 5' cap structure interactions, most
eukaryotic mRNA's have a single open reading frame and a single
translational initiation site that is usually the AUG codon in closest
proximity to the 5' end (Kozak, 1978). Although polycistronic mRNA's
are known to occur in eukaryotes, most are of viral origin. The
Modified Scanning Model (MSM) is the most comprehensive model
for the regulation of translational initiation for monocistronic and
polycistronic eukaryotic mRNAs. The MSM states that the frequency
that a ribosome initiates or bypasses a specific AUG depends on the
sequence context surrounding the AUG. Counting the A of the AUG
as +1, the most important nucleotides are found in the -3 and +4
positions, with purines favored over pyrimidines in these sites
(ACCAUGG optimal sequence context) (Kozak, 1986b; Kozak, 1989). In
addition, evidence suggests that efficient reinitiation of translation can
occur at downstream AUG codons if translation from the upstream
AUG codon is terminated at least 50 nucleotides before or after the
downstream AUG (Peabody et al., 1986; ). Kozak (1987) has
hypothesized that ribosomes are unable to efficiently recognize
translational initiation signals located very dose to the 5' end of an
mRNA. In simian virus (SV40) and yeast, experimentation has shown
that short (6 to 21 nucleotides) 5' untranslated leader increase the
translation of the downstream open reading frames (Sedman et al.,
1990; van den Heuvel et al., 1989).
To date, there are several examples in eukaryotic systems in
which two or more open reading frames are translated froma single
polycistronic mRNA (Kozak, 1986a). In tobacco plants and maize
chloroplasts there are reports that a single polycistronic mRNAcan
encode two or more proteins (Angenon et al., 1989; Barkan, 1988). In
vesicular stomatitis virus (rhabdovirus), a bicistronic mRNA is present
which produces two proteins (Herman, 1986). Cauliflower mosaic
virus has been extensively studied and shown to have a polycistronic17
mRNA (Dixon and Hohn, 1984; Bonneville et al., 1989; Futterer and
Hohn, 1991). Papillomavirus, Epstein-Barr virus, and SV40 all are
reported to have polycistronic mRNAs (Barbosa and Wettstein, 1988;
Wang et al., 1987; Sedman et al.,1989; Dabrowski and Alwine, 1988). In
poliovirus, the 5' end of the mRNA is not capped and terminates in
pUp (Hewlett et al., 1976). An internal ribosome binding site in the 5'
untranslated region is responsible for the translation of the poliovirus
polycistronic mRNA (Pelletier and Sonenberg, 1988). These systems
may have cis elements in their mRNAs or in the translational
machinery (i.e.,factors that promote reinitiation or internal initiation)
that allow the translation of polycistronic messages.
Transcriptional mapping of HindIII-M fragment of OpMNPV
that was mentioned earlier showed that this region contained five
ORF's oriented in the same direction, expressed late in infection and
coterminated at a single site downstream of ORF 5 (Fig. 1.3). The
nucleotide distances between the 5' cap and the AUG of each the first 3
ORF's are: 15 nucleotides (ORF 1), 18 nucleotides (ORF 2), 45
nucleotides (ORF 3). The ORF 1 AUG sequence context is strong
(GXXAUGG) whereas the ORF 2 and ORF 3 is moderate (GXXAUGA).
Since the 40S ribosomal subunits protect approximately 60 bases of
RNA from nucleases (Kozak, 1978), the possibility exists that 5'
mRNAs from ORF's 1 and 2 may contribute to the translation of PEP.
In Chapter 2, I examine whether the 5' upstream mRNA's from PEP
gene region contributed to the synthesis of PEP.
mRNA Stability
When steady state mRNA levels change in a system due to
manipulations of DNA sequences, a transcriptional or post-
transcriptional mechanism may be involved. An example of a
transcriptional mechanism could be an altered rate of transcription.
An altered rate of transcription could be caused by the deletion of an
enhancer element or some other cis acting element which modulates
transcription initiation, elongation or termination. Examples of post-
transcriptional mechanisms include splicing, transport (nucleus to18
cytoplasm), or mRNA stability. Manipulation of sequences involved
in splicing or transport could alter the steady state mRNA levels. The
deletion of a specific sequence or reduction in the length of an mRNA
could cause difference in steady state mRNA levels by affecting its
stability. To prove, for example, that mRNA stability is a regulatory
mechanism for a given mRNA transcript, other transcriptional and
post-transcriptional mechanisms must be disproved.
In cells, differential mRNA stability is an important regulatory
mechanism. Cells are known to differentially regulate the turnover of
mRNAs, such that some mRNAs are more rapidly degraded than
others. For example, c-myc mRNA has a half life of less than 15
minutes, whereas I3-globin mRNA has a half life of greater than 24
hours in erythroid cells (Dani et al., 1984; Ross and Pizarro, 1983). The
same mRNA may also be differentially regulated under different
conditions. Several well studied examples include tubulin, histone,
and transferrin receptor mRNA (Gay et al., 1989; Pandy and Marzluff,
1987; Chan et al., 1989). Tubulin mRNA stability is regulated largely by
the intracellular tubulin conentration. Researchers have shown that
degradation of tubulin mRNA is translation dependent (Gay et al.,
1989). Two models have been proposed. In first, the interaction
between the free tubulin heterodimers and the emerging tubulin
polypeptide causes ribosome stalling, resulting in unprotectedgaps on
the mRNA that may be targets for endoribonucleases. In second
model, the free tubulin/polypeptide complex activates a specific
ribosome-bound nuclease. Another example is histone mRNAs,
which contain a stem-loop structure in the last 30 nucleotides at the 3'
end of the RNA that is necessary and sufficient for cell cycle regulation
of the mRNA (Pandy and Marzluff, 1987). The transferrin receptor
mediates the cellular uptake of iron by binding to transferrin, the iron-
containing ligand. In the presence of iron, the levels of the transferrin
receptor mRNAs are reduced.Cis acting elements have been mapped
to two separate 60 nucleotide stem-loop domains in the 3' noncoding
sequence (Chan et al., 1989). Gel-shift and UV-crosslinking
experiments have identified a cytoplasmic RNA binding protein with
specificity for these domains (Mullner et al., 1989). These three19
examples have illustrated how some cis elements in the mRNAmay
regulate mRNA stability.
In viruses, differential mRNA stability is also an important
regulatory mechanism. Efficient virus assembly requires properly
timed synthesis and appropriate quantities of each structural protein.
mRNA stability is a regulatory mechanism that could assure that the
appropriate quanitity of a structural protein is synthesized without
constitutive high level transcription of the gene. Viral infections can
influence the cytoplasmic stability of both host and viral mRNAs. In
herpes simplex virus (HSV), the virion host shutoff protein (vhsl)
functions to degrade host mRNAs and later in infection also degrades
the mRNAs of the a and 13 gene classes (Oroskar and Read, 1989). A
vhsl minus mutant virus showed no decline of the affected mRNA
classes (Oroskar and Read, 1989). In adenovirus, 5' leadersequences are
spliced onto most late messages. The late Ll mRNAs primarily have
additional 5' leader sequences spliced on, called i-leader, which codes
for a 13.6 kDa protein (Soloway and Shenk, 1990). Soloway and Shenk
have shown that mutation of the i-leader results in a substantial
increase in the half-life of the Ll message over the wild type mRNA(26
hours versus < 4 hours). When the viral mutantwas co-infected with
wild type virus (providing the i-leader protein in trans),no effect on
the mutant Ll mRNAs was observed (Soloway and Shenk, 1990). The
authors believe that the synthesis of i-leader protein leads to the
destabilization of the Li mRNAs by a mechanism linked to on-going
translation. The authors speculate that the i-leader induced
destabilization is used as a fine tuning mechanism to control levels of
the other proteins encoded by the Li mRNAs which have been shown
to play a role in the assembly of virions. No sequences have been
identifed in baculoviruses that playa role in mRNA stability. In
Chapter 2, I provide the first experimental evidence forsequences that
may play a role in mRNA stability in a nuclear polyhedrosis virus.Fusion
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CHAPTER 2
Analysis of the Role of 5' and 3' Flanking Sequenceson the Expression
of the Baculovirus Polyhedron Envelope Protein Gene
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Abstract
The baculovirus polyhedron envelope protein gene is the third
in a series of five open reading frames (ORFs1-5) oriented in the same
direction.Individual mRNAs initiate at conserved late gene
promoter/mRNA start site (A/GTAAG) elements located upstream of
each ORF and the mRNAs coterminate after the fifth ORF. To
examine the influence of the upstream promoter elements and the
extensive 3' flanking sequence on the expression of the polyhedron
envelope protein gene, the region was cloned into a phagemid vector
and a chloroamphenicol acetyl transferase (CAT) reporter gene was
inserted downstream of the translational start site of the polyhedron
envelope protein gene. A set of clones were then constructed in which
individual or combinations of the late promoter elements of ORFs 1, 2,
and 3 were destroyed. These plasmid constructs were transiently
assayed for CAT activity in Orgyia pseudotsugata multicapsid nuclear
polyhedrosis virus infected Lymantria dispar cells. Inactivation of the
late promoter element immediately 5' of the polyhedron envelope
protein gene led to a 97% decrease in CAT expression. Destruction of
the ORF 2 promoter resulted in a 29% increase in the CAT expression.
In contrast, inactivation of the ORF 1 promoter resulted inno increase
in CAT expression. A variety of deletions in the 3' flankingsequence
of the polyhedron envelope protein gene demonstrated that this region
greatly influenced both CAT activity and steady state levels of CAT
mRNA.26
Introduction
Nuclear polyhedrosis viruses (NPVs) are members of the
Baculoviridae, which are a family of viruses pathogenic for arthropods,
primarily insects of the orders Lepidoptera, Hymenoptera, and Diptera.
The large (88-160 kb) double-stranded supercoiled DNA genomes of
NPVs replicate in the host cell nucleus. NPVs are characterized by a
complex infection cycle that involves the production of two
structurally distinct virion phenotypes. The budded virus (BV)
phenotype, which is responsible for systemic infection within the
insect host and between tissue culture cells, consists of nucleocapsids
that acquire an envelope when they bud through the cytoplasmic
membrane which has been modified by a virally encoded protein(s). In
contrast, the polyhedra-derived virus (PDV) phenotype, acquire a de
novo-assembled envelope within the nucleus and become occluded in
polyhedron-shaped crystals called polyhera. Polyhedra are surrounded
by another structure called the polyhedron envelope or polyhedron
calyx and are stable in the environment until ingested by insect larvae.
A protein component of the baculovirus polyhedron envelope
(calyx) was originally identified in the Autographa californica
multicapsid NPV (Whitt and Manning, 1988) and subsequently the
gene encoding this protein was identified and sequenced in both the
Orgyia pseudotsugata multicapsid NPV (OpMNPV) (Gombart et al.,
1989a) and AcMNPV (Gombart et al., 1989a; Oellig et al., 1987). These
investigations indicated that in both OpMNPV and AcMNPV, the
polyhedron envelope protein (PEP) gene is located as the third of five
contiguous ORFs oriented in the same direction. Transcriptional
mapping of the region surrounding the PEP indicates that each ORF
initiates from within a consensus late promoter/transcription start
sequence (G/ATAAG) which results in an overlapping set of mRNAs
that coterminate downstream of the fifth ORF (Gombart et al., 1989b;
Oellig et al., 1987). The overlapping transcriptional pattern seen in the
PEP gene region is common in NPV's and has also been reported for
four ORFs including the p6.9 DNA binding protein gene (Russell and
Rohrmann, 1990b) and a variety of other regions of the AcMNPV27
genome (Lubbert and Doerfler, 1984; Friesen and Miller, 1985;
Mainprize et al., 1986).Although this pattern of transcriptional
organization is likely to be of major importance to the virus, the
influence of such an arrangment on gene expression has not been
examined. In this report, we describe investigations employing a series
of PEP gene promoter-CAT constructs that were designed to determine
the influence that transcription from the upstream ORFs (ORFs 1 and
2) and the 3' flanking sequences has on the expression of the PEP gene.28
Materials and Methods
Construction of promoter-CAT fusions
To construct PEP gene promoter-reporter fusions, we used a
pBlueScribe plasmid (pBS(-), Stratagene) containing the 3.3 kbp BamHI-
Hind III fragment of OpMNPV that contains the 5' region of the ORF 1
gene (Blissard and Rohrmann, 1991). This plasmid was digested with
Sst I and Hpa I to remove upstream sequences, blunt-ended with S1
nuclease to allow religation of the plasmid which now contained only
240 by of the ORF 1 5' flanking sequence. Into this plasmid the
OpMNPV Hind III M fragment (Gombart et al.,1989a) was cloned in the
proper orientation and the plasmid was named p1,2,PEP and contains
the complete promoter regions, reading frames and intact
polyadenylation signal for ORFs 1-5. A unique Barn HI site was
constructed in the p1,2,PEP plasmid by site-directed mutagenesis
(Kunkel et al., 1987) one codon after the translational start site of the
PEP gene. This converted the native sequence ATGACGCC to
ATGGATCC using an oligonucleotide with the following sequence:5'-
TACGTTGTTGTTGGGATCCATATTGTGTGATAT-3'. The modified
p1,2,PEP plasmid was digested with Bam HI, and a 797 by Bam HI
fragment containing the CAT ORF (Mackett et al., 1984) was inserted
resulting in a functional PEP promoter-CAT gene fusion (p1,2,PEPCAT)
(Fig. 2.1a). A p1,2,PEP plasmid containing the CAT ORF in the opposite
orientation was also constructed. The functional p1,2,PEPCAT plasmid
was used in site-directed mutagenesis to create a series of plasmids with
mutations in the late promoter element of the first, second, and third
(polyhedron envelope protein) open reading frames. A sequence
containing the late promoter element of ORF 1 (TGTAAG) was
changed to a Bc11 site (TGATCA ). The promoter of ORF 2 (ATAAGT)
was mutated to a Bgl II site (AGATCT). The polyhedron envelope
protein promoter (ATAAG) was changed to (ATGAA) (Fig. 2.2). An
additional T four bases upstream of the promoter was changed toan A
creating a Xho I site. The sequence of the oligonucleotides used for
these changes were ORF 1 (5'-CATGTCAATGTCCGTTGATCATTAG
GGCGGAGAAAG-3'); ORF 2 (5'-GGCTAAAA CAGATCTTGA29
GGCACACCAGG-3'); PEP (5'-AAG GATAATAATTCATCTC
TCGAGCGCGGGC-3').To verify the mutations, all constructs were
sequenced using [35S] dATP (NEN) and Taq polymerase (Promega) by
the dideoxy chain termination method of Sanger et al. (1977) as
modified by Toneguzzo et al. (1988) for double stranded DNA. An
additional clone (pPEPCAT) used in these investigations contains only
the late promoter element of the PEP and was produced by cloning the
Kpn-Hind III fragment of p1,2,PEPCAT in pBS(-).
3' exonuclease III deletions of the polyhedron envelope protein
gene region
For functional analysis of the downstream region of the
polyhedron envelope protein gene, the plasmid pPEPCAT was digested
with Sst I, treated with S1 nuclease to remove Sst I site in the
polylinker and then site-directed mutagenesis was used to create
unique Sst I and Xba I sites at 28 and 37 nucleotides, respectively,
downstream of the PEP translational start. The sequence of the
oligonucleotide used to create the Sst I and Xba I sites was (5'-
CGGCGTCGATCCACATCTAGACGCGAGCTCGAACATTACGTTG-3').
A series of 3' deletion subclones were generated from the modified
pPEPCAT plasmid using exonuclease III (Fig. 2.5) (Henikoff, 1987). Each
deletion clone was sequenced to determine the precise size of the
deletion using a primer specific for the 3' end of the CAT gene.
3' Sal I-Apa I deletions of the polyhedron envelope protein gene
region
In order to examine deletions specifically in the region between
ORF 4 and 5,four of exonudease III deletion clones (see Fig. 2.6)
located between the Sal I-Apa I fragment were digested with Barn HI
sites which removed the CAT insert. The Barn HI sites were filled in
using the Klenow fragment of DNA polymerase I, Xho I linkers were
ligated to the blunt ends and the plasmid DNA was transformed into E.
coil JM 83 cells. The Xho I-Hind DI fragments (containing the deleted 3'
flanking sequence) were removed from each clone and inserted into a30
Xho I/Hind III digested parental pPEPCAT plasmid that had been
modified by the insertion of an Xho I linker at the Sal I site in ORF 4.
These constructs resulted in a nested set of deletions between the Sal I
and Apa I restriction sites (Fig. 2.6).
Transfections and CAT assays
Lymantria dispar (Ld-652Y) cells were propagated in T-flasks
using TNM-FH medium (Summer and Smith, 1987) supplemented
with 10% fetal bovine serum. For assay of the transient expression of
CAT, 1.5 x 106 cells were seeded on 35-mm-diameter wells of a multi-
well tissue culture plate (Falcon). After allowing cells to attach, the
medium was removed from each well and replaced with 800 p.1 of
medium containing OpMNPV virus at a m.o.i. of 10. Cells were
incubated at 27 0C for 4 hours and then transfected with 20 1.1g of
plasmid DNA by calcium phosphate precipitation (Graham and Van
Der Eb, 1973) as modified for insect cells (Summers and Smith, 1987).
The medium was removed and replaced with a transfection buffer-
DNA mixture and incubated at 27 °C. After 4 hours, the transfection
mixture was replaced with fresh medium and incubated at 27 0C for 72
hours. For smaller constructs, equimolar amounts of DNA were used
and supplemented with pBS(-) vector DNA to bring the total DNA to
20 lig. In addition to promoter-reporter constructs, cells were also
transfected with two control plasmids: pBS(-) and pCAT, a plasmid
containing the CAT ORF (Mackett et al., 1984) but no viral sequences.
To assay for CAT activity, transfected cells were gently removed from
the wells with a rubber policeman, pelleted (3 mins, 4000xg),
resuspended in 50 p.1 of PBS (120 mM NaC1, 2.7 mM KC1, 10 mM
Na2HPO4, 1.8 mM KH2PO4 (pH 7.4)) and 5 mM EDTA, lysed by three
freeze-thaw cycles, and the cell debris was pelleted at 8000xg for 3 min.
CAT assays were performed on the supernatants by the two-phase fluor
diffusion assay method (Neumann et al, 1987). For each CAT assay, 80
lig of protein, as determined by Bradford protein assay (Bradford, 1976),
was used in a 250 pl reaction mixture containing 100 mM Tris (pH 7.8),
1 mM chloramphenicol, and 0.1 p.Ci [14C] acetyl coenzyme A
(4 mCi/mmol; New England Nuclear). Reactions were performed in31
miniscintillation vials and each reaction mixture was overlaid with 5
ml of Econofluor (New England Nuclear). Acetylation of
chloramphenicol was measured by direct scintillation counting at 3-6
hours after the start of the reaction. Reactions containing 0.05 and 0.1
units of CAT (Sigma) were prepared and used as positive controls to
confirm the linearity of the assay at the times sampled. For each
experiment, the counts per minute of acetylated chloroamphenicol
obtained from extracts of cells transfected with different constructs were
directly compared. To determine the degree of variability between
transfections, triplicate transfections were performed for each construct.
RNA isolation, primer extension analysis, and RNase
protection
For isolation of total cell RNA, six 35-mm-diameter wells of a
multi-well tissue culture plate were seeded with 1.5 x 106 cells/well for
each sample. Cells were infected and transfected as described above.
After 48 hr, the supernatant was removed and the plates containing the
cells were quick-frozen at -80 °C. To isolate total infected cell RNA,
the frozen cells were scraped from the plates immediately into a 250 ul
guanidinium isothiocyanate solution (4 M guanidinium
isothiocyanate, 0.1 M 2-mercaptoethanol, 5 mM sodium citrate pH 7.0,
and 0.5% sarcosyl) (Glisin et al, 1974). The extract produced from six
wells was added to a 15 ml centrifuge tube containing 0.6 g of CsCl,
sonicated for 30 sec to shear DNA, layered on a pad of 1.4 ml of 5.7 M
CsCI, 0.1 M EDTA, and centrifuged at 110,000 g for 16 hr. After
removing the supernatant and pad, the RNA pellets were resuspended
in 1X TES (10 mM Tris pH 7.5, 5 mM EDTA, 1% SDS), immediately
extracted with phenol/chloroform, and ethanol precipitated. For
primer extension assays, 75 j.tg of each RNA sample was annealed to a
5' end-labeled oligonucleotide complementary to the 5' end of the CAT
ORF and processed as described in Chapter 5. RNase protection
experiment using 50 1.1.g of RNA were performed as described by Gross
et al. (1987). Primer extension and RNase protection products were
electrophoresed on 8% polyacrylamide 7 M urea gels.32
Results
Analysis of the influence of the transcription of upstream ORFs
on the polyhedron envelope protein gene-CAT expression
In order to examine transcription of the polyhedron envelope
protein (PEP) gene region, a plasmid was constructed that contained all
five ORFs from this region. The ORF encoding the PEP gene (ORF 3)
was altered by site-directed mutagenesis that allowed fusion of the
chloroamphenicol acetyl transferase (CAT) reporter gene immediately
downstream of the ORF 3 ATG (Fig. 1.1). Using site-directed
mutagenesis, four mutants were produced from this parent construct
in which the promoters elements of ORF 1, ORF 2, ORF 1 and 2, and
ORF 3 (PEP) (Fig. 2.2, Fig. 2.3) were inactivated. A Kpn I-Hind III
subclone of p1,2,PEPCAT was also constructed that contains only the
PEP late promoter element (Fig. 2.3). To determine the influence of
these promoter mutations on the expression of the PEP-CAT gene,
plasmid DNAs (in triplicate) were transfected into OpMNPV infected
Lymantria dispar cells. After 72 hr p.i., extracts of the cells were assayed
for CAT activity. It was found that inactivation of the ORF 3 (PEP)
promoter element resulted in a 97% reduction in CAT activity (Fig. 2.3,
number 1 versus 6).Inactivation of the ORF 1 promoter element
showed little effect on CAT expression (Fig. 2.3, number 2). When the
ORF 2, or ORF 1+2 promoter elements were inactivated, an increase in
CAT expression of over 15-25% was evident (numbers 3 and 4).
Deletion of both ORF 1 and 2 promoter elements, a 35% elevation of
CAT expression was detected (number 5). Controls included the
parental constructs with CAT in the reverse orientation, the pCAT
plasmid alone, pBS, or infected cells thatwere not transfected (Fig. 2.3,
numbers 7-11) and showed no activity.
To determine if the PEP-CAT transcripts from the transfected
plasmid constructs initiated at the same position as the PEPgene in
vivo, total cell RNA was isolated, annealed to a CAT-specific
oligonucleotide, and extended with reverse transcriptase. All
constructs, with the exception of the plasmid that contained the PEP33
promoter mutation, initiated at the T of the ATAAG (Fig. 2.4, lanes 1-5)
indicating that mutation of upstream promoter elements did not
influence the mRNA initiation site of the PEP-CAT gene construct.
Total cell RNA from mock and infected, cells that were not transfected
were also isolated for use as controls. They showed no primer
extension products (Fig. 2.4, lanes 7 and 8) indicating the primer
extension products in the other lanes are specific for CAT RNA
transcribed from the transfected plasmids.
Analysis of the influence of the downstream untranslated
sequence on the polyhedron envelope protein gene-CAT
expression
To examine the influence of the 3' flanking sequence on PEP-
CAT gene expression, site-directed mutagensis was used to insert a
unique Sst I and Xba I restriction sites at 28 and 37 nucleotides,
respectively, downstream of the PEP translational start (ATG). A
nested set of unidirectional deletions were constructed and selected
deletions were isolated (Fig. 2.5). Plasmid DNA was transfected into
OpMNPV infected Lymantria dispar cells and assayed for CAT activity.
For each construct, three independent transfection experimentswere
performed. Although deletion 2 (373 bp) showed almost parental
levels of CAT activity, deletions of 43, 755, 914, and 1261 by showed
lower levels of activity (58-74%) (Fig. 2.5, numbers 1,3-5) relative to the
parent construct.There was a 40% reduction in activity between the
1261 and 1645 by deletions (number 6). Deletion of 2164 by resulted ina
construct that contained much of ORF 5 and the intact polyadenylation
signal. This plasmid showed background levels of CAT activity (Fig.
2.5, number 8). Controls included the parental construct with CAT in
reverse orientation, pCAT alone, pBS plasmid, and extracts from
infected cells that were not transfected. These controls showedno
significant levels of CAT expression (Fig. 2.5, numbers 10-13).
Because there was a major reduction (40%) in CAT activity from
the constructs with deletions between the Sal I and Apa I sites (nt 1261
to nt 1615), this region was examined in greater detail. Deletions34
through the Sal I-Apa I region were constructed (Fig. 2.6), transfected
into infected cells and the levels of CAT activity was measured.
Deletion of 54 and 412 by downstream of the Sal I site resulted in 33
and 46% reduction, respectively, in CAT activity (Fig. 2.6, numbers 1
and 2). More extensive deletions (733 and 957 bp) resulted in the
progressive reduction in CAT expression levels (numbers 3 and 4).
These experiments suggested that certain regions of the 3' flanking
sequence influenced CAT expression levels and as the deletions
became more extensive a progressive declined in CAT activity was
seen. To determine if this decline was sequence dependent, Sst I-Sma I
and Sma I-Apa I deletions were "repaired" by the adding of filler DNA
that were comprised of baculovirus DNA sequences lacking regulatory
elements, e.g. a 750 by Sau 3A fragment from the AcMNPV DNA
polymerase ORF (Tomalski et al., 1988) was used to replace (in both
orientation) the 914 by Sst I-Sma I deletion. The Sma I-Apa I deletion
was "repaired" by adding in both orientations a 1418 by sequence (Bgl II
to Sst I fragment) from the OpMNPV p87 ORF (Muller et al., 1990) and
the 750 by AcMNPV DNA polymerase fragment fused to a 515 by
sequence (the first Sal I fragment) from the OpMNPV p39 ORF
(Blissard et al., 1989) was also placed in the Sma I-Apa I deletion site.
The Sst I-Sma I deletion replaced by the DNA polymerase fragment in
either orientation showed no increase in CAT activity was observed
(data not shown, see appendix A2.3). In the Sma I-Apa I deletion
replaced with the p87 ORF in both orientations showed an increase
from 60% to 61% of parental CAT activity was observed (data not
shown). In contrast, in the Sma I-Apa I deletion repaired with p39 ORF
and DNA polymerase fragment, no increase in CAT activity was
observed (data not shown, see appendix A2.3). These results suggested
that loss in CAT activity was influenced by a specific sequence rather
than the length of the 3' flanking sequence.
RNAse protection assays
As the 3' flanking sequence was progressively deleted, a decline
in CAT activity was observed. To determine if the decline in CAT
activity was regulated at the translational or transcriptional level,35
RNase protection assays were conducted to determine whether steady
state levels of CAT RNA had declined in constructs with low levels of
CAT activity. From each construct, 50 lig total infected cell RNA was
assayed. The RNAs from infected cell and synthetic RNA standards
produced from 17 promoter or yeast RNA (digestion control) were
hybridized to a complementary radiolabeled CAT RNA probe (Fig.
2.7a). After hybridization, nonhybridized sequences were removed by
RNase digestion and the protected fragments resolved by gel
electrophoresis. RNA isolated from cells transfected with plasmids
that showed high levels of CAT activity, showed substantial levels of
protected CAT-specific RNA (parent plasmid and lanes 1, 2, 4, Fig. 2.7b).
However, CAT-specific RNA from constructs that showed greatly
reduced levels of CAT activity, were present at greatly reduced levels
(lanes 3,5-8, and 1-4 on the right Fig. 2.7b). These result indicated that
deletions in the 3' flanking sequence either resulted in a reduction in
the level of transcription of the PEP-CAT gene or, more likely, resulted
in unstable transcripts that were readily degraded.36
Discussion
Baculovirus genes are often arranged in the same orientation
and transcribed such that a series of overlapping transcripts are
produced each from an independent promoter but terminating at the
same location. In this study we examined the influence of 5' and 3'
regions on the expression of the polyhedron envelope protein gene
region which is the third of five ORFs demonstrating this
transcriptional pattern. It has been suggested that a transcriptional
regulatory mechanism called promoter occlusion might be involved in
the regulation of these regions (Friesen and Miller, 1985). In promoter
occlusion, an RNA polymerase complex that is initated at an upstream
promoter interferes with the transcriptional initiation of downstream
promoters. This presumably is caused by blocking the formation of
transcriptional complexes as the polymerase complex moves through
the downstream sequence. Promoter occlusion has been described in
other systems including the human a-globin gene (Proudfoot, 1986);
Drosophila melanogaster alcohol dehydrogenase gene (Corbin and
Maniatis, 1989); avian retroviruses (Cullen et al., 1984); ribosomal RNA
transcription (Bateman and Pau le, 1988); E. coli (Gay et al., 1986;
Haus ler and Sommerville, 1979) and in bacteriophage lambda (Adhya
and Gottesman, 1982). In these systems, promoter occlusion has been
demonstrated to profoundly affect the expression of downstream genes
resulting in reduction in expression levels of 3 to 30 fold. By
constructing a series of upstream promoter mutations, we have been
able to examine the influence of upstream transcriptional initiationon
the expression of PEP-CAT gene construct. These investigations
indicated that whereas mutation of the the most distant promoter had
no affect on expression levels of PEP-CAT expression, mutation of the
promoter immediately upstream or deletion of the two upstream
promoters caused a modest (at most 35%) increase in the PEP-CAT
expression level. Therefore, ifinitiation from upstream baculovirus
promoter elements occluded downstream promoters, it occurs at a
level far lower than the other examples of promoter occlusion cited
above. Factors reported to influence low levels of promoter occlusion
are a large distance to the the upstream promoter or a low natural level37
of transcription through the downstream promoter. For example, in
lambda, promoter occlusion of the downstream promoter was
inversely proportional to the distance between the two promoters and
was also shown to be dependent on the strength of the upstream
promoter (Adhya and Gottesman, 1982).
We also demonstrated that the PEP-CAT gene expression was
regulated almost exclusively by the PEP gene late promoter element.
When the PEP promoter was inactivated, CAT expression was almost
completely eliminated even though copies of the PEP-CAT ORF were
present on the mRNAs originating from the ORF 1 and ORF 2
promoter elements. Therefore, these overlapping mRNAs do not
appear to function as polycistronic messages. Although evidence
suggests that efficient reinitiation of translation occurs on eukaryotic
polycistronic messages if the spacing between the termination codon
and the next ATG was 50 nt or less (Peabody et al., 1986). Spacing
between ORF 2 termination and PEP-CAT translational start (ATG)was
42 nt, yet no evidence of substantial levels of reinitiation of translation
was evident. In addition, it has been shown in SV40 and yeast that
short (6 to 21 nt) 5' untranslated leader sequences increased the
translation of the downstream ORFs on polycistronic mRNA (Sedman
et al., 1990; van den Heuvel et al., 1989). This may be due to the 40S
ribosomal subunit, which protects approximately 60 bases of mRNA
from digestion with nucleases (Kozak and Shatkin, 1978)may be
sterically hindered by short 5' leader sequences and therefore efficiency
of initiation at the 5' ATG is reduced. Although the untranslated
leaders sequences for ORFs 1 (15 nt) and ORF 2 (18 nt)are short, the
phenomenon did not appear to occur in this system.
Evidence from these investigations suggests a compelling role
for the 3' flanking sequence in regulating the levels of expression of the
PEP gene. A pattern of decline in CAT activity was observed in
plasmids from which progressively larger segments of the flanking
sequence were deleted. Using RNase protection analysis, we were
unable to detect parental mRNA levels in cells transfected with 3'
deletion constructs that showed low levels of CAT activity. These data38
indicate that these sequences are likely to influence the rate of
transcription or the stability of the mRNA. However, post-
transcriptional events in which the reduced 3' flanking sequences
causes a reduction in stability in the nucleus, inefficient
nucleocytoplasmic transport, or inhibition of polyadenylationcan not
be ruled out. There are a number of examples in which 3' untranslated
sequences influence mRNA levels. In contrast to this report, in
human papillomavirus, a negative regulatory element located in the 3'
end of Ll RNA that when deleted has been shown to increase mRNA
stability (Kennedy et al., 1991). In the bovine papillomavirus late 3'
untranslated region, an element has been identified that if deleted
increases cytoplasmic polyadenylated RNA. This element acts before
the mature mRNA reaches the cytoplasm (Furth and Baker, 1991).
These data suggested that the element effects nuclear stability and/or
inhibition of polyadenylation or nuclear transport.39
Fig. 2.1 The polyhedron envelope protein gene region showing the
location of the CAT reporter gene. A restriction map of the polyhedron
envelope protein gene region is shown at the top of the diagram. A
Barn HI site was mutated downstream of the PEP gene ATG for
insertion of the CAT reporter gene. The location and direction of ORFs
1-5 (ORF 3 is PEP) and the location of the CAT gene is shown directly
below the restriction map. A transcriptional map of the polyhedron
envelope protein gene region previously determined by Gombart et al.
(1989b) is shown at the bottom of the diagram. The arrows
representing each transcript is preceded by a late promoter sequence.
Abbreviations: Apa, Apa I; Barn, Bam HI; Bgl, Bgl II; Hind, Hind III;
Hpa, Hpa I; Kpn, Kpn I; Sma, Sma I; and Sal, Sal I.HpaHind KpnBarn lam Sal
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Fig. 2.2 Mutation of the ORF 1, 2 and 3 promoter sequences. The line
below each sequence indicates the changes that were made in the
promoter sequence. The late promoter elements and mutations are
underlined. The translational start (ATG) of each ORF is also
underlined and the restriction site created to screen for the mutations
are indicated.ORF 1 TGTAAGACGGACATTGACGACATG
Bc1 I
TGATCAACGGACATTGACGACATG
ORF 2 ATAAGTGAAAATTTTAGCCATG
Bgl ll
AGATGTGAAAATTTIAGCCATG
ORF 3 CTCGTGAGATAAGTTA (36 bp) AATATGACGCC
Xho I
CTCGAGAGATGAATTA (36 bp) AATATGGATCC
Fig. 2.2
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Fig. 2.3 The effect of upstream promoter mutations on the levels of
CAT expression from a polyhedron envelope promoter-CAT gene
fusion. In the upper left is a map showing the three promoter
elements regulating the expression of ORFs 1, 2 and CAT. Directly
below this map is shown a series of schematic maps (numbered 1
through 6) indicating which of the promoter elements were
inactivated. To the right of each map is a bar graph showing the levels
of CAT activity corresponding to each construct. The results of a series
of controls (numbered 7 through 11) are shown on the lower part of the
bar graph. Controls include: the CAT reporter gene in the reverse
orientation in the parent clone (see map 1, this figure) and the deletion
done (see map 5, this figure); pCAT, pBS and infected cells (IC) that
were not transfected with plasmid DNA. Relative CAT activity is
indicated on the X axis as counts per minute (above background) of
14C-acetylated chloroamphenicol. Error barsrepresent the standard
error detected from three transfections for each construct.Upstream Promoter Mutations
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Fig. 2.4 Primer extension analysis of transcripts from plasmid
constructs transfected into OpMNPV infected Lyman tria dispar cells.
Plasmid constructs (Fig. 2a) were used to transfect infected Ld cells and
total RNA was isolated and analyzed by primer extension analysis
using a 20-nt CAT primer (5'-CGGTGGTATATCCAGTGAT-3').
Numbers above lanes indicate: 1) parental construct; 2) ORF 1 promoter
mutation; 3) ORF 2 promoter mutation; 4) ORF 1 and 2 promoter
mutation; 5) ORF 1 and 2 5' sequences deleted; 6) PEP promoter
mutation; 7) uninfected cells; 8) infected cells. Size of primer extension
products were determined by comparison to a sequencing ladder
produced using the same CAT primer to sequence p1,2,PEPCAT
plasmid DNA. The primer extension products for the polyhedron
envelope protein late gene promoter are indicated on left by an arrow
that correspond to the T in the ATAAG.sae
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Fig. 2.5 The effect of deletions in the 3' flanking sequence on the levels
of CAT expression from a polyhedron envelope promoter-CAT gene
fusion. The left side of the figure shows the schematic representation
of the location and extent of each 3' deletion mutant. Below is shown a
scale indicating the position and number of base pairs deleted for each
mutation of the insert DNA. To the right of the constructs is a bar
graph showing the level of CAT expression from the corresponding
deletion mutant.The number to the left in parentheses is the deletion
size in base pairs. Controls include transfections with the wild type
construct with CAT reporter gene in the reverse orientation, pCAT,
pBS and infected cells (IC) that were not transfected. Relative CAT
activity is indicated on the X axis as counts per minute (above
background) of 14C-acetylated chloroamphenicol. Error bars represent
the standard error detected from three transfections.Xba
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Fig. 2.6 The effect of deletions from Sal I to Apa I on the levels of CAT
expression from a polyhedron envelope promoter-CAT gene fusion.
On the top left is shown a map of the parent construct. Below the
parent map are schematic maps showing regions deleted from a set of
deletion mutants. Below is shown a scale indicating the position and
number of base pairs deleted for each mutation of the insert DNA. To
the right of each map is shown a representation in a bar graph of the
level of CAT expression from each done. The number on the left in
parenthesis is the deletion size in base pairs. Controls and details are
the same as Fig. 2.5.Xba
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Fig 2.7 RNase protection analysis of the 3' deletion constructs. a)
Schematic diagram of the RNase protection assay. On the top is a map
showing the ORFs present in the parent construct. The region in
which the deletions were made is indicated. The dashed lines shows
the mRNA produced by the PEP-CAT promoter. The location of the
complementary CAT RNA used in the RNase protectionassay is
shown. b) CAT mRNA RNase protection assay. Lanes 1 through 8
correspond to the deletion construct 1 through 8 in Fig 2.5. Lanes 1
through 4 (to the right) correspond to the deletion constructs 1 through
4 in Fig. 2.6. The standard curve and controls are not shown.52
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Abstract
An open reading frame (ORF 1) located upstream of the
polyhedron envelope protein gene of the Orgyia pseudotsugata
multicapsid nuclear polyhedrosis virus (OpMNPV) was cloned in-
frame into a trpE expression vector. The fusion protein produced by
this construct was used for the preparation of a monospecific
antiserum. Western blot analysis of OpMNPV infected Lymantria
dispar cells and Autographa californica (AcMNPV) infected
Spodoptera frugiperda cells detected a 24 kDa protein in extracts from
cells late in infection. This antiserum also reacted with a 24 kDa
protein in preparations of budded and polyhedra derived virus from
OpMNPV and AcMNPV. Immunogold staining and electron
microscopy indicated that the OpMNPV p24 is associated with the
nucleocapsids of the budded and polyhedra derived viruses.55
Introduction
The Baculoviridae are a family of insect pathogens with large
double-stranded supercoiled DNA genomes of 88-163 kb. They are
characterized by a complex infection cycle in which nudeocapsids are
associated with two structurally distinct virion phenotypes. The
polyhedra-derived virus phenotype (PDV) consists of nucleocapsids
that become enveloped in the cell nucleus by a de novo-assembled
membrane and then are occluded in polyhedron-shaped occlusion
bodies or polyhedra. Polyhedra are released upon the death of the
insect and thereby disseminate the virus between insects. The occluded
virions remain viable for extended periods in the environment. In
contrast, nudeocapsids associated with the budded virus (BV)
phenotype are not occluded. After assembling in the nucleus, they are
transported to the cell surface where they derive their membrane by
budding through a virus-modified plasma membrane and disseminate
the infection from cell to cell within the host insect.
Although the PDV and BV phenotypes serve different functions
in the baculovirus infection cycle, the nucleocapsids appear to be
structurally similar. In addition to containing the genome and a
putative DNA binding protein of 6.5-7.5 kDa (Wilson et al., 1987;
Russell and Rohrmann, 1990b; Maeda et al., 1991), PDV and BV
nudeocapsids both appear to have at least two capsid-associated
proteins. The p39 protein is a major capsid component and has been
described from three NPVs (Blissard et al., 1989; Pearson et al., 1988;
Thiem and Miller, 1989; Bjornson and Rohrmann, 1992b). In addition,
another protein, p87, appears to be present in both AcMNPV and
OpMNPV capsids (Muller et al., 1990; Lu and Carstens, 1991). In
contrast, recent investigations by Kuzio et al. (1989), suggest that a
protein called p74 may be a specific component of PDV nucleocapsids
which is required for infectivity in insects but not cultured cells.
The protein p24 is encoded by the first open reading frame (ORF)
in a series of five late-expressed ORF's of the polyhedron envelope
protein gene region present in both the AcMNPV (Oellig et al., 1987,56
Whitford et al., 1989) and OpMNPV ( Gombart et al., 1989). In the E-
strain of AcMNPV, the p24 gene is interrupted by a transposable
element (Gombart et al., 1989a; Schetter et al., 1990) which has no
evident effect on the ability of the virus to replicate under laboratory
culture conditions. In addition, the gene has recently been sequenced
in the Lymantria dispar multicapsid nuclear polyhedrosis virus
(LdMNPV), and found to be lacking the amino terminal half of the
open reading frame. In contrast to AcMNPV and OpMNPV where p24
is a late-expressed gene, in LdMNPV p24 is preceded by an RNA
polymerase II promoter that is active in in vitro transcription systems,
suggesting it is expressed as an early gene (Bjornson and Rohrmann,
1992b).
In this report we describe investigations on the possible role of
the p24 gene in the infection cycle of the OpMNPV. This was
accomplished by the production of a monospecific antiserum against a
fusion protein that contained the complete p24 ORF. This antiserum
was used for both western blot analysis and immunocytochemical
localization of the protein using immunoelectron microscopy. These
data indicate that p24 is a capsid-associated component of both
phenotypes of AcMNPV and OpMNPV.57
Materials and Methods
Virus and insect cells
The cloned isolate of OpMNPV was described in Quant-Russell
et al. (1987). Lymantria dispar (Ld-652Y) cells were propagated in T-
flasks using TNM-FH media (Summers and Smith, 1987)
supplemented with 10% fetal bovine serum (FBS). For production of
the budded virus, Lyman tria dispar cells that had been adapted to
shaker culture (a gift from Stephan Weiss, Gibco Laboratories) were
grown in TNM-FH-10%FBS supplemented with 0.1% Pluronic-F68
(Gibco Laboratories). The AcMNPV E-2 strain was a gift from Dr
L.Volkman. The AcMNPV E strain was a gift from Dr. W. Doerfler.
Spodoptera frugiperda cells (Sf9 cells; ATTCC CRL 1711), obtained from
Gibco/BRL, were grown in TNM-FH-10%FBS. All TNM-FH media was
supplemented with penicillin G (50 units/m1), streptomycin (50
mg/ml, Whittaker Bioproducts), and fungizone (amphotericin B, 375
ng/ml, Flow Laboratories).
Purification of virus
For studies involving infected cells or budded virus, cells were infected
with OpMNPV BV at a multiplicity of infection (moi) of 10 following the
procedures of Bradford et al. (1990) unless otherwise indicated. For Western
blot analysis, budded virus was isolated from two 150 ml shaker cultures of
OpMNPV-infected L. dispar cells and AcMNPV-infected Spodoptera
frugiperda cells at 72 hrs.p.i.. After low speed centrifugation to remove cell
debris (2,000xg for 10 min), the supernatant was centrifuged at 80,000xg for 30
min. This pellet was resuspended in 3 ml of TE [10 mM Tris (pH 7.5), 1 mM
EDTA] and further purified by centrifugation through a 38-52 % sucrose
gradient at 80,000xg for 2 hrs. at 4 °C. The virion band was then removed,
diluted in TE, and sedimented at 80,000xg for 1 hr to remove the sucrose.
Viral occlusion bodies were isolated from infected Orgyia pseudotsugata
larval cadavers as previously described (Rohrmann et al., 1978).58
Construction of the trpE-p24 gene fusion
As part of another study (see Chapter 2), a plasmid (pBlueScribe
pBS, Stratagene) containing the ORF 1 gene region was modified by
changing the ORF 1 late promoter element from GTAAG to GATCA
creating a Bcl I site 17 nt upstream of the ORF 1 translational start site
by site directed mutagenesis. This pBS plasmid was maintained in a
dam- GM119 E. coli strain. A 683 base pair Bd I-Pst I fragment
containing the complete ORF1 gene was isolated and subcloned into
the trpE expression vector pATH 11 (Koerner et. al, 1991) cut with Barn
HI and Pst I (Fig. 3.1b). This resulted in a fusion protein of 58 kDa ( 37
kDa from trpE and 24 kDa from ORF 1) (Fig. 3.1c).
The trpE-p24 fusion protein: expression, isolation, and antibody
production
To express the trpE-p24 fusion protein, cultures of Escherichia
coli HB101 containing the trpE-p24 gene fusion plasmid were grown in
modified M9 medium as described previously (Gross and Rohrmann,
1990). For isolation of fusion protein, bacteria from a 100 ml culture
were harvested and then resuspended in 3 ml of 2 X SDS-PAGE buffer
[0.125 M Tris (pH 7.5), 4% SDS, 20% glycerol, 10% 13-mercaptoethanol,
0.002% Bromophenol blue] and boiled for 5 min. A 1.5 ml sample was
electrophoresed on a 20 cm long, 1.5 mm thick 10% SDS-
polyacrylamide gel in a Bio-Rad Protean II electrophoresis unit at 35
volts for 12-15 hrs. The fusion protein band was identified by cutting
three thin strips from the gel (one on each margin and one in the
center) and staining with Coomassie brilliant blue. The location of the
trpE-p24 fusion was determined and the band was excised from the
unstained gel and electroeluted overnight using a Schleicher and
Schuell Elutrap apparatus at 100 V. A New Zealand White female
rabbit was initially injected with approximately 500 pg [as determined
by Bradford protein assay (BioRad)] of fusion protein emulsified in
complete Freund's adjuvant. Subsequent injections of approximately
200 pg of fusion protein emulsified in incomplete Freund's adjuvant59
were given at biweekly intervals starting the third week after initial
injection. Immune serum was collected 7 days after the third boost.
Preimmune serum was collected before the initial injection.
Western blots
For analysis of the expression of the p24 protein in infected cells,
Lymantria dispar cells infected at moi 10 were collected at different
times post infection, lysed in 2X SDS-PAGE sample buffer (125 mM Tris
pH 6.8, 4% SDS, 10% 2-mercaptoethanol, 20% glycerol, and 0.002%
bromophenol blue) and an amount of protein equivalent to
approximately 4.8 X 104 cells per lane was electrophoresed on a 10%
SDS-polyacrylamide gel (Laemmli, 1970). Western blots were prepared
as previously described (Quant-Russell et al., 1987). The trpE-p24
antiserum was diluted 1:1000 in TBS-T (20 mM Tris (pH 7.5), 500 mM
NaCl, 0.05% Tween 20) and incubated on Western blots for 2 hours.
Blots were rinsed in three 10 mins washes of TBS-T and incubated 1-2
hours in a 1:7500 dilution of goat anti-mouse IgG conjugated with
alkaline phosphatase (Promega). Blots were rinsed three times for 10
mM in TBS-T. Immunoreactive proteins were detected by incubating
the blot in a substrate solution of 330 mg/m1 nitro blue tetrazolium
and 165 mg/ml 5-bromo-4-chloro-3 indolyl phosphate.
Immunoelectron microscopy
Lyman tria dispar cells were infected with OpMNPV at an m.o.i.
of 100. The cells were harvested at 84 hrs.p.i., fixed in 2.5%
glutaraldehyde, dehydrated with ethanol, and embedded in LR White
resin (Russell and Rohrmann, 1990a). The trpE-p24 antiserum was
used at a dilution of 1:1000. Immunogold labeling was carried out as
previously described using 10 nm gold particles (Russell and
Rohrmann, 1990a).60
Results and Discussion
Characterization of p24 expression
To investigate the expression of p24, an antiserum was generated
against the trpE-p24 fusion protein produced in a pATH 11 bacterial
expression plasmid (Fig. 3.1). The time course of expression was
initially examined using Western blot analysis of OpMNPV or
AcMNPV infected cell extracts from different times post infection. In
both OpMNPV and AcMNPV (E-2 strain) infected cells, p24 was first
detected at 24 hrs.p.i. and accumulated through 120 hrs.p.i., the last
timepoint assayed (Fig. 3.2a,b). These data are consistent with p24 being
expressed as a late gene in these viruses. To determine if p24 is
associated with a structural component of virions, preparations of BV
and occluded virus (OV) from OpMNPV and AcMNPVwere subjected
to Western blot analysis. This data indicates that p24 is present in
purified BV (Fig. 3.2c lane 1,3) and OV (lane 2,4) preparations from
OpMNPV and AcMNPV. Although the ORF 1 gene product showsan
apparent molecular weight of 24 kDa on Western blots, the molecular
weight predicted from the sequence is 21.2 kDa. To determine whether
p24 was N-glycosylated, budded virus was digested with N-glycanase
(Genzyme Corp.) according to the manufacturer's instructions. After
digestion, treated and untreated BV preparations were electrophoresed
on SDS-PAGE gels and Western blot analysis was performed using the
p24 antiserum and an antiserum to gp64 to detect a glycosylated control
(gp64) in the same samples. Although the gp64 proteinwas reduced in
size to about 55 kDa by digestion with N-glycanase, p24was unaffected
indicating that it is not N-glycosylated (data not shown). Similarly,no
evidence of N-glycosylation was found when viruswas grown in the
presence of tunicamycin (data not shown).
Immunoelectron microscopy of p24
Localization of p24 in OpMNPV infected L. dispar cellswas
examined by immunogold staining and electron microscopy. The p24
antiserum stained chromatin-like material around the margins of the61
nuclei of cells at 84 hrs. p.i. (Fig. 3.3a). In addition, it showed specific
staining of both non occluded and occluded nucleocapsids present in
the nucleus (Fig. 3.3a to d) and also nucleocapsids present in the
cytoplasm (Fig. 3.3d). No staining of cytoplasmic structures other than
virions was evident (Fig. 3.3d). The staining is randomly distributed
over the surface of the nucleocapsids suggesting p24 is a component of
the capsid rather than a specialized end structure. Neither uninfected
or infected cells showed significant staining with the trpE-p24 or anti-
trpE antisera, respectively (data not shown).
In this investigation of the localization of the p24 protein, we
have demonstrated that p24 is specifically associated with
nucleocapsids of both BV and PDV in AcMNPV and OpMNPV. These
data suggest that baculovirus capsids are composed of at least three
components; p39 (Blissard et al., 1989; Pearson et al., 1988; Thiem and
Miller, 1989), p87 (Muller et al., 1990; Lu and Carstens, 1991), and p24.
Although p24 was shown in this study to be highly specific to
baculovirus nucleocapsids, p24 is interrupted by a transposable element
in the E strain of AcMNPV (Gombart et al., 1989a; Oellig et al., 1987;
Schetter et al., 1990). Using trpE-SLP antiserum and Western blot
analysis the expression of the interrupted p24-ORF was not detected
(data not shown). In the CI 5-6 strain of LdMNPV the amino terminal
half of the p24 homologue is not present (Bjornson and Rohrmann,
1992b). These data suggest that a complete p24 ORF is not essential for
viability of these two virus strains. In addition, understanding the
possible role of the p24 protein is complicated by the observation that
the LdMNPV p24 gene appears to be regulated by an RNA polymerase
II (early) promoter element (Bjornson and Rohrmann, 1992b) rather
than being expressed as a late gene as observed in OpMNPV (Gombart
et al, 1989a). The implications of the variability of the structure and
expression of this gene remains to be elucidated.62
Fig. 3.1 Construction of a trpE-p24 gene fusion. a) Restriction map of
the p24 (ORF 1) region. b) Schematic diagram of the fusion of the trpE
protein to ORF 1 in the pATH 11 expression vector. c) Nucleotide
sequence at the fusion junction.a)
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Fig. 3.2 Western blot analysis of p24 in OpMNPV infected Lymantria
dispar cells, AcMNPV infected Spodoptera frugiperda cells and viral
phenotypes. a) Time course of p24 expression in OpMNPV infected
cells. b) Time course of p24 expression in AcMNPV infected cells. The
number on the top of each well indicates hours post infection when
proteins were isolated. Proteins from uninfected cells (U)are shown in
first lane. c) Western blot analysis of the p24 in OpMNPVor AcMNPV
budded and occluded viral phenotypes. Lanes: 1,3 Purified BV from
OpMNPV (OpBV), and AcMNPV (AcBV) respectively; 2,4 Polyhedra
from OpMNPV (OpOV) and AcMNPV (AcOV) respectively. Polyhedra
were solubilized in 2X sample buffer and boiled for 5 mins. The trpE-
p24 antiserum was used at a 1:1000 dilution. For all blots, sizes (kDa) of
the protein standards are indicated on the left and the location of the
p24 is indicated on the right.a)
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Fig. 3.3 Immunogold staining of OpMNPV infected Lymantria dispar
cells.a) nucleocapsids and chromatin-like material, b and c) occlusion
bodies, d) occlusion body in the nucleus and budded virus in the
cytoplasm. The p24 antiserum was diluted 1:2000 and the second
antibody was diluted 1: 20. All samples are from 84 hrs.p.i.. The scale:
1 cm is equal to a) 0.3 pm, b) 0.2 p.m, c) 0.3 pm, d) 0.2 p.m.a)
b)
Fig. 3.3
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Abstract
An open reading frame (ORF 2) located upstream of the
polyhedron envelope protein gene region of Orgyia pseudotsugata
multicapsid nuclear polyhedrosis virus (OpMNPV) was cloned in-
frame into a trpE gene fusion vector. The fusion protein produced by
this construct was used for the production of a monospecific
antiserum. Western blot analysis of OpMNPV infected Lymantria
dispar cells detected a 16 kDa protein at 24 hours post infection. The 16
kDa protein was determined to have N-glycosylation.
Immunofluorescence microscopy localized the 16 kDa protein to foci of
intense cytoplasmic staining near the nuclear membrane.
Immunogold staining and electron microscopy indicated that the 16
kDa protein was associated with the nuclear membrane, with lamellar-
like membranous structures peripheral to the nuclear membrane, and
with the envelopes of the budded virus in transit through the
cytoplasm. The 16 kDa protein was not associated with the purified
budded or polyhedra derived virus virions.73
Introduction
Nuclear polyhedrosis viruses (NPVs) are members of the
Baculoviridae, a family of large double-stranded DNA viruses with a
genome sizes of 88-160 kbp. They are pathogenic for arthropods,
primarily insects of the orders Lepidoptera, Hymenoptera, and Diptera.
NPVs replicate in the host cell nucleus and are characterized by the
occlusion of virions in polyhedron-shaped structures that are
composed predominantly of a single protein, polyhedrin, of about 29
kDa. The infection cycle of the Autographa californica multicapsid
NPV (AcMNPV) is complex and involves the production of two
structurally distinct virion phenotypes. The polyhedra-derived virus
phenotype (PDV) is the occluded form of the virus and has an
envelope that is assembled de novo in the cell nucleus. Upon
ingestion of polyhedra, the PDV are released when the polyhedra are
dissolved by the high pH of the insect midgut. The PDV invade and
undergo an initial round of replication in midgut cells and then spread
the infection to other cells throughout the insect. The virions that
spread the infection are not occluded and are called budded virus (BV).
Nucleocapsids destined to become budded virus, bud through the
nuclear membrane and temporarily acquire both the inner and outer
nuclear envelope. This double-membrane is then apparently lostas
the nucleocapsids are transported through the cytoplasm to the plasma
membrane (Granados and Lawler, 1981; Kawamoto et al., 1977b). The
nucleocapsids again acquire an envelope when they bud through the
cytoplasmic membrane that has been modified by a viral glycoprotein,
gp64.Although gp64 has been demonstrated to play an important role
in the life cycle, the role of other glycoproteins in the NPV life cycle has
not been well-documented. Recently Roberts (1989) reported that a 12
kDa protein (open reading frame (ORF) 2) is glycosylated in AcMNPV
to a MW of 16 kDa. ORF 2 is located in a series of 5 ORFs that are
oriented in the same direction at about map unit 81 in the AcMNPV
genome (Oellig et al, 1987). This region has also been sequenced in the
genome of the NPV of Orgyia pseudotsugata (OpMNPV) and ORF 2
shows 72% amino acid sequence identity between the AcMNPV and
OpMNPV making it one of the most highly conserved baculovirus74
ORFs (Gombart et al, 1989b). Roberts (1989) investigated gp16 in
AcMNPV infected Spodoptera frugiperda cells by immunofluorescence
microscopy, and found gp16 to be primarily localized to the cytoplasmic
perinuclear and nuclear membrane regions. In order to further
characterize the role of glycoproteins in the NPV infection cycle,we
have produced a monospecific antiserum toa trpE-ORF 2 fusion
protein. The antiserum was used to investigate the expression and
localization of the ORF 2 protein (gp16) in OpMNPV infected
Lymantria dispar cells.75
Materials and Methods
Cells and virus
The cloned isolate of OpMNPV was described in Quant-Russell
et al (1987). Lymantria dispar (Ld-652Y) cells were propagated in T-
flasks and using TNM-FH media (Summers and Smith, 1987)
supplemented with 10% fetal bovine serum (FBS). For production of
budded virus, Lymantria dispar cells that had been adapted to shaker
culture (a gift from Stephan Weiss, Gibco laboratories) were grown in
TNM-FH-10% FBS supplemented with 0.1% Pluronic-F68 (Gibco
Laboratories).
Purification of virus
For studies involving infected cells or budded virus, cells were
infected with OpMNPV BV at a multiplicity of infection (moi) of 10
following the procedures of Bradford et al. (1990), unless otherwise
indicated. For Western blot analysis, BV was isolated from two 150 ml
shaker cultures of OpMNPV-infected L. dispar cells at 72 hrs.p.i.. After
low speed centrifugation to remove the cells (2000xg for 10 min), the
supernatant was centrifuged at 80,000xg for 30 min. This preparation
was resuspended in 3 ml of TE (10 mM Tris [pH 7.5], 1 mM EDTA).
Samples of this preparation were further purified by centrifugation
through a 38-52% sucrose gradient at 80,000xg for 2 hr at 4 oC, and the
virion band was removed, diluted in TE (10 mM Tris pH 7.5, 1 mM
EDTA), and sedimented at 80,000xg for 1 hr toremove sucrose. Viral
occlusion bodies were isolated from infected Orgyia pseudotsugata
larval cadavers as previously described (Rohrmann et al., 1978).
Construction of the trpE-gp16 gene fusion
For another study (see Chapter 2), a plasmid (pBlueScribepBS,
Stratagene) containing the ORF 2 gene regionwas modified at two
positions by site directed mutagenesis. The ORF 2 latepromoter was
changed from ATAAG to AGATC, which created at Bgl II site 18nt76
upstream of the ORF 2 translational start site and a Barn HI site was
positioned at the ORF 3 (polyhedron envelope protein) translational
start site (the sequence ATGACGCC was changed to ATGGATCC) (Fig.
4.1a). A 375 base pair Bgl II-Barn HI fragment was isolated and
subcloned into pBS cut with Barn HI. The Eco R1-Hind III insert from a
subclone with the 5' end of ORF 2 adjacent to the EcoRI site in the
polylinker was subcloned into the trpE expression vector pATH 3
(Koerner et al., 1991) (Fig. 4.1b). The result was trpE gene fusion
containing the complete ORF 2 gene (Fig. 4.1c).
The trpE-gp16 fusion protein: expression, isolation, and
antibody production
To express the trp E-gp16 fusion protein, cultures of Escherichia
coli HB101 carrying the plasmid containing the trpE-gp16 gene fusion
were grown in modified M9 medium as described previously (Gross
and Rohrmann, 1990). For isolation of fusion protein, bacteria from a
100 ml culture were resuspended in 3 ml of 2 X SDS-PAGE buffer (0.125
M Tris (pH 7.5), 4% SDS, 20% glycerol, 10% (i-mercaptoethanol, 0.002%
Bromophenol blue) and boiled for 5 min. A 1.5 ml sample was
electrophoresed on a 20 cm long, 1.5 mm thick 10% SDS-
polyacrylamide gel in a Protean II (Bio-Rad) electrophoresis unit at 35
volts for 12-15 hr. The location of the fusion protein band was
identified by staining a portion of the gel with Coomassie brilliant blue,
the band was excised, and electroeluted at 100 V overnight by using a
Schleicher and Schuell Elutrap apparatus. A New Zealand White
female rabbit was initially injected with approximately 500 pg (as
determined by a Bradford protein assay [BioRad]) of fusion protein
emulsified in complete Freund's adjuvant followed by 200 gg
emulsified in incomplete Freund's adjuvant at biweekly intervals
starting the third week after initial injection. Immune serum was
collected 7 days after the third boost. Preimmune serum was collected
before the initial injection.77
Western Blots
For analysis of the expression of the gp16 protein, Lymantria
dispar cells from different times post infection (m.o.i. 10) were lysed in
2X SDS-PAGE sample buffer and an amount of protein equivalent to
approximately 4.8 X 104 cells was electrophoresed on each lane of a 10
% SDS-polyacrylamide gel (Laemmli, 1970). Western blots were
prepared as previously described (Quant-Russell et al., 1987). The trp E-
ORF 2 antiserum was diluted 1:1000 in TBS-T (20 mM Tris [pH 7.5], 500
mM NaCl, 0.05% Tween 20) and incubated on Western blots for 2
hours. Blots were rinsed in three 10 min washes of TBS-T and
incubated 1-2 hours in a 1:7500 dilution of goat anti-mouse IgG
conjugated with alkaline phosphatase (Promega). Immunoreactive
proteins were detected by incubating the blot in a substrate solution of
330 p.g/m1 nitro blue tetrazolium and 165 µg /m1 5-bromo-4-chloro-3
indolyl phosphate.
N-linked glycosylation assay
For the N-glycosylation studies, Lymantria dispar cells were
infected at an m.o.i. of 10 and subsequently grown in TNM-FH-10%
FBS medium containing 10 gg of tunicamycin per ml prepared froma
1mg/m1 stock in dimethyl sulfoxide. At 60 hrs.p.i. cellswere collected
and resuspended in electrophoresis sample buffer, separated by SDS-
PAGE and Western blot analysis was performed.
Immunofluorescence microscopy
Immunofluorescence microscopy studies of OpMNPV-infected
cells were performed as previously described (Pearson et al., 1988).
Cells were infected at an m.o.i. of 100 and harvested at 48 and 76
hrs.p.i.. The trpE-gp16 antiserum was used ata dilution of 1:1000 in
buffer A.78
Immunoelectron microscopy
Lymantria dispar cells were infected with OpMNPV at an m.o.i.
of 100. Immunogold labeling was carried out as previously described
using 10 nm gold particles (Russell and Rohrmann, 1990a). The cells
were harvested and fixed in 2.5% glutaraldehyde, dehydrated with
ethanol, and embedded in LR White resin. The trpE-gp16 antiserum
was used at a dilution of 1:1000.79
Results and Discussion
Characterization of gp16 expression and glycosylation
To study the expression of gp16, a specific antiserum was
generated against the trpE-gp16 fusion protein produced in a pATH 3
bacterial expression plasmid (Fig. 4.1). The expression of gp16 in
OpMNPV infected Lymantria dispar cells was investigated by reacting
Western blots of cell extracts from various times post infection with
trpE-gp16 antiserum. The gp16 was first detected at 24 hrs.p.i. and
increased through 120 hrs.p.i., the last time point assayed (Fig. 4.2a).
This data was consistent with gp16 being expressed as a late gene. The
transcriptional start site of gp16 has previously been mapped to the late
promoter sequence ATAAG (Gombart et al., 1989). To determine if
gp16 was associated with the structural components of virions,
preparations of BV and occluded (OV) from OpMNPV were subjected
to Western blot analysis. These data indicated that gp16 was not
present in purified BV and OV preparations (Fig. 4.2b lanes 1,2) but was
present in the infected cell control (lane 3).
The ORF 2 gene product has been shown to be N-glycosylated in
AcMNPV (Roberts, 1989). Broad ORF 2 bands were detected on
Western blots of OpMNPV infected cell extracts indicating that the
protein may be heterogeneous in size. To determine whether
OpMNPV gp16 was N-glycosylated, cells were infected in thepresence
of tunicamycin. At 60 hrs.p.i. extracts from cells treated with and
without tunicamycin were electrophoresed on SDS-PAGE gels and
Western blot analysis was performed. The untreated gp16 protein
(-Tun Fig. 4.2c) showed a slower mobility than the tunicamycin treated
gp16 protein (+Tun, Fig. 4.2c) indicating that gp16 is N-glycosylated.
From the predicted sequence (Gombart et al., 1989b) OpMNPV gp16 has
one N-glycosylation site this site is conserved in AcMNPV gp16.80
Immunofluorescence microscopy of gp16
To trace expression and location of the gp16 in infected L. dispar
cells, cells were examined by immunofluorescence microscopy using
the trpE-gp16 antiserum. At 48 and 76 hrs.p.i., the gp16 was
concentrated in foci of intense nuclear membrane staining and some
cytoplasmic staining (Fig. 4.3a, b). Only minimal staining of unifected
cells was observed (Fig. 4.3c). These immunofluorescence results
agreed with those reported in AcMNPV (Roberts, 1989) in which gp16
was primarily localized in cytoplasmic perinuclear and nuclear
membrane regions. Anti-trpE (an antiserum produced against the
non-fused truncated trpE protein) and preimmune serum controls
showed no staining of infected cells (data not shown).
Immunoelectron microscopy of gp16
To more precisely localize gp16 in OpMNPV infected Lymantria
dispar cells,cells were stained with immunogold and examined by
electron microscopy. At 48 hrs.p.i., gp16 was found to be associated
with aggregates of membrane-like structures located in the cytoplasm
near the nuclear membrane (Fig. 4.4a).It is unclear whether these
structures are generated by the viral infection or are a modification of
an existing cellular structure (e.g. endoplasmic reticulum), although
such structures are not observed in uninfected cells (data not shown).
At 72 hrs.p.i., gp16 was distributed along the nuclear membrane (Fig.
4.4b) and nucleocapsids appeared to be budding through the nuclear
membrane where it was associated with gp16 (Fig. 4.4b, d to e).
Nucleocapsids within envelopes containing gp16 were also observed in
the cytoplasm (Fig. 4.4c to e) at 72 and 84 hrs.p.i. These data indicate
that gp16 may be involved in the movement of nucleocapsids through
the nuclear membrane. Gp16 is also a component of the virions
present in the cytoplasm suggesting that gp16 may be involved in the
transit of virions to the cell surface. The absence of gp16 in virions that
have budded from the plasma membrane suggests that the gp16-
associated envelope observed at the nuclear membranewas lost during
the morphogenesis of the BV envelope.Neither uninfected or81
infected cells showed significant staining with the trpE-p24 or anti-trpE
antisera, respectively (data not shown).
In this investigation of the localization of the gp16 protein, we
have shown that gp16 was associated with cytoplasmic membrane-like
structures found in association with the nuclear membrane. gp16 was
also associated with the envelope of nucleocapsids after they budded
through the nuclear membrane.These results support previous
reports on NPV infection cycles, which have shown that nucleocapsids
destined to become budded virus bud through the nuclear membrane
and temporarily acquire both the inner and outer nuclear envelope
(Granados and Lawler, 1981; Kawamoto et al., 1977b). This double-
membrane is then apparently lost as the nucleocapsids are transported
through the cytoplasm to the plasma membrane. We have examined
purified preparations of BV by Western blot analysis and could not
detect gp16. This would be expected if the envelope is lost as the
nucleocapsid is transported to the cytoplasmic membrane.82
Fig. 4.1 Construction of a trpE-gp16 gene fusion. a) Restriction map of
the gp16 (ORF 2) region. b) The Bgl II-Bam HI fragment encoding the
gp16 ORF was initially cloned into pBS to obtain an EcoRI site in the
proper reading frame, then removed by digestion with EcoR I and Hind
Da and cloned into the pATH 3 expression vector. This resulted in a
fusion protein of 49 kDa ( 37 kDa from trpE and 12 kDa from ORF 2). c)
Nucleotide sequence at the fusion junction.a)
b)
c)
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Fig. 4.2 Western blots of a time course of infection and virion
phenotype of gp16. a) Western blot showing gp16 expression in
OpMNPV infected Lymantria dispar cells. The numbers at the top of
the wells indicates hours post infection. Proteins from uninfected cells
(U) are shown in the first lane. b) Western blot showing gp16was not
present in the purified preparation of BV and OV (lane 1 and 2) but was
present in the 60 hrs.p.i. infected cell control (IC, lane 3). The p24
protein was a positive control and present in both BV and OV (lane 1
and 2).c) Analysis of N-linked glycosylation of gp16 in OpMNPV
infected Lymantria dispar cells (see methods). The figure showsa
Western blot analysis of the gp16 treated without tunicamycin (-Tun)
and with tunicamycin (+Tun). Sizes (kDa) of the protein standardsare
indicated on the left and the location of gp16 is indicatedon the right.
The trpE-gp16 antiserum was diluted 1:1000.a) hrs. p. i.
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Fig. 4.3 Indirect immunofluorescence staining of OpMNPV infected
Lymantria dispar cells at various times p.i.. a) 48 hrs.p.i. b) 76 hrs.p.i.
c) Uninfected cells.a)
b)
Fig. 4.3
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Fig. 4.4 Immunogold staining of OpMNPV infected Lymantria dispar
cells at various times p.i..a) gp16 associated with membrane-like
structures near nuclear membrane (48 hrs.p.i.). b-d) gp16 associated
with membrane-like structure and the nuclear membrane (72 hrs.p.i.).
e) gp16 associated with membrane-like structure, nuclear membrane
and enveloped nucleocapsids in cytoplasm (84 hrs.p.i.). The trpE-gp16
was diluted 1:2000 and the second antibody was diluted 1:20. The scale:
1 cm is equal to a) 0.4 p.m b) 0.1 p.m c) 0.2 jam d) 0.1 pm e) 0.1 pm.a)
Fig. 4.4
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Abstract
The gene encoding the spheroidin-like protein of the Orgyia
pseudotsugata multicapsid nuclear polyhedrosis virus (OpMNPV) was
located and sequenced. It was found to have 62 and 37% amino acid
sequence identity with the spheroidin-like protein of the Autographa
californica MNPV and spheroidin of the Choristoneura biennis
entomopoxvirus, respectively. The mRNA start site of the OpMNPV
spheroidin-like protein gene was mapped within a late promoter
sequence (TTAAG). A trpE fusion protein containing 55% of the
OpMNPV spheroidin-like protein gene was used to generate a
monospecific antiserum.Western blot analysis of OpMNPV infected
Lymantria disparcells detected spheroidin-like protein expression
beginning at 24 hours post infection. Immunofluorescence microscopy
localized the spheroidin-like protein to intense foci surrounding the
nucleus. Immunogold staining and electron microscopy indicated that
the protein is concentrated in cytoplasmic inclusion bodies late in
infection. The OpMNPV spheroidin-like protein was not associated
with the polyhedron envelope of the occlusion bodies. In contrast, the
AcMNPV spheroidin-like protein was associated with the matrix of the
occlusion bodies and not with the polyhedron envelope.96
Introduction
Nuclear polyhedrosis viruses (NPVs) are members of the
Baculoviridae, a family of large double-stranded DNA viruses with a
genomes of 88-160 kbp. They are pathogenic for arthropods, primarily
insects of the orders Lepidoptera, Hymenoptera, and Diptera. NPVs
replicate in the host cell nucleus and are characterized by an infection
cycle that involves the production of two structurally distinct virion
phenotypes. The budded virus (BV) phenotype, is produced from
nucleocapsids which bud through and acquire their envelope from the
host plasma membrane which has been modified by at least one virally
encoded protein. Budded virus are responsible for the systemic
infection of the insect host. In contrast, polyhedra derived virus (PDV)
phenotype nucleocapsids are enveloped within the nucleus,
presumably by de novo synthesis, and are then occluded in
polyhedron-shaped crystals composed primarily of a protein called
polyhedrin.Polyhedra are surrounded by an electron dense structure
called the polyhedron envelope or polyhedron calyx. Polyhedra are
stable for extended periods in the environment and function to spread
the virus between insects.
Recently, Via lard et al., (1990) reported that the inclusion body
protein (called spheroidin) of an entomopoxvirus pathogenic for
Choristoneura biennis (CbEPV) shows over 39% amino acid sequence
identity with an open reading frame (ORF) from the Autographa
californica multicapsid nuclear polyhedrosis virus (AcMNPV) that
encodes a 37 kDa glycoprotein originally described by Wu and Miller
(1989). Using antibodies against the CbEPV spheroidin, in conjunction
with immunofluorescence microscopy and Western blot analysis,
Via lard et al reported that the spheroidin-like protein (SLP) of
AcMNPV appeared to be associated with the AcMNPV polyhedron
envelope.
In this report, we describe investigations on the SLP from a
related system. We located, sequenced, and transcriptionally mapped
the SLP gene from the NPV of Orgyia pseudotsugata (OpMNPV). In97
addition, a trpE-SLP fusion protein was constructed and used for the
production of a monospecific antiserum. This antiserum was used for
the characterization of the expression and immunocytochemical
localization of the SLP in OpMNPV infected Lymantria dispar cells.
Using the trpE-SLP antiserum we also localize SLP in AcMNPV
infected Spodoptera frugiperda cells.98
Materials and Methods
Virus, cells, and spheroidin antiserum
The cloned isolate of OpMNPV was described in Quant-Russell
et al. (1987). AcMNPV polyhedra were provided by John Kuzio.
Lymantria dispar (Ld-652Y) cells were propagated in T-flasks and using
TNM-FH media (Summers and Smith, 1987) supplemented with 10%
fetal bovine serum (FBS). For production of the budded virus,
Lymantria dispar cells that had been adapted to shaker culture (a gift
from Stephan Weiss, Gibco Laboratories) were grown in TNM-FH-
10%FBS supplemented with 0.1% Pluronic-F68 (Gibco Laboratories).
The CbEPV spheroidin antiserum was the gift of Jorge E. Via lard.
Purification of virus
For studies involving infected cells or budded virus, cells were
infected with OpMNPV BV at a multiplicity of infection (moi) of 10
following the procedures of Bradford et al. (1990) unless otherwise
indicated. For Western blot analysis, BV was isolated from two 150 ml
shaker cultures of OpMNPV-infected Lymantria dispar cells at 72
hrs.p.i.. After a low speed centrifugation to remove the cells (2000xg for
10 min), the supernatant was centrifuged at 80,000xg for 30 min. This
preparation was resuspended in 3 ml of TE (10 mM Tris (pH 7.5), 1 mM
EDTA) and is called the infected-cell supernatant in this report.
Samples of this preparation were further purified by centrifugation
through a 38-52% sucrose gradient at 80,000xg for 2 hr at 4 0C, the
virion band was removed, diluted in TE (10 mM Tris pH 7.5, 1 mM
EDTA), and sedimented at 80,000xg for 1 hr to removesucrose. Viral
occlusion bodies were isolated from infected Orgyia pseudotsugata
larval cadavers as previously described (Rohrmann et al., 1978).
Cloning and DNA sequencing
All cloning employed pBlueScribe (pBS) (Stratagene) maintained
in E. coli JM 83 cells using standard methods (Maniatis, 1982).Double-99
stranded plasmid DNAs were sequenced by using [35S] dATP and Taq
polymerase (Promega) by the dideoxy chain termination method of
Sanger et al. (1977) as modified by Toneguzzo et al. (1988). Exonuclease
III deletion mutants were produced by using the method of Henikoff
(1987). The SLP gene was sequenced in both directions.
RNA isolation and transcriptional mapping
Total Cell RNA for use in primer extension and S1 nuclease
analyses were isolated from OpMNPV infected Lymantria dispar cells
at various times post infection by a CsC1 centrifugation method similar
to Glisin et al. (1974) (for modifications see chapter 2). For
identification of the SLP transcription start sites, an 18-mer
oligonudeotide complementary to a sequence near the 5' end (nt 448 to
465, Fig 2) of the SLP open reading frame was synthesized and used for
primer extension analysis (Fig. 5.2). The synthetic oligonucleotide was
5' end-labeled as follows: To 100 ng of the primer was added 50 p.Ci [7-
32P]ATP ( 6000 Ci/mmol) (New England Nuclear), 2 p.1 of 10X kinase
buffer (500 mM Tris (pH 7.4), 100 mM MgC12, 50 mM DTT, 1 mM
spermidine), 7 units of T4 polynucleotide kinase, and incubated at 37
0C for 30 mM in a 20 pl volume. The labeled oligonudeotide (5 ng)
was annealed to 40 i.tg of total cell RNA at 50 0C for 45 min in a total
volume of 15 p.1 (10X annealing buffer: 2.5 M KC1 and 100 mM Tris, pH
8.3). To each annealing reaction, 24 p.1 H2O, 4.5 p.1 10 X primer
extension buffer [225 mM Tris, (pH 8.3), 400 mM KC1, 50 mM MgC12, 50
mM DTT, and 2.5 mM dNTP's] and 300 units M-MLV reverse
transcriptase (Bethesda Research Laboratories) was added and incubated
for 30 mM at 50 °C. Five pl of 3 M NaAc (pH 5.2) and 100 W of ethanol
were added and the nuclei acids precipitated at - 20 0C, resuspended in
6 gl of 0.1 M NaOH, 1 mM EDTA and incubated at 30 0C for 30 mM to
hydrolize the RNA. An equal volume of 95% formamide containing
0.05% bromophenol blue and 0.05% xylene cyanol dyes was added, the
solutions were heated at 80 0C for 3 mM, and electrophoresed on 8%
polyacrylamide, 7 M urea gels.For S1 nuclease mapping of the 3' end
of the SLP transcripts, 30 p.g of each RNA sample was annealed to a 3'100
end-labeled fragment. Annealing, hybridization, and S1 nuclease
digestion were performed as described by Favaloro et al. (1980).
SLP antibody production: construction, expression, and isolation
of the trpE-SLP fusion protein
The trpE-SLP gene fusion was constructed by digesting a plasmid
(pBlueScribepBS, Stratagene) containing 1.6 kb Kpn I-Pst I restriction
fragment (Fig. 5.1 ) with EcoR I and Hind In. The EcoR I-Hind III
fragment was subcloned into the trp E expression vector pATH 1
(Koerner et al., 1991) to construct an in-frame gene fusion containing
175 amino acids (---20 kDa) of the C-terminus of the SLP ORF.
Recombinant plasmids were transformed into HB101 and grown in
modified M9 medium as previously described (Gross and Rohrmann,
1990). For isolation of fusion protein, 100 ml cultures of bacteria was
centrifuged and resuspended in 3 ml of 2 X SDS-PAGE buffer (0.125 M
Tris (pH 7.5), 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.002%
Bromophenol blue) and boiled for 5 min. Half the sample (1.5 ml) was
electrophoresed on a 20 cm long 1.5 mm thick 10% SDS-polyacrylamide
gel in a Protean II (Bio-Rad) electrophoresis unit at 35 volts for 12-15
hours. The fusion protein band was identified by cutting three strips
out of the gel (one on each margin and one in the center) and staining
with Coomassie brilliant blue. The SLP fusion band was identified,
excised, and electroeluted at 100 V overnight using a Schleicher and
Schuell Elutrap apparatus.The amount of protein in the eluate was
determined by Bradford protein assay (BioRad). A New Zealand White
female rabbit was initially injected with approximately 500 .tg of fusion
protein emulsified in complete Freund's adjuvant. Subsequent
biweekly injections of approximately 200 pg of fusion protein
emulsified in incomplete Freund's adjuvant were given starting the
third week after initial injection. Immune serum was collected 7 days
after the third boost. Preimmune serum was collected before the initial
injection.101
Western blots analysis
For analyis of the expression of the SIT in infected cells,
Lyman tria dispar cells from different times post infection were lysed in
2X SDS-PAGE sample buffer and an amount of protein equivalent to
approximately 4.8 X 104 cells was electrophoresed on each lane of a 10%
SDS-polyacrylamide gel (Laemmli, 1970). Western blots were prepared
as previously described (Quant-Russell et al., 1987).The trpE-SLP
antiserum was diluted 1:1000 in TBS-T (20 mM Tris (pH 7.5), 500 mM
NaCl, 0.05% Tween 20) and incubated on Western blots for 2 hours.
Blots were rinsed in three 10 min washes of TBS-T and incubated 1-2
hours in a 1:7500 dilution of goat anti-mouse IgG conjugated with
alkaline phosphatase (Promega). Blots were rinsed (three times for 10
min) in TBS-T. Immunoreactive proteins were detected by incubating
the blot in a substrate solution of 330 gg/m1 nitro blue tetrazolium and
165µg /ml 5-bromo-4-chloro-3 indolyl phosphate.
N-linked glycosylation assay
To analyze for N-glycosylation, Lyman tria dispar cells were
infected at an m.o.i. of 10 and grown in TNM-FH-10% FBS medium
containing 10 gg of tunicamycin per ml prepared from a 1mg/m1 stock
in dimethyl sulfoxide. Cells were collected 60 hrs.p.i. in electrophoresis
sample buffer, separated by SDS-PAGE and Western blot analysis was
performed
Immunofluorescence microscopy
Immunofluorescence microscopy studies of OpMNPV-infected
cells were performed as previously described (Pearson et al., 1988). Cell
were infected at an m.o.i. of 100. The trpE-SLP antiserum wasused at a
dilution of 1:1000 in buffer A.102
Immunoelectron microscopy
Lyman tria dispar cells were infected with OpMNPV at an m.o.i.
of 100. The cells were harvested and fixed in 2.5% glutaraldehyde,
dehydrated with ethanol, and embedded in LR White resin (Russell
and Rohrmann, 1990a). The trpE-SLP antiserum was used at a
dilution of 1:2000. Immunogold staining was carried out as previously
described using 10 nm gold particles (Russell and Rohrmann, 1990a).103
Results
Nucleotide sequence of the OpMNPV SLP and similarity to
AcMNPV SLP and CbEPV spheroidin
The SLP gene of AcMNPV is located downstream of the DNA
polymerase gene (Wu and Miller, 1989). Because of the colinearity of
the OpMNPV and AcMNPV genome (Leisy et al., 1984), a region
downstream of the OpMNPV DNA polymerase gene was cloned and
sequenced. An ORF encoding the carboxy terminal 125 amino acids of
the DNA polymerase gene from (Fig. 5.2, nt 1 to 374) was shown to
have 54% amino acid sequence identity to the corresponding region of
the AcMNPV DNA polymerase gene. The complete SLP gene (Fig. 5.2,
401 to 1383 ) encoding a protein of 321 amino acids with a predicted
MW of 36.1 kDa, was identified immediately downstream of the DNA
polymerase gene. The OpMNPV SLP protein has 62.3% and 36.6%
amino acid sequence similarity with AcMNPV SLP and CbEPV
spheroidin protein, respectively (Fig. 5.3).Five conserved regions
previously identified by Via lard et al. (1990) are also conserved in the
OpMNPV SLP protein (Fig. 5.3) and except for region 2 show 80% or
greater identity between the three proteins.
Transcriptional mapping and temporal expression of the SLP
gene
To locate the transcriptional start site and the temporal
expression of mRNA from the SLP gene, a 5' end-labeled
oligonucleotide primer was annealed to total RNA isolated from
Lymantria dispar cells at various times p. i. and elongated with reverse
transcriptase. The size of the primer extension products were 58 and 59
nt as determined by comparison with a DNA sequencing ladder (Fig.
5.4). These products mapped to 13 and 14 nucleotides upstream of the
SLP open reading frame and were located at positions 3 and 4 (nt 407
and 408, Fig. 5.2) in the sequence, TTAAG. The earliest primer
extension products were detected at 24 hrs.p.i. and mRNA was present
to 72 hrs.p.i., the last time point assayed (Fig. 5.4).104
To map the 3' end of the SLP gene, S1 nuclease analyses were
performed using a 1.6 kb Xho I-Pst I fragment (Fig. 5.1) that overlaps the
3' end of the gene. The fragment was 3' end-labeled at the Xho I site
and annealed to RNA isolated from 36-72 hrs.p.i. (Fig. 5.5). The major
protected fragment was approximately 1.3 kb which indicates that the 3'
end of the gene is located approximately 890 nucleotides downstream
of the SLP translational termination and maps to a region not
sequenced (Fig. 5.1). Two other protected fragments were approximately
470 and 605 by were also detected (Fig. 5.5) that map to 60 and 190
nucleotides respectively downstream of the SLP translational
termination, a region not sequenced.
Characterization of SLP expression and N-linked glycosylation
To generate antibodies specific to the SLP, a gene fusion was
constructed in a pATH 1 bacterial expression plasmid (see methods)
(Fig. 5.2). The trpE-SLP fusion proteinwas induced, purified, and used
for antiserum production. The expression of the SLP in OpMNPV
infected Lymantria dispar cells was investigated by reacting Western
blots of cell extracts from various times post infection with trpE-SLP
antiserum. The SLP was first detected at 24 hrs.p.i. and increased
through 120 hrs.p.i., the last timepoint assayed (Fig. 5.6a). Preparations
of BV and occluded virus (OV) were also subject to Western blot
analysis. Although the SLP was present in material derived from
infected cell supernatants (lane 1, Fig. 5.6b), itwas not present in
sucrose gradient-purified BV or OV preparations (lanes 2 and 3, Fig.
5.6b). A positive control used in this analysiswas an antiserum against
virion associated protein, p24, which was observed in all three lanes.
An identical Western blot of the sucrose gradient purified OpMNPV
BV or OV preparations failed to react with the CbEPV spheroidin
antiserum described by Via lard et al, (1990) (data not shown).
Western blots of AcMNPV occlusion bodies produced in tissue
culture and a time course of extracts from AcMNPV infected
Spodoptera frugiperda cells were reacted with the trpE-SLP and105
spheroidin antisera. Both antisera identified bands of 32 kDa
(presumably the unglycosylated form of SLP), 37 kDa SLP (presumably
the glycosylated form) and an apparent SLP dimer of 61 kDa in both
occlusion bodies and infected cell extracts from 36 hrs. p.i. to 120 hrs.
p.i. the last time point assayed (data not shown). Although the cause of
the molecular weight difference between the monomer and dimer was
unclear, the suspected SLP dimer was always correlated with the
expression of the 37 kDa SLP monomer. In CbEPV, Western blots
using the spheroidin antiserum, demonstrated a similar dimer band
which was shown to be composed of the monomer by its partial
protease digestion pattern (Yuen et al., 1990). In OpMNPV, an SLP
dimer was not observed (Figs. 5.6a and b). To further examine the
location of SLP in AcMNPV preparations, occlusion bodies were
solubilized under several different conditions as described by Whitt
and Manning (1988). Initially AcMNPV polyhedra were dissolved in
dilute alkaline saline (DAS) and centrifuged at 12,000xg for 10 min.
This pellet contains polyhedron envelopes and entrapped virions. The
resulting pellet was resuspended in 100 pl of TE (10 mM Tris (pH 7.5), 1
mM EDTA) and incubated with 0.5% SDS or SDS plus 1% 2-
mercaptoethanol and then centrifuged at 12,000xg. SDS treatment
dissociates virions, but leaves the polyhedron envelope protein
component of the polyhedron envelope intact (Whitt and Manning,
1988; Gombart et al., 1989). The SDS plus 2-mercaptoethanol treatment
dissociates all components of the virions and polyhedron envelopes.
Western blot analysis indicated that the 37 kDa and 61 kDa SLP were
present in the DAS supernatant and pellet fractions, respectively. In
addition, the 61 kDa protein was present in the SDS and SDS/2-
mercaptoethanol supernatant fractions.If SLP behaves like the
polyhedron envelope protein, one would expect SLP to not be released
by the SDS treatment (data not shown). The appearance of the 37 kDa
SLP in the DAS supernatant suggests that the SLP is present in the
occlusion body matrix or in the PDV envelope region. We have
observed that alkali treatment also results in the removal of the PDV
envelope region (Russell and Rohrmann, 1990). In contrast, the 61 kDa
band required SDS for its release, which suggestsa different association
in the occlusion bodies.106
N-linked glycosylation of the OpSLP was examined by Western
blot analysis using the trpE-SLP antiserum and 60 hr.p.i. infected cell
extracts grown with and without tunicamycin. The faster mobility of
the tunicamycin treated SLP band (Fig. 5.6c, +Tun) when compared to
the untreated band (Fig. 5.6c, -Tun) indicates that OpMNPV SLP is N-
glycosylated.
Immunocytochemical localization of the SLP
Immunofluorescence microscopy studies were conducted using
the trpE-SLP antiserum to trace the expression and location of the SLP
in OpMNPV infected Lyman tria dispar cells. Anti-trpE (an antiserum
produced against the non fused truncated trpE protein) (Gombart et al.,
1989b) and preimmune serum controls showed no staining of infected
cells (data not shown). Although only minimal staining of uninfected
cells was observed (Fig. 5.7a). In 76 hrs. p.i. cells, the SLP was
concentrated in foci of intense cytoplasmic staining (Fig. 5.7b). This
staining also appeared to show a polar orientation such that one side of
the cells seemed to be distorted and stain relatively more intensely
than the rest of the cell.
To more precisely localize the SLP protein, OpMNPV-infected
Lymantria dispar cells were examined by immunogold staining and
electron microscopy. Intense staining of SLP was localized to
cytoplasmic inclusion bodies late in infection (Fig. 5.8a-b). These
inclusion bodies were normally located throughout the cytoplasm. No
significant staining of the polyhedra was seen at 84 hrs.p.i. (Fig. 5.8c) or
at other times in the infection. However, in AcMNPV infected
Spodoptera frugiperda cells the SLP protein was localized to occlusion
bodies by immunogold labeling using the trpE-SLP antiserum (Fig.
5.8d). The staining was found distributed throughout the occlusion
matrix and near the embedded virions. The AcMNPV polyhedron
envelope structure did not specifically stain. In AcMNPV, cytoplasmic
inclusion bodies similar to the ones seen in OpMNPV were found but
immunostained poorly (data not shown). Neither uninfected nor107
infected cells showed significant staining with trpE-SLP or anti-trpE
serum control antisera, respectively (data not shown).108
Discussion
The OpMNPV SLP gene is located downstream of the DNA
polymerase gene, which is the same location as the AcMNPV SLP gene
(Wu and Miller,1989). The predicted OpSLP amino acid sequence
shows 37% and 62% similarity with CbEPV spheroidin and AcMNPV
SLP, respectively. Strong conservation of the these genes was in the
core of the protein (73%), the N- and C- terminal regions(13 and 51
amino acids) demonstrated lower amounts of similarity (36% and
18%). The SLP of OpMNPV was shown to be N-glycosylated and the
amino acid sequence has one N-linked glycosylation site at amino acid
192, which is conserved amoung the three proteins (Fig. 5.3). The
spheroidin and AcMNPV SLP each has an additional N-linked
glycosylation site at amino acids 176 and 293, respectively (Fig. 5.3).
The 5' transcriptional start site was mapped within a late
promoter consensus sequence 13 and 14 nucleotides upstream of the
SLP ATG and mRNA specific to the SLP ORF was detected starting at 24
hrs.p.i. The SLP mRNA start site was located at the 3rd and 4th
nucleotides of TTAAG. Although late promoters most often have the
sequence A/GTAAG (Rohrmann, 1986), TTAAG has also beenreported
for the AcMNPV 35 K gene (Nissen and Friesen, 1989).In contrast to
OpMNPV SLP, the AcMNPV SLP 5' transcription start sites mapped to
two late promoter elements at 11 and 87 nucleotides (GTAAG and
ATAAG) upstream of the translational start site (Wu and Miller,1989).
The 3' transcription termination sites in OpMNPV were approximately
60, 190, and 890 nucleotides downstream of the translational
termination codon. In AcMNPV, three transcription termination sites
were also found approximately 30, 180, and 510 nucleotides
downstream of the translational termination codon (Wu and Miller,
1989).
Western blot analysis using a polyclonal antiserum produced
against a trpE-SLP fusion protein indicated that the SLP was expressed
by 24 hrs.p.i. and was not detected associated with the OpMNPV BV or
occlusion bodies (OB). These results differ from Via lard et al. (1990)109
who demonstrated the presence of the SLP in purified AcMNPV
occlusion bodies by Western blot analysis. We re-examined their
results by reacting the trpE-SLP and spheroidin antisera (provided by
Via lard) to Western blots of purified AcMNPV occlusion bodies. We
found that both antisera react with a 37 kDa SLP, which confirmed the
presence of the SLP associated with AcMNPV occlusion bodies as
reported by Via lard et al. (1990).
Immunofluorescence microscopy showed that SLP was
concentrated in foci of intense staining in the cytoplasm of OpMNPV
infected Lymantria dispar cells.Immunoelectron microscopy
demonstrated that the OpSLP, was highly concentrated in cytoplasmic
inclusion bodies late in infection. The almond moth (Cadra cautella)
and European fir budworm (Choristoneura murinana) infected with
NPV's have been reported to have cytoplasmic inclusions or protein
crystals (Adams and Wilcox, 1968; Huger and Kreig, 1968). Whether
these inclusion are composed of SLP is unknown. In contrast, in
AcMNPV SLP was located to the occlusion bodies matrix using the
trpE-SLP antiserum and immunoelectron microscopy. The reason for
the difference in SLP localization between the two viruses is unclear.
No evidence indicated that the SLP was associated with polyhedron
envelope structure of either OpMNPV or AcMNPV. Wu and Miller
(1989) reported that they were unable to delete the SLP gene from
AcMNPV genome which indicated an essential role in the infection
cycle.
Despite the difference in infection cycle and promoter structure
of the two types of virus (baculoviruses replicate in the nucleus
whereas entomopox virus replicate in the cytoplasm), it is intriguing to
speculate that the CbEPV speroidin gene was derived from a
coinfection with a baculovirus. While this theory is highly
speculative, it has recently been demonstrated that another entomopox
virus has a spheroidin gene completely different from the CbEPV gene.
This suggests that entomopox virus spheroidin may have an number
of independent lineages. This is in contrast to other genes identified in
entomopox viruses which are highly conserved with their110
homologues in orthopox viruses (Hall and Moyer, 1991; Banville et al.,
1992).111
Fig. 5.1 Location of the SLP gene on the OpMNPV genome. The Hind
III map of the OpMNPV genome is shown at the top and the positions
of cosmid clones 47,1,54,58, and 39 are indicated. The locations of the
polyhedrin (PH), DNA polymerase (DNA poly, p39 capsid protein
(capsid), budded virus envelope glycoprotein (gp64), polyhedron
envelope protein (PEP), and the p10 protein are shown below the Hind
III map. The expanded restriction map below the genome shows the
location of the SLP gene along with prominent restriction enzyme
sites. The location of the SLP mRNA is also indicated. The shaded box
indicates the area sequenced. The location of the open reading frame
encoding the SLP is shown in relation to the DNA polymerase gene.OpMNPV
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Fig. 5.2 Nucleotide sequence of the OpMNPV SLP gene region. The
amino acid sequence predicted from DNA polymerase (nt 1 to 374) and
SLP genes (nt 401 to 1383) is shown below the nucleotide sequence. The
location of the 18-mer oligonudeotide primer used for primer
extension analysis is shown above the sequence (primer) and the SLP
mRNA initiation site is indicated. The location of major restriction
sites including the Kpn I site used for the production of the SLP-trpE
gene fusion protein are indicated. Numbers to the right of the
sequence indicate the position of nucleotides and amino acids,
respectively.AAGCGTATCCGCTGCGTTTGTTCGACGCGCAAACCATGCGCATCAGTTGGCTCAAGCACATGACCATCTTAAACACTTTTATGAACGAGCTGCTAGAGATATTCGGGGACGAGCACAAGG 120 AYPLRLFDAETMRISWLKHMTILNTFMNELLEIFGDEHK
ACGCGCTGGCCGAGTGCTACAGCGCCATCCTCGAAAAGTACATGCAGCACCAAGCGTACGACAAAAAGCGCGCCGCGCTGGTCAAAATCGCCACGAAACGAAAGGCGCCCAGCGCGAGCG 240 D ALAECYSAILEKYMOHOAYDKKRAALVKIATKRKAPSAS
ACGCGTCCGGCAAACGCGCGCGCAAAGGGGCGGCGCCCAGCGACGACGAGAGCGGCTCCAGCGAGGACGAAGACGCGCCGTGCGAGCCCAAGTGCGCGAACAACACGTTCAAGTTTTGTC 360 D ASGKRARKGAAPSDDESGSSEDEDAPCEPKCANNTFKFC
al . .Primer .
TGTACAAAGCACAATAAACGCAGTCGTTACTCAATTGTGTATTATTAAGCGCCCCACAAAATGTACAAACTTTGCGCCGTCCTGTTTGCGCTGGCGGTGCCGGCGGTGCGCCCGCACGGC 480
LYKAQ MYKLCAVLFALAVPAVRPHG 20
TACCTGTCCACGCCCGTCGCCAGGCAGTACAAATGCTTTGCGGACGGCAACTTTTACTGGCCCGACAACGGCGACGGCGTTCCGGACGAGGCGTGCCGCAACGCGTACAAAAAAGTGTTC 600
YLSTPVARQYKCFADGNFYWPDNGDGVPDEACRNAYKKVF 60
CACCGATACCGCGCCGTGGGCGCGCCGCCGGGCGAAGCGGCCGCCGCGGCGCAGTACATGTTTCAGCAGTACGCCGAGTACGCGGCGGTGGCCGGCCCCAACTACCGCGACCTGGAACTG 720
HRYRAVGAPPGEAAAAAQYMFQQYAEYAAVAGPNYRDLEL 100
GTCAAGCGCGAAGTCCTGCCGCACACGCTGTGCGGCGCCGCGGCTAACGACCGCCACGCGCTGTTCGGCGACAAGAGCGGCATGGACGAGCCGTTCCACAACTGGCGGCCCGACGTGCTG 840 KREVLPHTLCGAAANDRHALFGDKSGMDEPFHNWRPDVL 140
.KpnI (trpE fusion site) .
TATGTGAACCGGTACCAGCGCGCGCATTCCTTCAACGTGCACTTTTGCCCCACGGCCGTGCACGAGCCCAGCTACTTCGAGGTGTACGTCACCAAGTTTACGTGGGACCGGCGCAGCCCC 960
YVNRYQRAHSFNVHFCPTAVHEPSYFEVYVTKFTWDRRSP 180
.XhoI SstI . . . Smal . . . . . .
GTCACGTGGAACGAGCTCOAQTACATCGGCGGCAACGGCTCGGGTCTGGTGCCGAACCCGGGCGACGCGTTTTGCGCCAGCGGGCAGCTTTACTCTATCCCCGTGTCGGTGCCGTACCGA 1080
TWNELEY IGGNGSGLVPNPGDAFCASGQLYS IPVSVPYR 220
CCGGGCCCGTTTGTCATGTACGTGCGCTGGCAGCGCATCGACCCCGTGGGCGAAGGCTTCTACAACTGCGCCGACCTCGTGTTCGGCACCGAGAACGACGAGTGCCGGTACGCGCGCGCC 1200
PGPFVMYVRWQR IDPVGEGFYNCADLVFGTENDECRYARA 260
GCCAAGGCCGTGCGCGACCAGCTGCGGCAACAAAACCTGTGCAATGATTGTGTTGAGGCGGGCCCCCAAGAATCGTGCGCGCCAACGCGCCCGCAACGGCGCGCCCACAATTATTTGCGC 1320
AKAVRDQLRQQNLCNDCVEAGPQESCAPTRPQRRAHNYLR 300
CGCGGCGGCGCGCACGACCAACAGGCCGACGGTGCCAGCGTGCGCGAGACCATTGACGAGTTGTGAGCGTCGGTGCGCCATTGATTATTGCCAAGTGAGTCGTGTTTAAAAAACGCG 1437
RGGAHDQQADGASVRET IDEL 321
Fig. 5.2115
Fig. 5.3 Comparison of the predicted amino acid sequence from
Choristoneura biennis EPV spheroidin, OpMNPV SLP, and AcMNPV
SLP genes. The double dots indicate identical amino acids with respect
to the OpSLP. Regions of high similarity identified by Via lard et al.
(1991) are underlined and specified by number. The N-linked
glycosylation sites for spheroidin (a.a. 176 and 196), OpSLP (a.a. 192),
and AcSLP (a.a. 193 and 293) are underlined.116
Spheroidin 1 MNKLILISL-IASLYOVEVDARGYMTFPIARQRRCSAAGGNWYPVGGGGIQDPMCRAAYQN
: . . . : : : : : : : :
OpMNPV 1 MYKL-CAVLF-A-LAVPAVRPHGYLSTPVARQYKCFADGNFYWPDNGDGVPDEACRNAYKK
AcMNPV 1 MIAL-LIALFAA-IHAPAVRSHGYLSVPTARQYKCFKDGNFYWPDNGDNIPDAACRNAYKS
Spheroidin61 VFNKVLNSNGGDVIDASEAANYMYTQDNEYAALAGPDYTNICHIQQRVVPSYLCAAGASDW
: : : : : : : : : :
OpMNPV59 VF-HRYRAVGAPPGEAAAAAQYMFQQYAEYAAVAGPNYRDLELVKREVLPHTLCGAAAND-
.
AcMNPV60 V-YYKYRALDLESGAAASTAQYMFQQYMEYAAVAGPNYDDFDLIKORVVPHTLCGAGSND-
1 2
Spheroidin122 SIRPFGDKSGMDLPGSWTPTIIQLSDNQQSNVVMELEFCPTAVHDPSYYEVYITNPSFNVY
::::::: :
OpMNPV118 RHALFGDKSGMDEPFHNWRPDVLYVDRYQRAHSFNVHFCPTAVHEPSYFEVYVT-KFTWDR
AcMNPV119 RNSVFGDKSGMDEPFNNWRPNTLYLNRYQPVYQMNVHFCPTAIHEPSYFEVFIT-KSNWDR
3 4
Spheroidin183 TDNVVWANLDLIYNNTVTLRPKLPESTCAANSMVYRFEVSIPVRPSQFVLYVRWQRIDPVG
: : : : : : : :
OpMNPV178 RSPVTWNELEYIGGNGSGLVP-NPGDAFCASGOLYSIPVSVPYRPGPFVMYVRWQRIDPVG
AcMNPV179 RNPITWNELEYIGGNDSNLIP-NPGDSLCDNSLVYSIPVVIPYRSNOFVMYVRWORIDPVG
5
Spheroidin244 EGFYNCVDMKFKYSEGPDEEDIIEPEYEVDNEAECFAYRTNSGNVNVNPLQENKYMAYANK
OpMNPV238 EGFYNCADLVF-GTE-NDECRYARAARAV-RDQLRQQNLCN-DCVEAGP-QE--SCA-PTR
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Fig. 5.4 5' transcriptional mapping of the SLP transcripts.
Transcription time course and location of the SLP transcription
initiation site was determined by primer extension analysis. A 5' end-
labeled oligonucleotide complementary to the 5' end of the SLP ORF
(see Fig. 5.2) was annealed to total RNA isolated at various hours p.i.
and elongated with reverse transcriptase. The size (nt) of the primer
extension products are indicated on the left. Sizes of primer extension
products were determined by alignment with a p1,2,PEPCAT sequence
ladder (the p1,2,PEPCAT clone is described in Gross and Rohrmann,
manuscript in prep.).118
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Fig. 5.5 3' transcriptional mapping of the SLP transcripts. The location
and transcription time course of the 3' ends of the SLP transcript was
determined by S1 nuclease protection. A 1.6 kb Xho I-Pst I fragment
was 3' end labeled with T4 DNA polymerase, hybridized to total RNA
isolated at various hours p. i. and digested with S1 nuclease. The size
of the S1 nuclease protected products are indicated on the left, as
determined by a labeled 1 kb ladder (BRL) and a Hae HI digested x174
ladder (New England Biolabs)hrs. p.i.
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Fig. 5.6 Western blot analysis of the SLP in OpMNPV infected
Lymantria dispar cells and viral phenotypes. a) Expression of SLP in
OpMNPV infected Lymantria dispar cells. The numbers on the top of
each lane indicate hours post infection. Uninfected cells are
represented by the letter U. b) Western blot analysis of the SLP in
purified OpMNPV budded and occluded viral phenotypes. Control
lane 1 infected cell supernatant (see purification of virus), lane 2
budded virus (BV), and lane 3 occluded virus (OV). c) Analysis of N-
linked glycosylation of SLP in infected Lymantria dispar cells (see
methods). The figure shows a Western blot analysis of the SLP treated
without tunicamycin ( -Tun) and with tunicamycin (+Tun). Sizes (kDa)
of the protein standards are indicated on the left and the SLP is
indicated on the right on all Western blots.a)
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.Fig. 5.7 Immunocytochemical localization of the SLP in OpMNPV
infected Lymantria dispar cells.a) Indirect immunofluorescence
staining of OpMNPV-infected Lymantria dispar cells at 76 hrs.p.i. b)
Indirect immunofluorescence staining of uninfected Lymantria dispar
cells. The antisera were diluted 1:1000.a)
b)
Fig. 5.7
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Fig. 5.8 Immunogold staining of OpMNPV infected Lymantria dispar
cells and AcMNPV infected Spodoptera frugiperda cells.a) Two SLP
inclusion bodies in the cytoplasm of an OpMNPV infected Lymantria
dispar cell (84 hrs.p.i.). b) SLP inclusion body in the cytoplasm of an
OpMNPV infected Lymantria dispar cell (72 hrs.p.i.).c) Two OpMNPV
occlusion bodies-immunogold labelled with anti-trpE-SLP. d)
AcMNPV occlusion body-immunogold labelled with anti-trpE-SLP.
The trpE-SLP antiserum was diluted 1:1000 (a) and 1:2000 (b-d). The
scale: 1 cm is equal to a) 0.2 p,M, b) 0.2 gM, c) 0.111M, d) 0.2 11M.a)
b)
Fig. 5.8
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CHAPTER 6
Analysis of Orgyia pseudotsugata Multicapsid Nuclear Polyhedrosis
Virus Mutants Lacking the p10 and Polyhedron Envelope Protein
genes.
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Abstract
To investigate the role of the p10 and polyhedron envelope
protein gene in polyhedron development, four deletion mutants were
constructed of the Orgyia pseudotsugata multicapsid nuclear
polyhedrosis virus. In the first two, the p10 gene was replaced with the
P-glucuronidase or the f3- galactosidase gene. In the third virus, the
polyhedon envelope protein gene was replaced with the 13-
glucuronidase gene. In the fourth virus, both p10 and the polyhedron
envelope protein genes were deleted and replaced with 13-galactosidase
and f3-glucuronidase genes, respectively. Insects were infected with
these recombinants and electron microscopy was used to examine
morphological effects caused by the deletion of these genes. In cells
from insects infected with the p10 minus virus, fibrillar structures were
not observed and the polyhedron envelope seen in the wild type
infection, was absent from polyhedron surfaces. However,
immunogold labeling showed that the polyhedron envelope protein
was localized around the polyhedra. In insects infected with the virus
lacking the polyhedron envelope protein, a distinct polyhedron
envelope was also not observed. However, immunogold labeling
showed that the p10- fibrillar structures were still present. In insects
infected with the recombinant lacking both the polyhedron envelope
protein and p10, the polyhedra were found to have a distinct cubic
morphology. In addition, the polyhedron envelope and the fibrillar
structures were not observed.132
Introduction
Nuclear polyhedrosis viruses (NPVs) are members of the
Baculoviridae,which are a family of viruses pathogenic for
arthropods, primarily insects of the orders Lepidoptera, Hymenoptera,
and Diptera. The large (88-160 kb) double-stranded supercoiled DNA
genomes of NPVs replicate in the host cell nucleus. NPVs are
characterized by a complex infection cycle that involves the production
of two structurally distinct virion phenotypes. The budded virus
phenotype (BV), consists of nucleocapsids that acquire their envelope
when they bud through the cytoplasmic membrane which has been
modified by at least one viral encoded protein. This phenotype is
responsible for systemic infection within the insect host. In contrast,
the polyhedra-derived virus phenotype (PDV), is occluded in infected
cell nuclei in polyhedron-shaped crystals composed primarily of a
protein called polyhedrin. These polyhedra are surrounded by another
envelope structure called the polyhedron envelope. The polyhedra are
stable in the environment until ingested by insect larvae and thereby
spreads the virus between insects.
A protein component of the baculovirus polyhedron envelope
(called the polyhedron envelope protein or polyhedron calyx) was
originally identified in the Autographa californica multicapsid NPV
(Whitt and Manning, 1988) and subsequently the gene encoding this
protein was identified and sequenced in both the Orgyia pseudotsugata
multicapsid NPV (OpMNPV) (Gombart et al., 1989a) and AcMNPV
(Gombart et al., 1989a; Oellig et al., 1987). Immunoelectron microscopy
has shown the polyhedron envelope protein (PEP) to be an integral
component of the polyhedron envelope (Russell and Rohrmann,
1990a; van Lent et al., 1990). In addition, PEP has been demonstrated to
be a component of 'electron dense spacer' which are formed at the
junctions of p10-containing fibrillar material (van Lent et al, 1990;
Russell and Rohrmann, 1990a). Deletion of the p10 gene results in the
absence of the fibrillar material and polyhedra lacking or with
fragmented polyhedron envelopes (Williams et al., 1989). In addition,
such polyhedra appear to be fragile and readily disintegrate (William et133
al., 1989). It has also been demonstrated that polyhedra produced in
vitro by an AcMNPV mutant lacking the PEP gene, did not have a
polyhedron envelope (Zuidema et al., 1989). These observations have
suggested that the proteins p10 and PEP interact and together play an
important role in polyhedron morphogenesis
In this report, we describe electron microscopic investigations of
insects infected with four recombinant OpMNPV's. In two of the
recombinant viruses, the p10 gene was replaced with either a 13-
galactosidase (lac Z) or P-glucuronidase (GUS) gene. The PEP gene was
replaced by a GUS gene in the third recombinant virus. The fourth
virus was a double recombinant expressing lac Z in place of the p10
gene and GUS in place of the PEP gene. In addition, we examined the
temporal expression of the p10 and PEP genes.134
Materials and Methods
Virus, insect cells lines, insects, and antisera
The cloned isolate of Orgyia pseudotsugata multicapsid nuclear
polyhedrosis virus (OpMNPV) was described in Quant-Russell et al. (1987).
Virus stocks were titrated by endpoint dilution assays as described by Bradford
et al. (1990). In case of titering the recombinant viruses, reporter gene activity
was used to detect the presence of virus as described below. Lymantria dispar
(Ld-652Y) cells were propagated in T-flasks and using TNM-FH media
(Summers and Smith, 1987) supplemented with 10% fetal bovine serum
(FBS). For production of budded virus, Lymantria dispar cells that had been
adapted to shaker culture (a gift from Stephan Weiss, Gibco Laboratories)
were grown in TNM-FH-10%FBS supplemented with 0.1% Pluronic-F68
(Gibco Laboratories). The Orgyia pseudotsugata fourth and fifth instar larvae
were kindly provided by USDA. The recombinant budded viruses were
injected into the insect larvae at approximately 50,000 TCIDailinsect. The p10
monoclonal antibody (Mab 210) and the polyhedron envelope protein
polyclonal antiserum were used as described by Quant-Russell et al. (1987) and
Gombart et al. (1989), respectively. The p39 monoclonal antibody (Mab 236)
and the p24 polyclonal antiserum were used as described by Pearson et al.
(1988) and Gross et al. (see Chapter 3), respectively.
Construction of p10 and polyhedron envelope protein gene
transfer vectors
To construct the p10 transfer vector a 2.4 kbp Hind III-Sal I from
Hind Ell Q was cloned into a pBlueScribe (pBS(-)) plasmid (Stratagene)
using standard methods (Sambrook et al.,1989). The p10 containing
plasmid was then digested with Xba I and Eco RI to remove restriction
sites from the polylinker. The digested plasmid was then blunt ended
with S1 nuclease religated and transformed in E. con JM 83 cells. Site-
directed mutagenesis was used to produce a unique Barn HI site three
codons after the translational start site of the p10 gene
(ATGTCCAAGCCC /ATGTCGGATCCC) by the method of Kunkel
(1987). The primer used to create the mutation was (5'-135
CTGCAATATCATC ATGTCGGATCCCAGCATTTTGACGC-3'). The
modified p10 plasmid was digested with Barn HI and Sst I. A 2.1 kbp
Bam HI-Sst I fragment containing the GUS gene was inserted, which
resulted in a functional p10 promoter-GUS gene fusion (Fig. 6.1a). To
construct a functional p10 promoter -lac Z gene fusion a 3899 by Barn
HI-SstI fragment which contained the lac Z gene was cloned into the
modified p10 plasmid (Fig. 6.1b).
To construct a polyhedron envelope protein (PEP) gene transfer
vector, we used a plasmid from another study (see Chapter 2) which
contained the entire PEP gene region. This plasmid had a unique Barn
HI site one codon after the PEP translational start site and a Sst I site at
the 11th PEP codon were produced by site directed mutagenesis (see
Chapter 2). The PEP construct was digested with Bam HI and Sst I and a
2.1 kbp Barn HI-Sst I fragment containing the GUS gene was inserted,
which resulted in a functional PEP promoter-GUS gene fusion (Fig.
6.1c).
Construction and purification of recombinant viruses, using 0
glucuronidase and I3-galactosidase assays
To construct mutants lacking the p10, polyhedron envelope
protein or both p10 and polyhedron envelope genes, Lymantria dispar
cells were seeded at 1.5 x 106 cells per well in six-well tissue culture
plates. Transfections of these cells using 1 pg of wild type OpMNPV
DNA and 2 pg of a transfer plasmid were performed as described by
Summers and Smith (1987). After 5 days, the supernatants containing
mixtures of wild type and recombinant virus were collected and
recombinant viruses were cloned by a limiting dilution protocol (Fung
et al., 1988) using either a 13-glucuronidase or 13-galactosidase activity to
identify a recombinant virus. 13-glucuronidase was assayed by the
method of Jefferson (1987) modified for small volumes. Supernatants
from the recombination experiment were serially diluted in 96-well
microtiter plates resulting in a final volume of 200 1.11/well. Samples
(120 111) were removed and stored 4 0C in a new plate. The remaining
80 IA was frozen and thawed once and 150 ml of 13-glucuronidase assay136
buffer (Jefferson,1987) was added and incubated for several hours at 37
0C and then scored for fluorescence on a long UV (365 nm)
transilluminator.
Cells infected with the recombinant virus containing the 3-
galactosidase gene were assayed for 13-galactosidase by the method of
Miller (1972) modified for small volumes. To 80 p.1 cell extracts
prepared as described above, and 120 1./1 of buffer Z (60 mM Na2HPO4,
40 mM NaH2PO4, 10 mM KC1, 1 mM MgSO4 and 0.27% 2-
mercaptoethanol) was added. After incubation at 37 0C for five min, 40
p.1 of 4 mg/ml o-nitrophenyl -13 -D- galactoside (ONPG) in 0.1 M NaPO4
(pH 7.0) was added and incubated at 37 0C for several hours.
After the recombinant viruses had been cloned by three rounds
of endpoint-dilution, 150 mls of Lyman tria dispar cells grown in shaker
flask were infected, budded virus was purified, viral DNA was isolated
(Summers and Smith, 1987). Restriction site analysis was performed to
confirm that correct recombination events had occurred and that the
virus stocks were pure.
Assay of reporter gene expression at various times post infection
To examine the expression of the reporter genes during a time
course of virus infection, Lymantria dispar cells (1.5 X106) were seeded
in 6-well tissue culture plates (Falcon) and allowed to attach for three
hours. Cells were infected at an m.o.i. of 10 with the appropriate
recombinant virus in 800 p.1 of medium for 1 hour. The medium was
removed and replaced by 1 ml of fresh medium. For each timepoint,
three independent wells were used. Cells were harvested at various
time post infection with a rubber policeman, transferred to microfuge
tubes and spun at 4000xg for three min. Supernatants were removed,
cell pellets were resuspended in 500 p.1 of PBS (120 mM NaC1, 2.7 mM
KC1, 10 mM Na2HPO4, 1.8 mM KH2PO4 (pH 7.4)) and frozen at -80 0C.
To assay for reporter gene activity, cells were lysed by one freeze-thaw
cycle, debris was pelleted and 5 p.1 of supernatant was transferred to a 24
well plate (Falcon). To the 5 IA, 595 p.1 of 37 0C GUS assay buffer137
(Jeffferson, 1987) was added quickly to all wells and incubated at 37 'DC
for 15 min. Three time points were taken every 15 min by removing
100 j.11 of the reaction mix and transferring it to a microfuge tube
containing 900 µl of 0.2 M Na2CO3. The quanitity of the fluorogenic
product from each time point was measured in a fluorimeter
(Jefferson, 1987).
Western blots analysis
To verify that the recombinant viruses did not express the
inactivated genes, Western blot analysis was performed. For analysis of
p10 and PEP expression, Lymantria dispar cells infected with the
recombinant viruses after 60 hrs.p.i. were lysed in 2X SDS-PAGE
sample buffer and an amount of protein equivalent to approximately
4.8 X 104 cells was electrophoresed on each lane of a 10% SDS-
polyacrylamide gel (Laemmli, 1970). Western blots were prepared as
previously described (Quant-Russell et al., 1987). The antisera were
diluted as follows: p39 (Mab 236) 1:7000; p10 (Mab 210) 1:5000; PEP 1:500
and p24 1:1000 in TBS-T (20 mM Tris (pH 7.5), 500 mM NaC1, 0.05%
Tween 20) and incubated on Western blots for 2 hours. Blots were
rinsed in three 10 min washes of TBS-T and incubated 1-2 hours in a
1:7500 dilution of goat anti-mouse IgG conjugated with alkaline
phosphatase (Promega). Blots were rinsed (three times for 10 min) in
TBS-T. Immunoreactive proteins were detected by incubating the blot
in a substrate solution of 330 mg/ml nitro blue tetrazolium and
165mg/m1 5-bromo-4-chloro-3 indolyl phosphate.
Electron Microscopy
Insects were injected with BV wild type or recombinant
OpMNPV at a 50,000 TCID50. Fat body tissue was dissected out after
incubation for 4 days and fixed in 2.5% glutaraldehyde, dehydrated with
ethanol, and embedded in LR White resin as previously described
(Russell and Rohrmann, 1990a). The p10 monoclonal antibody (Mab;
210) and the polyhedron envelope protein polyclonal antibody were
used at dilutions of 1:1000 and 1:2000, respectively. Immunogold138
labeling was carried out as previously described using 10 nm gold
particles (Russell and Rohrmann, 1990a).139
Results
Western blot analysis of wild type OpMNPV and recombinant
viruses
To verify that the p10 and polyhedron envelope proteins were
not expressed in the appropriate recombinant viruses, infected
Lymantria dispar cell extracts from 60 hrs.p.i. were subjected to
Western blot analysis. The p10-lac Z and p10-GUS recombinant viruses
showed no expression of the p10 protein (Fig. 6.2a, lanes 1 and 2
respectively). The double recombinant virus (p10-/ac Z and PEP-GUS)
showed no expression of either p10 protein (Fig. 6.2a,lane 3) or
polyhedron envelope protein (Fig. 6.2b, lane 1). The PEP-GUS
recombinant virus showed no expression of the polyhedron envelope
protein (Fig. 6.2b, lane 2). The wild type OpMNPV showed expression
of both p10 protein (Fig 6.2a, lane 4) and polyhedron envelope protein
(Fig 6.2b, lane 3). The p39-capsid monoclonal antibody (Mab 236) was
used as a positive control for the analysis of p10 protein expression (Fig.
6.2a, lanes 1-4). The p24 polyclonal antiserum (see Chapter 2) was used
as a positive control for the analysis of polyhedron envelope protein
expression (Fig. 6.2b, lane 1-3).
Temporal expression of the p10 and PEP genes
To examine temporal expression of the p10 and PEP genes,
Lymantria dispar cells were infected at an m.o.i. of 10 with the
appropriate recombinant virus and were assayed for GUS activity
various times post infection (see Methods). P10-GUS expression was
initially observed at 20 hrs.p.i. and reached maximum expression at 96
hrs.p.i. (Fig. 6.3). In contrast, the PEP promoter GUS gene fusion
activity from the double recombinant virus showed GUS expression
beginning at 28 hrs.p.i. and reaching a maximum at 96 hrs.p.i. (Fig. 6.3).
These results indicated that p10 expression began earlier and was
approximately 12 fold greater than PEP expression at 96 hrs.p.i.140
Orgyia pseudotsugata insect larvae infected with OpMNPV p10-
lac Z and OpMNPV p10-GUS recombinants
Electron microscopy was used to examine the cytopathological
and morpholgical effects caused by two recombinant virus which
lacked the p10 gene and instead expressed lac Z or GUS reporter genes.
No differences were evident between cells infected by these two virus.
Therefore the data presented was from the recombinant virus with the
p10 promoter-GUS gene fusion. No fibrillar structures were seen in
the cytoplasm or in the nucleus, but high concentrations of what
appeared to be microtubules were found in the same general locations
(Fig. 6.4b). The lack of the p10 protein appeared not to have affected the
shape of the polyhedra in infected insects (Fig. 6.4a). To determine the
location of PEP in recombinants lacking p10, an anti PEP antiserum
along with immunogold staining was employed. Intense immunogold
staining was localized to the surfaces near the polyhedra (Fig. 6.4 a,c).
This result indicated that p10 was not required for the transport or
localization of PEP to the polyhedra surface. A distinct polyhedron
envelope, however, was not observed in the recombinant (Fig. 6.4a,c)
as compared to the wild type (Fig. 6.6c). However, on the polyhedron
surface short patchy diffuse polyhedron envelope fragments were
attached and stained heavily with immunogold specific for PEP (Fig.
6.4a). At higher magnifications, the polyhedra showed a diffuse zone
that was different in texture from the internal part of the polyhedra
and it stained with the PEP antiserum (Fig. 6.4c).
Orgyia pseudotsugata insect larvae infected with OpMNPV PEP
deletion mutant
Insects infected with recombinant virus (PEP promoter-GUS
gene fusion) that lacked a functional PEP gene, were examined by
electron microscopy. The lack of PEP did not to affected the shape of
the polyhedra (Fig. 6.5a). The distinct polyhedron envelope structure
seen with the wild type (Fig. 6.6c) was never observed in the PEP-GUS
recombinant virus (Fig. 6.5a). The fibrillar structures were observed
(Fig. 6.5a,b) and immunogold labeling of the plO showed staining141
uniformly distributed throughout the fibrillar structures (Fig 6.5b).
These results indicted that PEP was an essential component in the
formation of the polyhedron envelope structure.
Orgyia pseudotsugata insect larvae infected with OpMNPV
double recombinant p10-lac Z and PEP-GUS
Insects infected with the double recombinant virus were
examined by electron microscopy for morphological changes. The
most striking feature was that the cross sections of polyhedra show
square or triangular profiles (Fig. 6.6a,b) as compared to wild type (Fig.
6.6c) This result indicated that double recombinant forms cubic
polyhedra. Fibrillar structures and polyhedron envelopes were not
observed in the double recombinant (Fig. 6.6a,b). Normal occlusion of
the virions was observed (Fig. 6.6a,b). Neither the p10 or PEP minus
virus showed a high frequency polyhedra with cubic morphology.
These data suggested that the lack of p10 and PEP influenced the shape
of the polyhedra.142
Discussion
In this report, we have shown that both p10 and PEP were
essential for the proper formation of the polyhedron envelope
structure in OpMNPV. In Autographa californica MNPV, the 51 N-
terminal amino acids of the p10 gene were fused to the 0-galactosidase
(lac Z) gene in a recombinant virus and examined in cell culture, and
the resulting polyhedra did not display a polyhedron envelope
structure (Williams et al., 1989). Another p10 minus recombinant
virus was examined in which the 65 of the 94 amino adds were deleted
from the C-terminal end of the p10 gene (Williams et al., 1989). This
virus showed polyhedra with a polyhedron envelope that was patchy
and not properly attached to the surface of the polyhedra (Williams et
al., 1989). We have shown by immunogold labeling that the PEP was
highly localized to the surface of the polyhedra in the recombinant
viruses that contain a p10 promoter GUS or lac Z gene fusions. These
results taken together would support the hypothesis that p10 plays a
direct or indirect role in the proper formation or attachment of the
polyhedron envelope structure rather than a transport function.
Orgyia pseudotsugata insect larvae infected with a OpMNPV
virus lacking a functional PEP gene and of expression the GUS gene
under the control of the PEP promoter showed no distinct polyhedron
envelope structure. An AcMNPV recombinant that expressed the lac Z
gene under the control of the PEP promoter also showed that
polyhedra produced from this virus in cell culture did not have a
polyhedron envelope (Zuidema et al., 1989; van Lent et al., 1990). An
initial report on the composition of the polyhedron envelope showed
that it consisted primarly of carbohydrates (Minion et al., 1979) but
more recent reports have indicated that the polyhedron envelope also
has a protein component (Gombart et al., 1989a,b; Whitt and Manning,
1988). The results presented here and those of others support the
hypothesis that the PEP is an essential component in the formation of
the polyhedron envelope structure.143
Polyhedra from Orgyia pseudotsugata insect larvae infected with
a OpMNPV double recombinant virus which contained a p10 promoter
lac Z and PEP promoter GUS gene fusions showed a striking cubic
morphology. This result suggested that the cubic polyhedra
morphology was caused by the lack of p10 and PEP. It is possible that
PEP and p10 somehow block the formation of crystalline lattice such
that cubic structures cannot form. However, there may be alternative
explanantions for this phenotype. For example, a mutation in the
polyhedrin gene that changes a leucine to a proline at amino acid 58
has been reported to cause a cubic morphology in the polyhedra
(Carstens et al., 1986). We are currently replacing the lac Z gene with
the p10 gene in the double recombinant. If the normal polyhedra
morphology is restored then the possibility that a mutation had
occurred in the polyhedrin gene or elsewhere in the genome will have
been rule out. A less likely second explanation for the cubic
morphology might be the co-expression of the two reporter genes in
the infected insect cell. This possibility may be examined when a
different double recombinant virus is constructed which expresses
these two reporter genes.144
Fig. 6.1 Maps of the transfer plasmids used for constructing the
recombinant viruses. The construction of this plasmid is described in
detail in the Methods. a) p10 promoter GUS gene fusion transfer
vector. b) p10 promoter Lac Z gene fusion transfer vector. c) PEP
promoter GUS gene fusion transfer vector. The solid bars represent the
pBS sequences; the stippled and cross-hatched bars represent p10 and
PEP flanking sequences respectively; the thin lines with the arrows at
the end represent the Lac Z and GUS reporter genes. The nucleotide
sequences of the cloning junctions are indicated.a) p10 -GUS transfer plasmid
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Fig. 6.2 Western blot analysis of wild type OpMNPV and recombinant
viruses. a) Western blot analysis using the p39 (Mab 236) and p10 (Mab
210) monoclonal antibodies. Total protein extracts from Lymantria
dispar cells infected 60 hr.p.i. with the appropriate recombinant and
wild type virus were blotted. The lanes contain: 1) p10 -Lac Z
recombinant virus 2) p10 -GUS recombinant virus 3) p10 -Lac Z and
PEP-GUS double recombinant virus 4) wild type OpMNPV infected
cell extracts. b) Western blot analysis using the PEP and p24 polyclonal
antisera. The lanes contain: 1) p10 -Lac Z and PEP-GUS double
recombinant virus 2) PEP-GUS recombinant virus 3) wild type
OpMNPV infected cell extracts.a)
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Fig. 6.3 Temporal expression of three recombinant viruses that
contained either a p10 promoter-GUS gene fusion or PEP-promoter
GUS gene fusion.Temporal expression of
p10 and PEP promoter-GUS gene fusions
(3 replicates)
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Fig. 6.4 Electron microscopy of cells from Orgyia pseudotsugata larvae
infected with OpMNPV p10 promoter-GUS gene fusion recombinant.
a) Occlusion body immunogold stained with PEP antiserum. b)
Microtubule-like structures c) Surface of an occlusion body at high
magnification. The PEP antiserum was diluted 1:2000. The scale: 1 cm
is equal to a) 0.2 p.m, b) 0.5 p.m, c) 0.1 p.m.a)
Fig. 6.4152
b)
c)
Fig. 6.4 continued153
Fig. 6.5 Electron microscopy of cells from Orgyia pseudotsugata larvae
infected with OpMNPV PEP-promoter GUS gene fusion recombinant.
a) Occlusion body and fibrillar structure b) Fibrillar structure
immungold stained with anti-p10. The p10 (Mab 210) antiserum was
diluted 1:1000. The scale: 1 cm is equal to a) 0.2 p.m, b) 0.2 pm.Fig. 6.5
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Fig. 6.6 Electron microscopy of cells from Orgyia pseudotsugata larvae
infected with OpMNPV double recombinant p10 promoter-Lac Z gene
fusion and PEP promoter-GUS gene fusion. a) infected fat bodies b)
recombinant occlusion body c) wild type occlusion bodies. The scale:
1 cm is equal to a) 17.0 .tin, b) 0.3 j.tm, c) 0.4 p.m.a)r 4 ),
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Appendix 1: Supplementary data for Chapter 2
Fig. A2.1 Relative CAT activity detected from the 3' restriction site
deletion constructs. These restriction site deletions were initially
constructed in attempt to localize the reduction in CAT activity. The 3'
deletion constructs were constructed in the pPEPCAT plasmid using
standard techniques. A restriction map of the polyhedron envelope
protein gene region is shown at the top left of the diagram. The
location and direction of ORFs 2-5 and the location of the CAT gene is
shown directly below the restriction map. The restriction
endonucleases used in the deletion constructs are indicated on the left.
The number in parentheses is the deletion size in base pairs. Relative
CAT activity is indicated on the X axis as counts per minute (above
background) of 14C-acetylated chloroamphenicol. Error bars represent
the standard error detected from three independent transfections. The
restriction site deletions had the following % CAT activity as compared
to the parent plasmid: Bgl II/Sma I A 85%; Sst I/Sma I A 74%; Sma
I/Apa I A 18%; Sal I A 5%; and Bgl II/Apa I A 4%.Krn Barn
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Fig. A2.2 Relative CAT activity detected from the 3' restriction site
deletion constructs in the p1,2,PEPCAT plasmid. In this experiment I
demonstrated that the reduction in CAT activity also occurred in the
construct with all five ORFs present. A restriction map of the
polyhedron envelope protein gene region is shown at the top of the
diagram. The location and direction of ORFs 1-5 and the location of
the CAT gene is shown directly below the restriction map. The
restriction endonucleases used in the deletion constructs are indicated
on the left. The number in parentheses is the deletion size in base
pairs. Relative CAT activity is indicated on the X axis as counts per
minute (above background) of 14C-acetylated chloroamphenicol. Error
bars represent the standard error detected from three independent
transfections. The CAT activty of the Bgl II/Sma I A was 104% and the
Sma I/Apa I A was 30% of the CAT activity of the parent plasmid.Xba
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Fig. A2.3 Relative CAT activity detected from rescue constructs. The
aim of this experiment was to differentiate between a length
dependency or a sequence dependency in the 3' flanking sequence. To
determine this the deletions were "repaired" by adding filler DNA that
was comprosed of baculovirus DNA sequences lacking regulatory
elements. The parent plasmid, deletion, and rescue constructs are
indicated on the Y axis. Relative CAT activity is indicated on the X axis
as counts per minute (above background) of 14C-acetylated
chloroamphenicol. Error bars represent the standard error detected
from three independent transfections. The deletion size for the Sst
I/Sma I D is 914 by and had 82% of the parental CAT activity. The
deletion size for the Sma I/Apa I D is 1250 by and had 13% of the
parental activity. The Sst I/Sma I deletion construct had a 750 by
fragment (Sau 3A fragment, Tomalski et al., 1988) of the AcMNPV
DNA polymerase ORF inserted into the deleted region in both
orientations. The result was no increase in CAT activity supporting a
hypothesis that the 3' flanking sequence was sequence dependent.
The Sma I/Apa I deletion construct had a 1418 by fragment (Bgl
II to Sst I fragment, Muller et al., 1990) of the p87 ORF inserted into the
deleted region in both orientations. The result was a 47% increase in
CAT activity which would support a hypothesis that there was some
length dependency. Alternatively, the p87 Bgl II to Sst I fragment may
contain uncharacterized sequences that were capable of rescuing the 3'
deletion constructs. The Sma I/Apa I deletion construct also had a 515
by fragment (the first Sal I fragment, Blissard et al., 1989) of the p39 ORF
inserted in the reverse orientation plus a 750 by fragment of the DNA
polymerase ORF inserted in the forward (or sense) orientation. This
construct showed no increase in CAT activity which supports the
sequence dependency hypothesis. These results indicated that the loss
in CAT activity was influenced by sequence rather than the length of
the 3' flanking sequence.Xba
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Fig. A2.4 Relative CAT activity detected from constructs used to
examine for the presence of an enhancer in the Sma I-Apa Ifragment.
The RNase protection analysis has shown that the decline inCAT
activity was caused by a reduction in the CAT specific RNA levels.
This result indicated that the effect was caused by either a
transcriptional or a post-transcriptional mechanism. The aim ofthis
experiment was to identify enhancer sequences in the 3' flanking
sequences. The constructs were constructed inthe pPEPCAT plasmid
using standard techniques.
A restriction map of the polyhedron envelope protein gene
region is shown at the top of the diagram. The location and direction
of ORFs 2-5 and the location of the CAT gene is shown directly below
the restriction map. The schematic representation of the constructs
used to test for enhancer activity are indicated to the left. Relative CAT
activity is indicated on the X axis as counts per minute (above
background) of 14C-acetylated chloroamphenicol. Error bars represent
the standard error detected from three transfections. The CAT activity
from each construct as compared to the parent plasmid were as follows:
Sma I-Apa I deltion 20%; Sma I-Apa I fragment reversed 75%; Sma I-
Apa I fragment 5' (upstream) and in the sense (forward) orientation of
the transcription unit 72%; Sma I-Apa I fragment 5' (upstream) and in
the anti-sense (reverse) orientation of the transcription unit 1%; An
additional Sma I-Apa I fragment 5' (upstream) and in the sense
(forward) orientation of the transcription unit 124%; and An additional
Sma I-Apa I fragment 5' (upstream) and in the anti-sense (reverse)
orientation of the transcription unit 105%. These results showed that
there was not an enhancer sequence present. However, these data
showed that there was orientation dependent and a position dependent
activating sequence(s) present in the 3' flanking sequence.Xba
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Appendix 2: DNA Mini-Prep Procedure
1. Transfer 1.5 ml of the 2.0 ml bacterial cultures into 1.5 ml eppendorf
tubes. (Be sure your samples are numbered or labeled!)
2. Centrifuge the eppendorfs for 30-45 seconds. (You should now have
bacteria pellets at the bottom of the tubes.)
3. Aspirate off the media supernatant, leaving the pellets on the bottom.
Prepare a boiling water bath for step 7.
4. Add 300 i..t1 STET to each tube. (To save on tips, squirt the liquid into
the tube without touching the tip to the tube.)
STET 100m1
sucrose 8% 8.0 g
Triton X 0.5% 0.5 ml
EDTA pH 8.0 50 mM 10.0 ml of 0.5M EDTA
Tris pH 8.0 10 mM 1.0 ml of 1M Tris
5. Prepare lysozyme cocktail: (Recipe shown is for 24 samples)
10 mg lysozyme
1.0 ml TE
(Mix by vortexing)
6. Add 25111 of lysozyme cocktail to each eppendorf.
7. Vortex pellets into solution. Boil for 40 seconds in hot water bath.
8. Centrifuge for 7 mM. Pull the white, stringy goobers out witha
toothpick and discard.
9. Add 300 1.1.1 of isopropanol to each tube and mix. (Place another
eppendorf rack over the top of the racked tubes and shake for 15
seconds.)186
10. Centrifuge for 15 min. The DNA is now in tiny pellets at the bottom
of the tubes. Carefully aspirate off the supernatant with a vacuum
driven pastuer pipet that is capped with a sequencing pipet tip.
11. Add 100 pl of water to each tube, and vortex briefly. Resuspension is
much easier if allowed to soak a half hour to an hour. This is a good
place to stop by storing the tubes at 40C for less than a week or -200C for
greater than a week. If the plasmid DNA is to be used for sequencing, it
should be stored at 40C only, and used within a week.
12. Resuspend pellet with a yellow pipet tip or by vortexing.
13. Transfer 5 p.1 to a 0.5 ml eppendorf. (Be sure to label these, too!) If
your DNA is a pATH vector, use 10 pl because it has a lower copy
number. Accordingly, you should reduce the water in step 14 by 5 pl.
14. Mix the restriction enzyme cocktail. Make 15 pl of cocktail for each
tube, plus a little extra. Recipes shown are for one sample.
one restriction enzyme two enzymes
enzyme #1 0.3 pl (10 units/p1) 0.3 pl
enzyme #2 none 0.3 p.1
10X buffer (REACT) 2.0 IA 2.0 pi
distilled water 12.7 gl 12.4 gl
15.0 p.1 15.0 pl
15. Add 15 p.1 of restriction enzyme cocktail to each tube containing
DNA, mix (by pipeting up and down) and incubate in 37 °C water bath
for 1 hour.187
16. Add loading buffer in order to run the samples on a gel.If you expect
DNA fragments of less than 1000 bp, then you need to have RNAse A in
your loading buffer so you can see the smaller bands on the gel. (Consult
Sambrook et al., 1989 for preparation of RNAse A.) Recipes for one tube:
DNA > 1000 by DNA < 1000 by
loading buffer 5.0 p.1 4.5 p.1
RNAse A (10 mg/ml) none 0.5 pl
17. Gels can be made in TAE or TBE buffer. TAE should be used if bands
of DNA are to be recovered. TBE should be used if high resolution of the
DNA bands is important. TBE also allows gels to be run faster, because
higher voltage may be used.
50x TAE (2L)
484.0 g Tris
74.4 g EDTA
114.0 ml Acetic acid
10x TBE (2L)
216.0 g Tris
7.44 g EDTA
110.0 g Boric acid
The amount of agarose in the gel depends on the fragment size of the
DNA:
DNA fragment size
100 bp to 3 Kb
200 bp to 4 Kb
500 by to 6 Kb
> 6 Kb
% agarose
2.0%
1.5%
0.9%
0.6%
For example, for a 0.9% TAE gel, use 100 ml IX TAE and 0.9 grams of
agarose. Add 0.5 pl of ethidium bromide per 100 ml of 1X TAE.
18. Load each tube containing 25 p.1 of sample into a well of the gel. Do
not forget to load the one Kilobase ladder as size standard.188
Appendix 3: Vector Upping Procedure
Component
DNA in restriction buffer
1 M Tris pH 8.0
1:10 Diluted cip enzyme
in TE pH 8
(undiluted cip is at 1 unit/m1)
volume for
10 pg of DNA
100 ill
5 p.1
10 p.1
Incubate@ 370C for 15 min then
@ 550C for 15 min
volume for
5pg of DNA
50 pl
2.5 pl
5 p.1
If 3' recessed or blunt ends then add another half aliquot of diluted cip.
Incubate@ 370C for 15 min then
@ 550C for 15 min
Immediately Phenol / Chloroform extract
then
Do one of following:
1)Add:
1 volume of 7.5 M NH4Ac
2 volumes of 95% ETOH
Store @ -80 0C for 15 min
Spin @ 4 0C for 15 min
Remove Supernatant
Respin @ 4 0C for 5 min
Remove remaining supernatant
Resuspend in TE
Vector may now be used for cloning
2) Run out on TAE gel.Appendix 4: Large Scale Plasmid Isolation
1) Pellet 250 mis of bacteria in Sorvall at 5K for 20 minutes
2) Gently resuspend bacteria in 5 mis
25 mM Tris HC1 pH 8.0
10 mM EDTA
50 mM Glucose
3) Transfer cell suspension to a sterile 125 ml flask
4) Add 10 mg (2 mg/ml) of lysozyme directly as powder and mix well
5) Incubate on ice for 30 mins
6) Add 5 mis of Alkaline-SDS solution
Final conc.
1% SDS
0.2 M NaOH
189
250 ml of 20% SDS
200 ml of 5 M NaOH
added to 4.55 mis MQ water
7) Mix throughly, incubate on ice for 5 mins
8) Add 3.75 mis of 3 M Na Acetate pH 4.8, Mix throughly
9) Incubate on ice for 30 mins mixing every 15 mins
10) Transfer the solution to a sterile 30 ml Corex tube
11) Centrifuge at 10,000 rpm for 15 mins at 40C
12) Remove as much (if any) loose white floculant material from the
top of the tube as possible with a sterile toothpick. Pour the
supernatant into a new sterile 30 ml Corex tube.190
13) Add equal volume of isopropanol mix and leave at -70 °C for 15
mins
14) Centrifuge at 10,000 rpm for 15 mins at 4 °C
15) Pour off the supernatant and leave the tube upside down for a few
minutes to allow the isopropanol to drain off
16) Resuspend the pellet in 3 mls of TE pH 8.0
17) Add 1.5 mis of 7.5 M Ammonium Acetate, mix and leave on ice for
20 mins
18) Centrifuge for 15 mins at 10,000 rpm at 4 °C Save Supernatant
19) Pour the supernatant into a new sterile Corex tube and add two
volumes of 95% Ethanol
20) Leave at -70 °C for 15 mins
21) Centrifuge for 20 mins at 10,000 rpm at 4 °C
22) Drain the pellet well,
If a CsC1 gradient is to be run (using a VTi 80 rotor) then
resuspend the pellet in 4.22 mls of TE pH 8.0 Transfer to a sterile 15 ml
conical centrifuge tube and add exactly 4.33 grams of Cs Cl. Mix
throughly until completely dissolved and then add 75 ml of ETBr (10
mg/m1) Transfer solution to an ultra centrifuge tube.
After the Cscl, run transfer the DNA solution into 1.5 ml eppendorfs.
Extract three times with an equal volume of butanol saturated with 10
mM Tris pH 8, 1 mM EDTA, 5 M NaCl to remove the ETBR.
Centrifuge briefly after each extraction to set phases. Remove the pink
top layer to organic waste bottle.191
After the last extraction, combine the 1.5 ml eppendorfs that contain
the same sample into a 15 or 30 ml corex tube. Add equal volume of
MQ water, mix, and then 2 volumes of 95% ETOH. If there was a lot of
DNA appears, centrifugation may take place right away. Otherwise
leave at 4 °C overnight. Be sure the CsC1 does not come out of
solution. If CsC1 comes out of solution, warm tube to room
temperature until solubilization is complete.
If no gradient is to be run then proceed to step 23.
23) Resuspend the pellet in 2 mis of TE pH 8.0 and transfer to a sterile
15 ml Corex tube
24) Add RNase to a final concentration of 0.5 mg/ml from 10 mg/ml
stock that has been treated so that RNase solution is DNase FREE
(Add 100 ml of 10 mg/nil RNase stock to 2 mis)
25) Incubate on ice for 30 mins
26) Phenol/Chloroform extract: Add 1/2 volume of phenol vortex and
add 1/2 volume of chloroform and vortex
Centrifuge at 10,000 rpm at 4 °C for 15 mins
Transfer supernatant to a new sterile 15 ml Corex tube and add an
equal volume of Chloroform and vortex
Centrifuge at 10,000 rpm at 4 °C for 15 mins
Transfer supernatant to a new sterile 15 ml Corex tube. Add equal
volume of 7.5 M Ammonium Acetate (2 mis) and then two volumes
of 95 % Ethanol (8 mis)
27) Leave at -70 °C for 15 mins
28) Centrifuge at 10,000 rpm at 4 °C
29) Resuspend pellet in 1 ml of TE pH 8.0 and transfer to a 1.5 ml
eppendorf tube.192
Appendix 5: Viral DNA Isolation Procedure
1) Spin out the insect cells in the International harvester at 2500 rpm
for 15 mins
2) Save Supernatant (may be stored at 4 0C until ready to use) and place
in SW28 tube (fill up to the top with TE pH 8) and balance
3) Spin in the ultracentrifuge at 24,000 rpm for 30 min at 4 0C
4) Drain pellet and bring up in 500 ml of extraction buffer (Summers
Manual page 24). Transfer to 1.5 ml eppendorf
For 1 liter of extraction buffer:
12.1 g Tris pH 7.5
33.6 g Na2EDTA 2H20
14.9 g KC1
5) Add 2 p.1 of 10 mg/ml of proteinase K (20 mg)
6) Incubate at 53 0C for 2 hours
7) Add 50 gl of 10% Sarkosyl and incubate at 53 0C overnight
8) Be careful not to shear DNA from here on out (use sterile 5 ml pipet
to transfer liquid)
9) Phenol/Chloroform extract twice
10) Ethanol precipitate add two volumes of ethanol (Add No Salt)
Leave at -80 0C for 20 mins or -20 'DC for 2 hours or longer
11) Pellet DNA at low speed (2,500xg for 30 mins)
12) Resuspend DNA in 250 41 of TE pH 8 and incubate at 65 0C for
15 mins. Then overnight at 4 0C
13) Sometimes a lot of RNA is also isolated. It therefore becomes
necessary to quantify the amount of DNA on a gel before setting up a
digest. (Normally requires about 50-100 ill of DNA for a digest)
14) The DNA is usually digested in 100 pl reaction and then ethanol
precipitated and brought up in a smaller volume to load onto a gel.193
Appendix 6: Virus Titration Procedure
1. Figure cell concentration
2. Dilute cells to 5E5 cells/ml
3. In a 96 well plate, place 100 IA of cells so that there are 5E4 cells
per well. Half the number of cells should be used when
cytopathology will be used to determine infection. Use a
multipipetor for this task. Incubate at 27 C overnight so that cells
attach to plate. However, cell attachment is not necssary.
4. For the viral dilutions, you need 8 wells of a 24 well plate for each
virus. In wells 1 and 2, put 990 gl of medium. Put 900 µl of medium
in the other wells.
5. Put 10 gl of virus in well 1 and mix. With a new pipet tip,
transfer 10 gl to well 2 and mix. Transfer 100 p.1 from well 2 to well
3 with a new tip and mix. Then 100 gl from 3 to 4, and so forth.
000000 000000
Well Dilution:
1 10-2
2 10-4
3 10-5
4 10-6
5 10-7
6 10-8
7 10-9
8 10-10
6. Add 100 gl of the titered virus to each 96 well according to
the diagram on the next page. The wells covered by dashed
arrows are control wells and 100 gl of medium, not virus,
should be added to these.194
control:
100 R1
00 medium
104 000000
10-500000 000000
10-600000 000000
10-700000 000000
10-8000000000000
10-9000000000000
10_1000000 000000
controlOHC}C) 0-0 000000
7. Put the sticky plastic film over the wells to reduce evaporation. You
should also put the plates in a plastic bag and include a damp paper
towel to maintain a high level of humidity.
8. Incubate for 5 days at 27 C.
9. For a more accurate endpoint, it is necessary to amplify the virus.
This is done by making a copy of the plate that was set up in step 6. To
do this, put 100 [11 of cells in each well of a 96 well plate, as in step 3.
Then transfer 100 .tl of virus from the step 6 plate to the corresponding
wells in the new plate. Use a multipipet for this task. Incubate for 5
days and then check to see which wells contain a virus. However, when
using a reporter gene as an identifier amplification is not necessary.
Calculations:
1. Look at the amplification plate. Fill out the table below, including a
column for the last totally positive dilution, the first totally negative
dilution, and every dilution between. For example, if your amplification
plate looks like this:
Amplification plate from step 9:195
10-4
10-5
10-6
10-7
10-8
10-9
10-10
Control
O 00O 00O 00O 00O 00O 00 O 0000-0
Control
medium
O o
O 0
O 0
O 0
O 0
O 0
O 0e
O 00000 O 00000 O 00000 O 00000 O 00000 O 00000 O 00000 O 00000
The table would look like this, with four columns. Definitions of the
rows given below the table.
Dilution
positive rate
positive number
negative number
positive total
negative total
pos. ratio total
percent positive
10-6 10-7 10-8 10-9
5/5 3/5 1/5 0/5
5 3 1 0
0 2 4 5
9 4 1 0
0 2 6 11
9/9 4/6 1/7 0/11
100 67 14 0
positive rate: the ratio of positive wells to the total wells for each
dilution; the number of wells in this protocol is 5 per dilution.
positive number: the number of positive wells for each dilution; this is
the numerator of the positive rate.
negative number: the number of negative wells for each dilution; this is
equal to 5 positive number.
positive total: the sum of the positive wells for the given dilutions and
all higher dilutions. It is the summation of the positive number of the
given column and each positive number to the right. Inspect the sample
to alleviate confusion.
negative total: the sum of the negative wells of the given dilution and
all lower dilutions; the opposite of the positive total. It is the summation
of the negative number for each dilution and all negative numbers to the
left in the table. Again, inspect the sample.196
positive ratio total: Use the following equation:
positive ratio = positive total
totalpositive total + negative total
percent positive: this is simply the positive ratio total converted to a
percent.
We can now use the above table to figure out the 50% endpoint:
1. Take the log of the lowest dilution that does not have all positive wells
(next above 50%). Example: log 10-7= -7
2. Figure out the proportional distance with the following equation:
proportional distance =
(% pos. next above 50%)-50%
(% pos. next above 50%)-(% pos. next below 50%)
67%-50% = 0.32
67%-14%
3. Subtract the proportional distance from the log of the lower dilution.
7 0.32 = -7.32
4. The tissue culture infectious dose (TCID) for 50% infection is ten
raised to the power of your answer for step three:
- 7.32
10= 4.8E-8
5. To convert to milliliters, take the reciprocal of your answer for step 4
and divide by .01, since one one-hundredth of a milliliter was originally
taken in step 5 of the procedure.
4.8E-8 = 1/ 2.1E7
2.1E7/.01 = 2.1E9 TCID(50) /ml197
6. Assuming that 50% of the virions form plaques (a 50% infection
efficiency), multiply by 0.5 to find the number of plaque forming units
(PFU) per milliliter.
2.1E9 TCID/ml x 0.5 = 1.05E9 PFU/ml198
Appendix 7:Mini-Prep dsDNA Sequencing with Sequenase
1) Use 2-4 p.g of mini-prep DNA for plasmid sequencing.
a. A normal 1 ml mini-prep will yield 5-7 ggof DNA. Therefore, use ---
40%.
b. Mini-preps should be processed by the boiling method, precipitated
in isopropanol, and resuspended in 100 gl of MQ H2O.
c. The dsDNA from the miniprep should beused as is without RNAse
treatment.
2) Add 10 ng of primer
The primer : template should be a 10:1 ratio for best results.
3) Add 2 M NaOH, 2 mM EDTA and denature.
Denature the dsDNA/primer mixture at 85 0C for 5 mins. Chill on ice
for 3 mins.
EXAMPLE: 40 gl of mini-prep DNA (from 100 ml Mini preps)
4 gl of Primer (@2.5 ng/p.1)
5 gl of 2 N NaOH, 2 mM EDTA
49 gl
4) Neutralize the mixture. Ethanol precipitate.
Add: 6 gl of 3 M NaOAc (5.2), mix and add 150 pi of EtOH
Precipitate @ -80 0C, 10 minutes.
5) Pellet DNA in 4 0C microfuge, 15 minutes.
6) Resuspend DNA pellet in 8 p.1 of H2O
7) Add 2 p.1 of 5X Sequenase Buffer and mix.
8) Anneal @ 37 0C for 15 minutes.
9) Dilute dITP Labeling Mix 1:3 in H2O199
For cloning site sequencing dilute labeling mix 1:5 or 1:10. Also use a
12% gel.
10) Dilute Sequenase Enzyme 1:8 in ice-cold TE buffer [10 mM Tris
(7.4), 1 mM EDTA]
Store on ice.
Note: Use diluted enzyme within 1 hour after diluting.
11) LABELING REACTION:
To the tube containing the annealed template/primer, add:
1.0 al of 0.1 M DTT
2.0 al of Labeling Mix (dITP mix, Diluted 1:3)
0.5 al of 35S-alpha-dATP (10 aCi/al, 1000-3000 Ci/mmol)
2.0 al, of Sequenase Enzyme (freshly diluted)
Incubate @ RT for 1-10 minutes.
Note: To get more label in the smaller fragments:
Dilute the Labeling mix 1:10 or 1:15
Incubate for shorter periods 2-3 min.
To sequence long a distance:
Use the Labeling Mix undiluted
Add 1.5 al 35S-dATP (15 aCi)
Incubate @ RT for 10 minutes
12) TERMINATION REACTION:
Add 3.5 al of from the above tube to all 4 termination tubes, each
containing 2.5 al of the appropriate dideoxy termination mix (dITP; G,
A, T, or C)
Incubate @ 37 0C for 15 to 30 minutes
13) Add 4 al STOP Buffer to each tube200
Store @ -20 OC.
Load 1p.1 per well (96 well comb) or 2 Ill per 48 well comb
8% INSTA-GEL:
38 g Acrylamide
2 g Bis-acrylamide
210 g Ultra Pure Urea
50 ml 10X TBE running buffer
MO Water to 500 ml of final volume
Filter through Whatman #1 filter paper
Store @ RT in a foil wrapped bottle.
[Note: insta-gel will go bad after approximately 6 monthsit will
polymerize very fast but is still be usable. If old, use only about 1/2 the
amount of 10% ammonium persulfate as per normal and pour fast]
To 70 ml of Insta-Gel, add 0.6 ml of freshly made 10% Ammonium persulfate
in MQ H2O and mix
Add 15 p,1 of TEMED, mix and immediately pour the gel.
Allow the gel to polymerize for 35 min to 1 hr (be sure it is completely
polymerized)
Component 6 % 7 % 8 % 9 % 10 %
40 % acrylamide11.2 ml 13.1m115.0m116.9m118.8m1
(1:19 ratio)
10x TBE 7.5 ml
Urea 34.5 g
Water
Total 75 ml201
Appendix 8: Cell Culture Transfection Procedure
STEP 1
1) Prepare cells for transfection by removing the old medium and
adding 10 mis of fresh medium to a confluent T-150 flask (confluent T-
150 contains roughly 2.5 X 107 viable cells).
2) Knock off cells and transfer to a 50 ml Falcon tube.
3) Take 0.5 ml into 13 X 100 mm culture tube and add 50 pl of 0.5%
Trypan Blue in 2 X PBS (use 1: 10).
4) Let sit for 2 mins.
5) Prepare and load the hemocytometer. Remember to swirl the tube
just before loading because the cells settle out quickly.
6) Take the actual number counted in the field and use the following
formula.
Actual # X 104 = cells/ml
7) Place 1.5 X 106 cells in each well of a six well plate (Falcon #3046).
8) Allow cells to attach for about 4 hours to overnight.
9) Determine the correct amount of DNA and mix with 400 pl of
transfection buffer. For example :If 20 jig of DNA is to be transfected
mix 25 pg with 500 pl of transfection buffer. The extra 100 pl and 5 pg
of DNA allows for pipeting error. Allow the mixture to come to room
temperature before using.
STEP 2
1) Remove the medium from each well and replace it with 800 pl of
medium.202
2) Add the correct MOI of virus to each well. (The virus may be
premixed with 800 pl of medium and then dispensed) Always do the
low multiplicity of infection first.
3) Incubate the plates for 4 hours.
4) Remove the 800 p.1 of media containing the virus.
5) Add 400 p.1 of Graces with 10% Fetal Bovine Serum and Antibiotics
to each well.
6) Rock the plate a couple of times to allow the liquid to spread evenly
throughout the well.
7) Now add 400 pl of transfection buffer containing the DNA. Add in a
dropwise fashion evenly throughout the well.
8) Rock the plate a couple of times to allow the liquid to spread evenly
throughout the well.
9) After 4 hours take off the liquid and add 1 ml of media.
10) Put in a zip lock bag with a wet paper towel and incubate for 72
hours.
STEP 3
1) To harvest the transfected cells scrape the cells loose with a sterile
rubber policeman.
2) Transfer to a 1.5 ml eppendorf tube.
3) Spin at 60% for 3 mins.
4) Take off supernatant; spin again for 15-20 sec at 60%.
5) Take off supernatant.203
6) Add 50 ill of 1 X PBS + 5 mM EDTA (Filter sterilized).
7) Vortex and freeze at -80 0C for 5 mins (can stop at this point).
8) Thaw at room temperature for 5 mins
9) Vortex
10) Repeat steps 7-9 three times.
11) To destroy de-acetylating activity, heat the extract to 65 0C for 15
mins.
12) Pellet the cell debris (10 mins in microfuge) and transfer the
supernatants to new tubes.
13) Store the supernatant extract at -80 0C
14) Determine the total protein concentration by using Bradford Assay
Solutions
Transfection Buffer For 1 liter
25 mM Hepes (238.3 g/mole) 5. %g
sigma H-3375
140 mM NaC1 (58.44 g/mole) 8.18g
125 mM CaC12 2 H2O (Fw 147.03) 18.38g
Filter Sterilized pH 7.1 at room temperature (25 0C)
lx PBS-EDTA
495 ml of lx PBS Sigma premix (pH 7.4) and 5 ml of 500 mM EDTA
(pH 7.1)204
Appendix 9: CAT Assay Procedure
Two Phase Fluor Diffusion Assay from NEN
1) Infect or transfect insect cells with a construct that has a Promoter-CAT
gene fusion.
For transfections, I typically use: 1.5 x 106 cells/well in a 6 well plate (35 mm
diameter wells) and transfect with 10 1.ig of plasmid DNA in a total volume of
0.8 ml (0.4 ml Graces complete + 0.4 ml transfection buffer w/ DNA)
After 4 hrs, the transfection buffer is removed and replaced with 1 ml of
TNM -FH. Hours post transfection (hpxf) is calculated from the time when
the 1 ml of TNM-FH is added. See Appendix 8
2) At 72 hpxf, scrape the cells off with a rubber policeman and pipet the
cells/media into an eppendorf tube.
Pellet the cells gently in the microfuge 3 mM @ 60% setting (Dupont
microfuge). Carefully remove and discard the supernatant. Respin briefly,
carefully remove and discard all the supernatant.
3) Resuspend the cells in 50 1.1.11 X PBS and 5 mM EDTA
4) Lyse the cells by freezing and thawing 3 times.
Freeze the cells at -80 0C for 5 min. / Thaw at RT 5 mM., then vortex /
Repeat 3x
5) Pellet the debris in the microfuge3-4 min at full speed.
Use the supernatant for CAT assays.
Store tube (super + pellet) @ -200 C. Pellet debris before using.
CAT ASSAY
Always include controls of
i) Negative control (uninfected cells)
ii) Positive control (0.05-0.1 unit Sigma CAT enz. added)
iii) No-cell extract control205
6) Add 25-30 0 of the cell extract (80 ug of protein as determined by Bradford
Protein Assay to a glass mini-scintillation vial.
7) Add 230 0 of the MASTER MIX. Mix by swirling gently
MASTER MIX
1 rxn 10 rxns
194.5 0 1.945 ml H2O
23 0 230 0 1 M Tris (pH 7.8)
2.5 0 25 gl Chloramphenicol (100 mM in EtOH)
10 0 100 1.1.1 14C-Acetyl Co-A (NEN,0.01 p.Ci/0
230 0 2.3 ml or 0.1 1.1.Ci/rxn)
8) Gently overlay with 5 ml of Econofluor (NEN).
9) Incubate at 37 0C for 1 hour before counting.
10) Count each sample for 1 minute at 1-2 hour intervals.
Reagents:
1 M Tris (7.8)sterile
14C-Acetyl Coenzyme A (NEN Catalog #NEC-313L)
Chloramphenicol (Sigma): Make a 100 mM solution in EtOH as per Maniatis.
Store at -20° C
Econofluor NEN Cat. No. NEF-941 or formula 989 = Econofluor NEF-989
Glass Mini-scintillation vials (VWR)7 ml capacity
mini-vial holdersplastic
Rubber policeman (clean and sterile)1 per well
References:
J. R. Neumann, C. A. Morency, and K. 0. Russian (1987). A novel rapid
assay for chloramphenicol acetyltransferase gene expression.
Biotechniques (1987) Vol. 5, No. 5, p 444-447.
NEN pamphlet supplied with 14C-Acetyl Co-A contains a more detailed
account of the procedure with tips and recommendations.206
Appendix 10: Frozen Competent Cells CaC12 and DMSO Procedures
Culturing of Bacteria:
1) Inoculate 200 ml of Luria broth with 2 ml of a fresh overnight
culture (6-14 hour culture in log phase growth).
2) Incubate at 37 0C for approximately 1.52 hours until the OD600
reaches 0.3-0.4.
3) Pellet cells in 250 ml bottle in Superspeed (Sorvall) centrifuge(4000
rpm for 5 mM). Discard supernatant. Complete either the FCCCaC12
or DMSO procedure.
Frozen Competent Cells CaC12 Procedure:
1) Resuspend the cells gently in 100 ml of sterile ice-cold 50 mM CaC12,
10 mM Tris (pH 8.0) (1/2 original volume).
Place the resuspended cells on ice for 15 mins.
2) Pellet cells in Servall centrifuge (4000xg for 5 mins).
Discard supernatant.
3) Gently, resuspend the cells in 13 ml of Sterile ice cold 50 mM CaC12,
10 mM Tris (pH 8.0)(1/15 the original volume). Place the resuspended
cells on ice for 10 mins. before using. (The cells may be stored on ice at
4 0C for 48 hours without ill effect. Transformation effeciency
increases at 24 hrs. and decreases to the original efficiency at 48 hrs.)
4) To freeze the cells after 24 hrs. on ice, add cold Sterile Glycerol to a
final concentration of 15% (2.8 ml 80% glycerol + 13 ml cells). Mix by
gently pipeting with a 5 or 10 ml sterile pipet.
Place on ice for 10-15 mins.207
5) Aliquot 300-700 p.1 per 1.5 ml epp tube and immediately place tubes
on ice. Precool pipet tips at 4 0C prior to pipeting.Tubes should be pre-
chilled by placing at -80 0C for approximately 30 mins.
6) Store tubes at -80 OC.
Transformation Using Frozen Competent CaC12 Cells:
1. Thaw a tube of FCC in ice water bath (app. 2-4 mins). Place on ice.
2. Add DNA (ligation or other transforming DNA) to a sterile 17 x 100
mm culture tube. Add 300 p,1 of FCC to each tube andmix. If you are
transforming a low melt agarose ligation do not place on ice until the
DNA and FCC are mixed.
When testing the effiency of frozen competent cells add 10 p.1 of a 10
ng/ml stock of pBS DNA.
3. Incubate on ice for 45 mins.
4. Heat shock cells in a 42 OC waterbath for 90 sec.
Place the cells on ice for 2-3 mins.
5. For plasmid cloning, add 4 volumes SOC to the FCC (i.e. 1200 p.1 of
SOC to 300121 of FCC)
Incubate in a 37 0C shaker for 1 hour.
Plate varying quantities of the culture on plates containing the
appropriate antibiotic and perhaps IPTG and Xgal.
IPTG50 gl of 20 mM IPTG spread on the surface of the plate
XGal50 pi of 2% XGal (in N-N-Dimethyl formamide) spread on the
surface of the plate.
Allow 14-16 hours for blue color to develop.
Note: JM83 and DH5a cells do not require that IPTG be added.208
Frozen Competent Cells DMSO Procedure:
1. Gently resuspend pelleted bacteria in 1/10th volume of 1 X TSS on
ice.
2. Aliquot resuspension into prechilled 1.5 ml eppendorfs and freeze at
-80 0C.
Transformation and Storage Solution (TSS)
1 X TSS is LB media containing 10% (wt/vol) polyethylene glycol, 5%
(vol/vol) dimethyl sulfoxide (DMSO), and 50 mM MgSO4 at pH 6.5.
Transformation DMSO Frozen Competent Cells (FCC):
1. Thaw a tube of FCC in ice water bath (app. 2-4 mM), then place on
ice.
2. Add DNA (ligation or other transforming DNA) to a sterile 17 x 100
mm culture tube. Add 300 pl of FCC to each tube and mix. If you are
transforming a low melt agarose ligation, do not place on ice until the
DNA and FCC are mixed.
3. Incubate on ice for 45 mins. If you are simply retransforming circular
DNA, 5 mM on ice is sufficient.
4. For plasmid cloning, add 4 volumes SOC to the FCC (i.e. 1200 pl of
SOC to 300 pl of FCC). Incubate at 37 0C in a shaker for 1 hour.
5. Plate varying quantities of the culture on plates containing the
appropriate antibiotic and perhaps IPTG and Xgal. If desired, cells may
be tranferred to a 1.5 ml eppendorf and centrifuged to concentrate cells
before plating.I usually plate a ligation on three plates at the following
percentages 5%, 25%,and 70%.209
SOB Medium:
2% Bacto Tryptone, 0.5% yeast extract, 10 mM NaC1, 2.5 mM KC1, 10
mM MgC12, 10 mM MgSO4.
SOB medium is prepared without Mg and autoclaved. After cooling,
add 1/100 vol. of sterile 1 M MgC12 and 1/100 vol. of sterilel M MgSO4.
SOC Medium:
SOC is SOB + 20 mM glucose. Make a 2 M glucose solution in H2O and
sterile filter it. Use good sterile technique as the glucose and SOC
solutions are easy to contaminate. Add 1/100 vol of the 2M glucose to
SOB.
Calculations for Transformation Efficiency:
If 300 pl of cells are transformed with 100 ng of pBS DNA, the
following calculations apply: Final concentration of DNA = 100 ng in
1.5 ml Therefore, DNA = 0.066 ng/p1
If 300 p.1 of cells are transformed with 100 ng of plasmid DNA, plate out
the following amounts: 1.5 µl,15 ill, 150 1.11 and use the table below to
determine efficiencies.
Amount plated# colonies expected at this efficiency
1x105 1x106 1x107 1x108
1.5 pi = 0.1 ng 10 100 1,000 10,000
15 p.1 = 1 ng 100 1,000 10,000 100,000
150 pl = 10 ng 1,000 10,000 100,000 1,000,000
> 1 x 107 = good to excellent
1 x 106 to 1 x 107 = acceptable
1 x 105 to 1 x 106 = usable in a bind but not good
< 1 x 105 = Discard and try again
Reference
DMSO procedure: Chung, C.T., Niemela, S.L., and Miller, R.H. (1989)
One-step preparation of competent Escherichia coli: Transformation
and storage of bacterial cells in the same solution. Proc. Natl. Acad. Sci.
86; 2172-2175.210
Appendix 11: Site-Directed Mutagenesis Procedure
III ER HELPER PHAGE M13K07
1) Prepare a 25 ml culture of MV 1190 (or any other strain that contains
an f-plasmid) in LB and incubate at 37 0C with shakingovernight.
2) Prepare 5 tubes of top agar by melting it in the microwave oven and
pipet 3 ml of agar into sterile tubes. Keep at 50-55 0C until use.
3) Prepare 4 serial dilutons of the M13K07 stock ( 102-fold,104-fold, 106-
fold, 108-fold) in sterile tubes in LB. For example: 5 ill of M13k07 stock
in 495 ill of LB (102-fold) and so on.
4) Place 0.2 ml of the overnight culture of MV 1190 into another 4
sterile tubes. Add 100 p,1 of the last three dilutions into one of these
tubes (the fourth will serve as a control).
5) After 5 minutes at room temperature, pipet the contents of each tube
containing the cells and phage into a tube of top agar. Pipet up and
down (Do not introduce any bubbles). Plate IMMEDIATELY ONTO AN
LB PLATE.
6) Allow the top agar to harden for 15 mins, then invert the plates and
incubate at 37 0C overnight.
7) The following morning, count the plaques on the plate that has a
countable number on it. Use the following formula to get the titer:
The titer =(# of plaques x 10 x dilution factor)pfu /ml211
TEMPLATE PREPARATION
1) An Fl origin containing plasmid that contains the sequence to be
mutagenized should be transformed in either CJ 236 (ung-, dut-) or
RZ1032 (ung-, dut-).
2) Prepare a 10 ml overnight culture from one colony in 2XYT. When
CJ 236 cells are used, grow in 501.1g/m1 of AMP and 30 µg /ml of
Chloramphenicol. When RZ 1032 cells are used, grow in 50 µg /ml of
AMP and 12.5 µg /ml of Tetracycline.
3) In a 250 ml flask, inoculate 100 mis of 2XYT and 50 µg /ml of AMP
only with 2 ml of overnight.
4) Grow to OD600 of 0.3 ABS (1 to 4 hours)
5) This represents 1 X 107 cell/ml. Add enough M13k07 helper phage
to obtain 20 phage/cell.
6) Incubate in shaker at 37 0C for 1 hour. Add 233 ill of a 50 mg/ml
Kanamycin stock per 100 ml of media.
7) Continue to incubate 18 to 20 hours.
8) Transfer culture to 4 corex tubes (25 mis /tube) and spin at 10 K for 15
mins
9) Repeat step 8, transfer Supernatant to a new sterilized corex tube and
spin at 10 K for 15 mins
10) Transfer 20 mis of the Supernatant to a fresh corex tube and add 100
1.ig of RNase A or 10 p.1 of 10 mg/ml stock. Incubate this mixture at
room temperature for 30 mins
11) Add 2.5 mis of 7.5 M NH4oAc and 2.5 mis of 40% PEG 8000 to each
20 ml of supernatant. Incubate on ice 30-45 mins.212
12) Centrifuge 10 K for 30-60 mins. Decant off supernatant, resuspend
each 25 ml tube pellet in 150 1.1.1 of High salt buffer.
High salt buffer
300 mM NaC1
100 mM Tris pH 8.0
1 mM EDTA
Transfer to a 1.5 ml Eppendorf tube
Chill on ice for 30 mins
Centrifuge for 2 min and transfer to a fresh tube
13) May be stored overnight at 4 0C (should not store longer than a
couple of days) or extracted immediately
14) The 600 ill of high salt buffer should be extracted:
1 X phenol (add half volume)
1 X phenol / chloroform (add 1/4 volume of each)
1 X chloroform (add 1/2 volume)
15) Add 1/ 10 volume of 7.5 M NH4oAc and 2.5 volume of 95 %
ethanol (60 pi and 1320 Ill respectively). Need to split into two 1.5 ml
eppendorf tubes.
16) Keep at - 80 0C at least 30 mins
17) Centrifuge in the cold for 15 - 30 mins. Remove supernatant
carefully and resuspend the pellet(s) in a total of 50-100 11.1 of TE pH 8.0.
Avoid dissolving any residue that may cling to the side of the tube.
18) Transfer the DNA to a new tube. Run a small aliquot on an agarose
gel with a known amount of single-stranded DNA to determine the
concentration.PHOSPORYLATION OF THE MUTAGENIC OLIGONUCLEOTIDE
1) In a sterile 500 pl tube prepare the following reaction:
Component: Volume added Final concentration
Oligonucleotide 10 p.1 66.6 pmol/p.1
200 pmol/g1
1 M Tris pH 8.0 3 IA 100 mM
0.2 M MgC12 1.5µl 10 mM
0.1 M DTT 1.5p1 5 mM
10 mM ATP 1.3 p.1 0.4 mM
DDH2O 12.7 ul
Total 30 p.1
2) Add 4.5 units of T4 Polynucleotide Kinase
3) Mix and incubate at 37 0C for 45 mins
4) Stop reaction by heating at 65 0C for 10 mins
ANNEALING OF THE MUTAGENIC OLIGONUCLEOTIDE TO THE
TEMPLATE
1) In 500 ill tube prepare the following reaction mix:
Component
Uracil containing
DNA
Kinased mutagenic
oligo
10X Annealing Buffer
DDH2O
TOTAL VOLUME
Volume added
213
Final Concentration
or Mass
0.3 pmoles
9.0 pmoles
3 ill 20 mM Tris pH 7.4
2 mM MgC12
50 mM NaC1
3Oµ1
The optimum template to mutagenic oligo ratio is between 1:20 or 1:30214
Useful formulas for calculating ratios
template (1.1g or ng) x (# of bases in oligo)
(# of bases in template)
= amount (1.ig or ng) of oligo needed for 1:1 ratio.
Molecular weight of base = 330 g/mole or 3.30 x 10-4 lig/pmole
To determine the MW of the oligo or the template:
# of bases x 3.3 x 10-4 p.g/pmole = Molecular Weight (pg/pmole)
2) Prepare an identical tube containing No primer. Controls for
nonspecific endogenous priming.
3) Place reaction mixtures in a 70 OC water bath for 3 mins. Allow the
reaction mixture to cool in the water bath at a rate of 1 0C/min to 30 0C
4) Place reaction on ice for 2-3 mins.
SYNTHESIS OF COMPLIMENTARY DNA STRAND
1) Add the following to each annealing reaction (Keep tubes on ice as
much as possible throughout this step)
10 X Synthesis buffer 3 ill 0.4 mM each dNTP
0.7 mM ATP
17.5 mM Tris HC1
pH 7.4
3.75 mM MgC12
1.5 mM DTT
T4 DNA Ligase 2 IA
(1 unit/111)
Sequenase diluted 1:4 1 p.1
(3.25units/p1)
OR USE
Klenow 1 1.1.1
diluted to 5 units/u1215
2) Allow reactions to sit on ice for 5 mins after adding components.
If Sequenase is used:
1) Transfer the reactions to 25 0C for 5 mins; then to 37 0C for 90 mins.
OR
2) Transfer reactions to 15 0C water bath for 8 hours to overnight.
If Klenow is used:
Transfer reactions to 15 0C water bath for 8 hours to overnight.
Transform about 10 111 of each of the in vitro reactions with competent
cells and plate.216
Appendix 12:Total Cell RNA Isolation using CsC1 Cushion
Harvesting RNA Samples
Do all samples individually through step 3
1) Aspirate off cell culture media
2) Rinse culture dish with 1 x PBS and aspirate off PBS
3) Immediately place dish at -80 0C on cold melt surface. Keep dishes
stored at -80 0C until needed.
Isolating RNA Samples
Work in the hood
Do all samples individually through step 6
4) Remove one sample at a time from the -80 0C freezer and
immediately place 250 Ill of Guan-Thio solution in each of the 6 well
plate. Scrape up all cells into this solution. Do not thaw out the plate.
5) Place the sample in a 15 ml disposable centrifuge tube that contains
0.6 g of solid Cs Cl. Invert to dissolve and adjust volume to 1.5 ml with
Guan-Thio (if needed).
6) Sonicate homogenate for 30 sec at maximum with small sonicator
probe.
7) Layer homogenate on a 1.4 ml CsC1 pad (5.7 M CsCI, 0.1 M EDTA) in
a 3 ml heat seal tube (use a 3cc syringe 18.5 gaugeneedle to load on the
CsC1 pad and a P-200 pipetman tipped with a sequencing tip to load on
the homogenate).
8) Centrifuge at: 49k rpm in Beckman 100.3 rotor (110,000g) using a
Beckman Tabletop Ultracentrifuge (TL100) for 16-20 hours at 25 0C.
Work quickly and process samples individually through step 12
Work in the hood
9) Cut off the top of the tube and remove the supernatant above the
pad with a sterile pasteur pipet.217
10) Cut off the top portion of the tube, with a pastuer pipet removethe
floating cell pellet and the Guan-Thio layer. Pour off the CsC1pad and
allow the tube to drain. RNA is at the bottom and lookslike a contact
lens.
11) Take up the clear, contact lens-like pellet in 200 pl of 1XTES. Rinse
with a another 200 pl of lx TES. (If pellet does not dissolve completely
add another 400 p.1 of IX TES and split the sample into two 1.5ml
eppendorf tubes.) Transfer all 400 pl to a tube containing 100 p.1of
phenol (water saturated) and 100 gl of Chloroform (24:1 CHC13 :
Isoamyl alcohol). Vortex vigorously for 1 min.
12) Microfuge and remove aqueous phase to a fresh tube containing200
pl of Chloroform. Vortex and microfuge.
13) Remove aqueous to a fresh tube and add 50 p.1 of 3M NaAc pH5.2
and 1000 p.1 of 100% Ethanol (RNA Grade, stored in -20 0C).
Gaun-Thio
Component Stock Reci pe
4 M guanidinium 25.0 g
isothiocyanate
0.1 M 2- mercaptoethanol 12.8 M 414 ill
5 mM sodium citrate pH 7 1 M 265 p.1
0.5% sarcosyl 10% 2.65 ml
Milli-Q water 27 ml
Total 53 ml
10 X TES
Component Stock Recipe
10% SDS 20% 25 ml
Milli-Q water 15 ml
Boil to sterilze, then add sterile ingredients below
0.1 M Tris pH 7.5 1 M 5 ml
50 mM EDTA 0.5M 5 ml218
Appendix 13: Primer Extension Procedure
5' End Labeling the Oligonucleotide
(T4 Polynucleotide Kinase)
X p.1 of H2O
2.0pl of 10X Kinase Buffer
X pl of Oligonucleotide (300 ng,100 ng )
X pi of 32P-gamma-ATP (50-100 p.Ci @ 6000 Ci/mmol)
X pl of Polynucleotide Kinase7 units)
20 p.1
Incubate @ 37 oC for 30 min.
Incubate @ 65 0C for 5 min.
Store at -20 oC
Final Concentration = 5 ng/p1
Use 1 pl (5 ng) for annealing to RNA
Annealing Oligo to RNA
1. Dry down RNA samples (if needed) using a Speed Vac. Use 1.5 ml
eppendorf tubes
2. Mix 1 p.1 (5 ng) of 32P-labeled
X p.1 of (20-50 lig) total or cytoplasmic RNA
X p.1 of H2O
1.5 pl of 10X Annealing Buffer
15.0 pl
3. Heat @ 70 oC for 3 min.
4. Allow primer to anneal 45 min @ X oC.
X = = 5 0C below the denaturation temp (Td) [can be 2-3 0C below)
Td = 4(G+C) + 2(A+T)
Td is the temperature at which 1/2 of the primer:template
complexes are disassociated and is in oC219
Primer Extension Reactions:
Using MMLV Reverse Transcriptase
To each 15 Ill of Annealing Rxn add 30 p.1 of PE MIX
PE Mix: 4.5 µl10x MMLV RT buffer (GWB)
1.5 p,1MMLV RT (200 units/p.1)
24.0 piDDH2O
45.0 1.L1total
Incubate @ X 0C or 50 0C for 30-45 mins
Using AMV Reverse Transcriptase
To each 15 µl of Annealing Rxn add 30 p.1 of PE MIX (keep samples at
annealing temp)
PE Mix:4.5 ill10X RT Mix (see below)
X µlH2O
Xm.1AMV Rev.Transcriptase (Promega; app 5 units/rxn)
45 piTotal Volume
Incubate @ Annealing Temp "X" for 45 min
Note: If "X" is > 500 C , use 50 0 C.
AFTER EXTENSION REACTION DO A or B:
A. If desired RNAse treat as folows:
To each tube add:
1 1.1.1 of 0.5 M EDTA, Mix
1 p.1 of RNAse (1 mg/ml; DNAse free)
Incubate at 37 0C, 20 min. Stop the P.E. rxn;
Stop the P.E. rxn ; EtOH ppt.
5 1.1.1of 3 M NaAc pH 5.2, mix
100 illof EtOH220
Incubate at -80 0C for 20 min or @-20 0C for lhr - overnight
Pellet PE rxns 30 min in a microfuge. Carefully aspirate supernatant.
Remove all EtOH.
Resuspend each pellet in 5 W of Formamide Sample buffer or
Sequenase STOP Buffer. Heat to 80 0C and load on a gel
B. Alkaline treat as follows (recommended)
To each tube add:
5 p.1of 3M NaAc pH 5.2, mix
100 IAof EtOH
Incubate at -80 0C for 20 min or @ -20 0C for lhrovernight
Spin, resuspend in 6 gl of 0.1M NaOH and 1 mM of EDTA ; Make sure
the RNA is properly dissolved.
Incubate at 30 0C for 30 min
Add to each tube, 6 ill of Formamide Sample buffer or Sequenase STOP
Buffer
Heat to 80 0C and load on gel
10X Kinase Buffer
500 mM Tris (7.4), 100 mM MgC12, 50 mM DTT, 1 mM Spermidine
6.05 g Tris
2.03 g MgCl2
0.771 g DTT
0.025 g Spermidine
To 100.0 ml w/ H20; pH to 7.4; Filter Sterilize
10X Annealing Buffer:
2.5 M KC1, 100 mM Tris (8.3) (pH 9.0 @ 25 oC)
Concentration ComponentStock Volume Final
2.5 M KC1 4 M 625 pl 250 mM
100 mM Tris 1 M 100 p.1 10 mM
MQ Water 275 g1
Filter Sterilize221
MX Extension Buffer (GWB)
225 mM Tris (pH 9.0 @ 25 0C), 400 mM KC1, 50 mM MgC1, 50 mM DTT,
2.5 mM dNTP's
Concentration Component StockVolume Final
225 mM Tris 1 M 50 pl 25 mM
400 mM KC1 4 M 20 pl 40 mM
50 mM MgC1 1 M 10 pl 5 mM
50 mM DTT 100 mM 100 p.1 5 mM
2.5 mM dNTP's 100 mM 5 p.1 0.25 mM
(5 p.1 of each dNTP for a total of 20 p.1)
Total volume 200 p.1
5X MMLV RT BRL BUFFER (supplied)
250 mM Tris-HC1 pH 8.3
375 mM KC1
50 mM DTT
15 mM MgC12
10X AMV RT Mix
0.5 M Tris (8.0), 0.5 M KC1, 50 mM MgC12, 50 mM DTT,
2.5 mM dATP, 2.5 mM dCTP, 2.5 mM dTTP, 2.5 mM dGTP,
1. Prepare a large stock of 10 RT Mix without dNTPs (app. 30-50 ml)
0.556 M Tris (8.0), 0.556 M KC1, 55.55 mM MgC1 2, 55.55 mM DTT,
2. Prepare smaller aliquots of the complete 10X RT Mix by adding a
dNTP mix.
1.35 ml of 10X RT Mix without dNTPs
0.15 ml of dNTP Mix (25 mM each dNTP)
1.50 ml 10 RT Mix
(aliquot to 5 tubes @ 300 pl/tube)
Store at -20 °C
Formamide Sample Buffer
100% Formamide w/ 0.3% Bromophenol Blue and 0.3% Xylene Cyanol222
Appendix 14: (3-Galadosidase Assay
24 well plate assay
For recombinant virus assay
1) Plate 1.5 x 106 cells/well and allow cells to attach for at least one
hour.
2) Dilute the amount of virus used (MOI) for each well in 800 p.1 of
media. Always calculate (virus and media) for a few extra wells.
3) Remove media and place the 800 p.1 of media containing virus in
each well. Incubate for one hour.
4) After one hour (called time zero), remove the 800 pl and replace
with 1 ml of fresh media.
For transient expression assay (start here)
5) After the desired incubation time, scrape cells loose of 6 well plate
with policeman.
6) Transfer to 1.5 ml eppendorf tubes.
7) Spin cells for 3 mins at 60% in microfuge.
8) Take off supernatant and respin briefly to remove any remaining
supernatant. Add 500 IA of 1 x PBS, vortex pellet in solution and freeze
at -80 °C.
9) Thaw cell extracts.
10) Centrifuge to pellet cell debris. If desired, transfer supernatant to a
fresh tube and store at -80 °C.
11) Make at least two identical controls wells, they will be used to zero
the spectrophotometer. Choose from one of two methods: a) replace
the 5µl of cell extract with 5 41 of 1 x PBS. b) Use a 5 p.1 of a cell extract
that has not seen a lac Z construct.
12) Place 5 ill of cell extract in each well and incubate at 37 0C for 5
mins.
13) Add quickly 995 p.1 of Buffer Z in 24 well plate mix, and place at 37
0C for 5 mins.
14) Then add 200 p1 of ONPG, mix and incubate at 37 °C.223
To quantitate:
For recombinant virus: incubate for 5 to 10 mins and begin taking
timepoints every 5 to 10 mins. Take at least 4 timepoints.
For transient expression assay: incubate for 30-60 mins and begin taking
timepoints every 30-60 mins. Take at least 4 timepoints.
15) At each timepoint remove 200 41 of the assay and transfer to a 1.5
ml eppendorf containing 800 p.1 of 0.5 M Na2CO3.
96 well plate assay
1) Pipet up and down several times and then remove 80 41 of sample
to a new 96 well plate. Store the remainder at 4 0C.
2) Freeze and thaw at -80 0C one time.
3) Add 120 41 of Buffer Z (pipet up and down to mix )
4) Incubate 5 mins at 37 0C
5) Add 40 p.1 of ONPG (pipet up and down to mix)
6) Wrap plates in foil and incubate at 37 0C for 2 hours to overnight.
7) Stop reaction by addition of 50 pl of 1 m Na2CO3
Solutions
Buffer Z 100 mis:
1.61 g Na2HPO4 7H20 (0.06M)
0.55 g NaH2PO4 H2O (0.04M)
0.075 g KC1 (0.01M)
0.024 g MgSO4 7H20 (0.001M)
0.27 ml 2-Mercaptoethanol
Stored at room temperature in a tightly sealed bottle good for 1 to 2
months
1 M Na2CO3: 4.2 g/40 ml
0.5 M Na2CO3: 2.1 g/40 ml
Stored at room temperature good for 1 week
ONPG:
ONPG 4 mg/ml in 0.1 M NaPO4 (pH 7.0)
Store at -20 0C and wrap in foil.224
Appendix 15:Non-CsC1 Method To Isolate Total Cell RNA
1) Plan to work in the Hood! To harvest RNA remove media from
one well at a time and add 400 Ill of 1 x PBS to rinse(gently rock plate
back and forth). This procedure is scaled for 1 to 1.5 X106 cells/well
2) Remove all liquid from cells
3) Add 600 .tl of solution D to the well and use a rubber policeman to
scrape loose the gelatinous cell debris. Transfer to aneppendorf.
4) Return to step 1 and harvest the next well; after harvesting all wells,
add 60 pl of 2 M Sodium Acetate pH 4.0. Mix by vortexing.
5) Add 600 p.1 of water-saturated phenol and mix by vortexing.
(Note Phenol should be nucleic acid graded and equilibrated with only
RNA Grade water. Do not use Tris equilibrated phenol)
6) Add 120 ill of Chloroform mix by vortexing for 10 sec. Cool on ice
for 15 mins.
7) Centrifuge samples at 10,000g for 30 mins at 4 0C
8) Transfer aqueous phase to fresh eppendorf and add 600 pl of
isopropanol. Place at -20 0C for at least an hour to precipitate the RNA.
9) Centrifuge at 10,000g for 20 mins at 4 0C
10) Resuspend RNA pellet in 100 p.1 to 300 p.1 of solution D and mix.
11) Reprecipitate with 1 volume of isopropanol. Leave at -20 0C 1
hour.
12) Centrifuge for 20 mins at 4 0C
13) Wash RNA pellet with 75% ETOH and pellet
14) Vacuum dry (15 mins) and dissolve in 50 IA of RNA GRADE
WATER.
15) Read the OD260 to determine the concentration
Concentration= (0D260) (dilution factor)(50 ggign
1000
REAGENTS
Solution D :4 M guanidium thiocyanate, 25 mM Sodium Citrate pH
7.0, 0.5% Sarcosyl, 0.1 M b-Mercaptoethanol.
2 M Sodium Acetate pH 4.0
Phenol (Water-Saturated only)225
Appendix 16: Taq Sequencing Procedure
1) DNA to be sequenced should be prepared as described in the DNA
Mini-prep protocol. For best results the DNA should be used within
one week. Prepare four 0.5 ml termination tubes labeledA,C,G,T for
each sample and add 1 pl of the proper deazo dNTP to each tube. Store
on ice.
2) Use 0.5 ml eppendorf tube and add the following components:
44 p1 of a Mini-prep DNA resuspended in 100 p.1 of water or TE
of 2mM EDTA 2 M NaOH
49 ill
3) Heat 5 mins at 85 °C
4) Place on ice 3 mins
5) Add:
6µl of 3 M NaAc pH 5.2 mix
150 pi of Ethanol
6) Place at -80 °C for 15 mins
7) Spin for 20 mins in the microfuge at 4 0C.
Remove supernatant, respin and carefully remove remaining
supernatant with a sequencing tip.
8) Add to each sample:
15.5 p.1of MQwater
2.5 p.1of primer 10 ng/p1
5.0 piof 5X Taq polymerase buffer
2.0 plof extension/labeling mix
25.0 IA
9) Anneal at 37 0C 25 mins. Remove and cool to room temperature
slowly.
10) Add to each sample:
2.0 p.1 of 35S-dATP
1.6 IA of Taq polymerase
11) Incubate at 37 °C for 5 mins
12) Add 6 IA of the reaction to each of the four terminantion tubes.
13) Incubate at 70 °C for 17 mins
14) Add 4 p.1 of stop solution to each termination tube. Store at -20 0C226
Appendix 17: RNase Protection Procedure
In vitro RNA Synthesis
1) Linearize 20 pg of CsC1 purified plasmid (digest at 0.1 µg/u1 of
plasmid DNA) overnight with the appropriate restriction enzyme.
Verify that the digestion is complete by loading on a gel.5' overhangs
are best, blunts are marginal and 3' overhangs are poorlinearization
sites.3' overhangs allow polymerase to turn around and synthesize
back on the non-coding strand.
2) Phenol/Chloroform extract, then Chloroform extract. Ethanol
precipitate using 1/10 volume of 3 M NaAc and 2 volumes of ethanol.
Precipitate at -80 0C for 20 mins.
3) Microfuge 30 mins at 4 0C and remove supernatant. Respin and
remove remaining supernatant. Resuspendlinearized plasmid DNA
in water at 0.5 pg/ul. Store at -20 0C until needed.
4) Assemble the transcription reaction in a 1.5 ml eppendorf tube.
Component Stock Volume
2 pg of linearized plasmid 0.5 1.1.g/p1 4 p.1
lx Transcription buffer 5x 4 pi
10 units of RNasin 40 units OA 41
10 mM of DTT 100 mM 2µl
50 1.1.M of Cold UTP 1 mM 2 gl
50-60 p.Ci of 32P UTP 10 pri/ µl 5
0.5 mM of rGTP rCTP rATP 5 mM each 2 p.1
Polymerase (T7,T3 or Sp6) 20 units/p1 1 p.1
MQ Water
20 p.1
5) Incubate at 37 0C for 1 hour.
6) Add 1.5 p.1 of RNasin 40 units/g1
3.0 p.1 of Yeast RNA 10 ug/ill
0.6 gl of DNase (free of RNase) 5 units/p1
7) Incubate 37 0C for 30 mins, then add 175.5 gl of 1x TES. Remove 1 pl
and dilute in 99 pl of MQ water. Add 5 p.1 to a scintillation vial and
save (Crude input counts Diluted 20X). Storesample at -20 °C.
8) Prepare column using a 5 ml disposable pipette cut off at -2 ml mark
and plug with baked glass wool. Fill column with G-50/1x TES.227
9) Load the remaining 199 ul of the reaction onto the column that has
no buffer over the gel bed. After the sample hasbeen absorbed onto the
column, add more buffer. Do not let the column dry out. Monitor the
separation of the unincorporated vs the incorporated counts withthe
gieger counter.
10) Collect the first peak (incorporated counts usually come off in a 1
ml volume) in a 1.5 ml eppendorf (split into four 1.5 ml eppendorfs).
Precipitate by adding 1/20 volume of 5 M NaCl and 3 volumes of 95%
ethanol. Store at -800C for 2 hours. Microfuge for 30 mins, remove
supernatant, respin, remove remaining supernatant.Resuspend in 100
to 150 ill of water. Remove 1 gl and dilute in 99 p.1of water. Then add
5 ill to a scintillation vial and save (diluted 20X). Store at -20 °C.
11) Calculate the mole of RNA synthesized:
Compute % incorporation= pure counts x 20
crude counts x 20
12) Compute pmoles of UTP (hot plus cold) and add to the
transcription reaction.
1/(800 Ci/mmole x 103 mmole/mole) 50x10-6 Ci
=6.25x10-11 mole
6.25x10-11 + 1.0x10-10 = 1.625x10-10 moles = 160 pmole
13) pmol = (pmol input UTP (% inc./100)(4 NTP/UTP))
probe probe length
pmol = ug/(0.66)(kb)
mole = pmol 10-12 = fmol 10-15 = attomol 10-18
Solutions
5X Transcription Buffer
0.2 M Tris pH 7.5
30 mM MgCl2
10 mM spermidine228
lx TES
10 mM Tris pH 7.5
5 mM EDTA
1% SDS
RNase protection assay
Tris 0.5 ml of 1 M
EDTA 0.5 ml of 0.5 M
Make up standards and controls
Tubes 1-5 are standards
1) 6000 attomoles xi! mRNA 5 p.1 + 5 IA 10 pg/p.1 yeast RNA
2) 1600 attomoles v mRNA 5 gl + 5 1.11 10 pg/p1 yeast RNA
3) 400 attomoles Iv mRNA 5 p.1 + 5 pl 10 µg/ µl yeast RNA
4) 100 attomoles Ni mRNA 5 p.1 + 5 IA 10 pg/p1 yeast RNA
5) 20attomoles IV mRNA 5 p.1 + 5 gl 10 µg /µl yeast RNA
No protection control
6) Just probe and 10 p.1 of 5 pg/g1 yeast RNA
No digestion control
7) Just probe and 10 p.1 of 5 pg/g1 yeast RNA. Leave out of RNase
digestion
A) Prepare samples in 1.5 ml eppendorfs using 30 pg/p1 of total RNA
and 20 pg/p1 of yeast RNA. Dry down samples.
B) Add Hybridization mix (volume 30 p.1) to each sample.
Hybridize at 55 0C for 12-15 hours.
Hybridization mix
24 pl of 100% formamide
3.7 p.1 of Hybridization buffer
x pi of probe 5 fmoles (max volume 2.3pl)
Iy.1 of water
30 pl Total229
Hybridization buffer (25 samples)
Component Stock Volume Final Concentration
NaC1 5M 80p.1 0.4M
EDTA 0.5 M 2 p.1 1 mM
Pipes pH 7.0 1 M 40 pl 40 mM
@ 25 °C
Sigma P-6757
C) Centrifuge briefly
Add 300 pl of RNase mix to each sample.
# samples/3 = # mis of RNase mix
0.3x RNase Mix ** (make fresh)
Volume Component
1.0 ml ix RNase Digestion buffer
1.0 pl 10 mg/ml RNase A
1.0 pl 350 units/p1 RNase T1
** Just add RNase Digestion buffer to standard tube # 7
Cap tubes, Flick several times to spread RNase to all surfaces ofthe
tube. Microfuge briefly
Place at 37 0C for 1 hour
lx RNase Digestion Buffer
Concentration Component Stock Volume
10 mM Tris pH 7.5 1 M 100 p.1
5 mM EDTA 0.5 M 100 p.1
300 mM NaCl 5 M 600 g1
Water 9.2 ml
10.0 ml230
D) Add 20 gl of Proteinase K Digestion mix
Proteinase K mix
50 p.1 of 20 mg/ml proteinase K
50 p.1 of 10 mg/ml Yeast RNA
900 gl 10X TES
1000 gl
Incubate 15 mins at 37 OC
E) Extract one time with phenol/chloroform, then Ethanolprecipitate
Add:
40 p.1 of 3 M NaAc pH 5.2
880 gl of 100% Ethanol -80 0C 1 hour or -20 0C overnight
F) Centrifuge 30 mins and resuspend in 10 p.1 of a mixture(2 gl of water
and 8 gl of loading buffer). Be sure samples are resuspended.
Store at -20 0C.231
Appendix 18: GUS Assay
24 well plate assay
For recombinant virus assay
1) Plate 1.5 x 106 cells/well and allow cells to attach for at least one
hour.
2) Dilute the amount of virus used (MOI) for each well in 800 p.1 of
media. Always calculate (virus and media) for a few extra wells.
3) Remove media and place the 800 pl of media containing virus in
each well and incubate for one hour.
4) After one hour (called time zero) remove the 800 pl and replace
with 1 ml of fresh media.
For transient expression assay (start here)
5) After the desired incubation time, scrape the cells loose of 6 well
plate with policeman.
6) Transfer to 1.5 ml eppendorf tubes.
7) Spin cells for 3 mins at 60 % in microfuge.
8) Take off supernatant and respin briefly to remove any remaining
supernatant. Add 500 pl of 1 x PBS, vortex pellet in solution and freeze
at -80 OC
9) Thaw cell extracts.
10) Centrifuge to pellet cell debris. If desired transfer supernatant to a
fresh tube and store at -80 OC.
11) Place 5 pl of cell extract (for recombinant virus) or 50 pl (for
transient assay) to each well and incubate at 37 0C for 5 mins.
12) Add quickly 595 pl(for recombinant virus) or 600 p.1 (for transient
assay) of GUS assay buffer in 24 well plate and place at 37 0C.
To quantitate:
For recombinant virus: incubate for 5 to 10 mins and begin taking
timepoints every 5 to 10 mins. Take at least 4 timepoints.
For transient expression assay: incubate for 30-60 mins and begin taking
timepoints every 30-60 mins. Take at least 4 timepoints.
13) At each time point, remove 100 IA of the assay and transfer to a 1.5
ml eppendorf containing 900 IA of 0.2 M NaCO3.232
Calibration of Fluorimeter
Make a 1 mM stock of MU (Na methyl-umbelliferone Sigma #1508) in
MQ water. Dissolve 9.91 mg/50 mis. Wrap in aluminum foil and store
at 4 °C. Good for one month.
Make 1 p.M and 100 nM solution of MU in 0.2 M Na2CO3.
Add 100 ill of 1 mM MU to 900 W of 0.2 M Na2CO3.
1 1.tM MU: Add 100 111 of this dilution to 9.9 ml of 0.2 M Na2CO3.
100 nM MU: Add 1.0 ml of 1 JAM MU to 9.0 ml of 0.2 M Na2CO3.
Use the 1 gM and 100 nM MU standards to calibrate the fluorimeter.
Set the excitation at 365 nm and emission at 455 nm.
96 well plate assay
1) Pipet up and down several times. Remove 150 p.1 of sample to a
new 96 well plate. Store the new plate at 4 °C. Take original platethat
contains approximately 50 IA and use it for the assay.
2) Freeze and thaw one time at -80 °C.
3) Add 150 gl of GUS assay buffer (pipet up and down to mix)
4) Incubate at 37 0C for 2 hours to overnight.
Solutions
GUS assay buffer
Component Stock Volume Concentration
NaPO4 pH 7.0 1 M 2.5 ml 50 mM
2-Mercaptoethanol 14.4 M 35 111 10 mM
EDTA 0.5 M 1.0 ml 10 mM
Sarcosyl 10 % 0.5 ml 0.1 %
Triton X-100 10 % 0.5 ml 0.1 %
Water 45.47 ml
Total Volume 50 ml
Mix then add 22 mg of 4-Methyl umbelliferyl 13 -D- glucuronide
Mix and store at room temperature. Good for several months.
Stop Buffer
0.2 M Na2CO3 1.06 g/50 mlAppendix 19: Exonuclease III Deletion Procedure
1) Dissolve 10 gg in 60 gl of lx Exo III buffer
2) Prepare 12 or 24 tubes (0.5 ml) marked with the appropriate time
points and aliquot out 7.5 gl of Si mix containing Si Nuclease
Si mix 27 gl 10x Si buffer
172 111 water
pinch of Si nuclease (pinch = < 0.5 gl)
233
3) Incubate 30 gl (for 12 tubes) or 60 111 (for 24 tubes) of DNA in Exo III
buffer at the desired deletion temperature. Deletion rates are
approximately 37 0C/300 by or 30 0C/150 by
4) Add 2.9 111 (for 30 gl of DNA) or 5.8 ul (for 60 gl of DNA) of Exo III
217 units /111. Quickly mix and place again at the desired deletion
temperature.
5) Remove 2.5 111 at each time point and mix with the appropriate S1
tube.
6) Incubate Si tubes at 30 0C for 20 mins.
7) Add 1 gl of Si Stop solution to each tube.
8) Incubate tubes at 70 0C for 10 mins.
9) Add 2 gl of a mixture containing 1 gl of Klenow mix with Klenow at
0.5 units/111 and 1 111 of 0.125 mM dNTP's mix to each tube.
10) Incubate at 37 0C for 5 mins.
11) Total volume of each tube is 13 gl
12) DNA samples may now be run out on a TAE gel to determine the
extent of the deletion. Recommend loading 3111 for determining
deletion distance and 6-12 gl if samples are to be gel purified. Load the
last deletion time point next to the first deletion time point to allow for
easier analysis of the deletion distance. Samples loaded on a gel may be
run into low melt agarose and cut out for immediate ligation. Running
the samples out on a gel and into low melt agarose is strongly
recommended when particular deletion size is desired. DNA samples
may also be ligated directly without running them on a gel.234
Ligation Reaction
10 41 of deletion DNA
10 W of5X ligase buffer
30 111 of MQ water
1 p.1 of Ligase 1 unit/p.1
Incubate overnight at room temperature
Solutions
10X Exonuclease III buffer
660 mM Tris pH 8.0
6.6 mM MgC12
10X Si buffer
Component Stock Volume
KOAc pH 4.6 3 M 1.1 ml
NaC1 5 M 5.0 ml
Glycerol 5.0 ml
ZnSO4 30.0 mg
Si Stop solution
0.3 M
0.05 M
Trizma Base (no HC1)
EDTA pH 8.0
Klenow mix
Component Stock Volume
Tris pH 8.0 0.1 M 3 p.1
MgC12 1.0 M 6µl
MQ Water 20 pl235
Appendix 20: Si Nuclease Protection
Labeling DNA Probe (3'end labeling)
1) Linearize DNA probe. Verifiy digestion on a gel.
2) In a 1.5 ml eppendorf, set up the following:
DNA: (2 p.g)
10X T4 DNA Polymerase buffer:
MQ water:
X pl
2 gl
?Sill
20 gl
3) Incubate at 70 0C for 5 mins, cool on ice 2-3 mins
4) Add 1 pl of T4 DNA Polymerase (1 unit/g1), mix andtransfer to
37 0C for 5 mins
5) Add 1 p.1 of 2 mM (dATP,dTTP,dGTP) stock.
6) Add 2 pl of 32P dCTP (3000 Ci/mmole), mix and incubate5 mins at
37 oc.
7) Add 1 pl of cold 2 mM dCTP and incubate at 37 0C for 10mins.
8) Transfer to 70 0C to stop reaction.
9) Dilute reaction to 40 pl and store at -20 0C.
Si Nuclease Treatment
1) Calculate the quantity of DNA to use for hybridization toRNA by
estimating the molar quantity of specific mRNA present intotal RNA
of infected baculovirus cells. Use a 5 molar excess of DNAprobe:specific
mRNA. (I recommend using 0.05 ug of labeled probe for30 p.g of total
RNA for a baculovirus late gene.)
2) Add the 1 pl of 0.05 pg/p.1 of labeled DNA probe and 30 pg oftotal
RNA to a 1.5 ml eppendorf tube.
3) Add 10 pl of 3 M NaAc and MQ Water to total volume of 100pl.
4) Add 200 pl of 95% ETOH mix and store at -800C for 20 mins.
5) Pellet in microfuge 20 mins. Respin and remove all supernatant.
6) Resuspend pellet in 20 pl of S1 Hybridization buffer(resuspendwith
pipet to make sure it is resuspended)
7) Incubate at 85 0C for 15 mins.
8) Transfer very quickly to 52 0C water bath (using a beakerwith at least
52 0C water.236
9) Incubate 3 hours at 52 0C
10) While tubes are still in 52 0C bath, add 300 p.1 of ice-coldS1 nuclease
digestion buffer (with 48,000 units of Si nuclease per ml).Transfer to
ice bath for 2-3 mins.
The proper amount of Si nuclease needs to be determined byeach
individual. If the the Si nuclease is fresh then 600 to 6000 unitsis
probably sufficient.
11) Incubate at 25 0C for 30 mins.
12) Add 75 p.1 of Si nuclease termination plus 1 p.1 of 10 µg /µlof yeast
RNA as carrier.
13) Add 2 volumes of ETOH (800 pl), and mix
14) Store at -80 0C for 20 mins and then microfuge for 20 mins.
Resuspend in a mixture of 4 pl of MQ water and 12 p1 of loadingbuffer.
SOLUTIONS
T4 DNA Polymerase Buffer: (45 mM Tris pH 8.0, 5 mMMgC12, 5 mM
DTT)
10X TDPB: 1.0 ml
1 M Tris pH 8.0 450 gl
1 M MgC12 50 pl.
100 mM DTT 500 pl
S1 Nuclease Hybridization Buffer: (80% formamide, 40 mM PIPESpH
6.4, 1 mM EDTA, 0.4 M NaC1)
5X Hybridization buffer without formamide 50 mis
PIPES 3.025 g
NaCl 6.845 g
EDTA 0.085 g
pH to 6.4 (PIPES will not fully dissolve until pH 6.4 is reached)
Bring to 50 ml with MQ water. Filter Sterilze and store at 4 0C.
Add 1 volume of 5X hybridization buffer to 4 volumes of 100%
deionized formamide. Aliquot in 500 p1 and store at -80 0C.237
Si Nuclease Digestion Buffer: (0.28 M NaC1, 0.05 M NaAc pH 4.4, 4.5
mM ZnC12, 20 p.g /ml of denatured Calf Thymus DNA)
50 mis
NaC1 2.9 g
3 M NaAc pH 5.2 1.25 ml
ZnC12 Fw 136.3 30.7 mg
pH to 4.4 with acetic acid
Bring to 50 ml with MQ water, and Filter Sterilize.
Add 200 pl of denatured Calf Thymus DNA (5 mg/ml).
To denature Calf Thymus DNA should be placed in a boiling water
bath for 2 min, then quenched on ice. Aliquot and Store at 4 °C.
Finally added S1 Nuclease just before use and keep solution on ice.
Si Nuclease Termination Buffer: (2.5 M NH4Ac, 50 mM EDTA)
40 ml
7.5 M NH4Ac 13.3 ml
0.5 M EDTA pH 7.4 4.0 ml
MQ water 22.7 ml
Reference: Favoloro et al., 1980. Methods of Enzymology 65:718-749.238
Appendix 21: Low Melt Agarose Cloning and Addition of DNA Linkers
Low Melt Agarose Cloning
1) Load and run out your DNA digestions on a TAE gel to separate
desired fragments.
2) Always use only the long UV transilluminator to visulalize your gel
2) After separation of desired fragments is complete cut away the
agarose below the desired bands as illustrated onthe next page. Place
the tray that contains the gel with the removed agarose below your
bands in the 4 'DC cold room. Pour the low melt agarose into the hole
and let solidify. Use Only SEA PLAQUE LOW MELT AGAROSE from
FMC. After solidification, place gel back in electrophoresis box and run
desired bands into the low-melt agarose.Low Melt Agarose
I
239
Top view of cut band
Side view of cut band
Trim off all low melt agarose
that does not contain DNA
brightly stained with ETBR.
With a razor (that is washed between each sample), cut thedesired
bands from the low-meltagarose.You are only interested in agarose
that contains DNA brightly stained with ETBR. Turn the cut-out
agarose block of DNA on its side andtrim away all agarose not brightly
stained with ETBR. Place the block in an eppendorftube. Note the
intensity of the various bands as, this will help youdetermine what
volume of each of the bands should be used in ligation.Store at 4 0C
until needed.
Low-Melt Agarose Ligations
1) Determine on the ratio of insert to vector DNA.240
If vector is not cipped, use a molar ratio of 1 to 1insert/vector.
If vector has been cipped, you may want to use a molarratio of 1 to 1
insert/vector or 1 to 2 insert/vector. Remember, vectorshould not be
able to religate. Using more vector will prevent insert toinsert
ligations.
After determining the proper insert to vector ratio, set up theligation
reactions. First, mix MQ water and 5X ligation buffertogether then put
DNA samples in the 70 0C water bath to melt the agarose
(approximately 5 mins). First mix the DNA-agarose samples to ensure
homogeneity. Quickly mix the insert DNA with thewater-buffer
mixture. Rapidly follow with vector DNA, then with Ligase.Use
another pipetman set at 20 pl to give the final mixing bypipeting up
and down. Be careful not to generate air bubbles.
Always do a vector control ligation reaction with each vector you use.
You may also want to do a insert control ligation if youhad a difficulty
separating insert from the parent vector.
Ligation Reaction
MQ water X p1
5X ligation buffer 4 p1
Insert DNA X IA
Vector DNA X pl
Ligase (1 unit/u1) 1.5 pl
Total volume 20.0p1
Vector Control Ligation Reaction
MQ water X 1.1.1
5X ligation buffer
Vector DNA
Ligase (1 unit/0
Total volume
4 p1
X pl
1.5 pl
20 pl
X= MQ water + insert
from ligation reaction
same amount as in
ligation reaction241
Store ligations for 2 hours to overnight at room temperature and then
transform.
Kinase DNA Linkers
Linkers 0.5 µg /µl 1.5 p.1
1 M Tris pH 8.0 3.0 1.11
0.2 M MgCl2 1.5 pl
0.1 M DTT 1.5µl
10 mM ATP 1.3µl
MQ water 21.2 IA
30.0 IA
Add 5 units of T4 polynucleotide kinase (5 units/p1)
Incubate for 45 mins at 37 OC
Freeze at -20 0C or use immediately
Blunt 5' DNA overhangs using Klenow or T4 DNA polymerase
Klenow (preferred over T4 DNA polymerase)
DNA (0.1 i.tg/i.t1) 18 p.1
10 mM dNTP's 4 p.1 (1 pi of each)
10X Nick translation buffer 3 pi
MQ water lill
Total 30 p.1
Add Klenow (5units/g1) 1 p.1
Incubate at 37 0C for 30 mins
Heat inactivate at 65-70 oC for 10 mins
10X Nick translation buffer: (5 mis)
0.5 M Tris pH 7.2
0.1M MgSO4
1 mM DTT
MQ water
2.5 mis of 1 M Tris pH 7.2
0.5 mis of 1 M MgSO4
50 j.11 of 0.1 M DTT
1.95 mis
500 µg /ml of BSA fraction V 2.5 mg
Divide into small aliquots and store at -20 0C242
T4 DNA polymerase (may also be used to blunt 3' overhangs)
DNA (0.1 p.g/p.1) 18 pi
10 mM dNTP's 4 ill (1 p.1 of each)
New England Biolabs 3 p.1
buffer #4
MQ water 5p.1
Total 30 pi
For 5' overhangs incubate at 37 0C for 30 mins
For 3' overhangs incubate at 12 0C for 15 mins
Heat inactivate at 65-70 0C for 10 mins
Note: Using T4 DNA polymerase on 3' overhang leave out the dNTP's
for first 5 mins of incubation (this facilitates the removal of the 3'
overhang).
S1 Nuclease treatment to blunt 3' overhangs (preferred method)
1) Digest 3 lig of DNA with the appropriate restriction enzyme in a 30
1.t1 reaction. Confirm linearization of the plasmid on a agarose gel.
2) Add 25 pi of S1 mix to the 30 µl of DNA.
SI MIX
27 pi of 10X S1 buffer
172 pi of MQ water
0.25 p.1 to 0.5 p.1of S1 nuclease
3) Incubate at 30 0C for 20 mins.
4) Add 1 pi of S1 stop solution
5) Incubate tubes at 70 0C for 10 mins.
6) Add 30 p.1 of Klenow mix and 0.5 IA of Klenow (5 units/A.
Transfer to 37 0C.
7) Incubate for 3 min and follow with 1 p.1 of 0.125 M dNTP's stock.
Then incubate for 5 mins at 37 0C.
8) If DNA is to be used in linker ligation, extract one time with
phenol/chloroform. ETOH precipitate with 50 p.1 7.5 M NH4Ac and 300
p.1 ETOH 95%. Leave at -80 0C for 15 mins and centrifuge for 20 mins at
4 0C. Remove supernatant. Respin briefly and remove remaining243
supernatant. Resuspend in 50 p.1 of MQ water and use 30p.1 in the
linker ligation described below.
If DNA is simply to be ligated to itself, then take:
10 illof Si treated DNA mixture
10 IA of 5X ligase buffer
30 ill of MQ water
1 ill of Ligase (1 unit/p.1)
Incubate for 2 hours to overnight at room temperature and then
transform.
Linker Ligation
Kinased linkers 30 ill
Blunted DNA 30 p.1
5X Ligase buffer 17 p.1
Ligase (lunit/g1) L.1.1
Total 85 pl
Incubate overnight at room temperature
If the restriction site where the linker was ligated to was already blunt
from a blunt end cutter like Sma I then just take 10 pl of the 85 IA
ligation and transform. Screen 12 colonies and more than likely, most
will have a linker(s) inserted. Beware that these clones may have more
than one linker inserted. In most cases you will be inserting
something into the newly created linker site. When you reopen the
linker site to insert a fragment, digest with excess enzyme to removed
extra linkers.
If the restriction site required blunting then I recomend the following:
1) Add 5 ilg of tRNA as a carrier and bring the ligation to a volumeof
100 p.1 with MQ water.244
2) Add 50 p.1 of phenol/chloroform and vortex. Centrifuge for 3 mins
to set phases.
3) Transfer supernatant to a fresh 0.5 p.1 eppendorf tube and add 50 pl
of 7.5 M NH4Ac and 300 pl of 95% ETOH. Incubate at -80 0C for 30
mins. Centrifuge at 4 0C for 30 mins. Carefully remove supernatant
and recentrifuge for 5 mins. Remove the remaining supernatant with
a sequencing tip.
4) Resuspend DNA pellet in 81 pl of MQ water. Add 10 µl of the
appropriate 10X restriction buffer and 9 pl of the linker restriction
enzyme (10 units/p.1). Incubate for 5 to 6 hours.
5) Add 5 pg of tRNA as a carrier, 50 pl of 7.5 M NH4Ac and 300 p.1 of
95% ETOH. Incubate at -80 0C for 30 mins. Centrifuge at 4 0C for 30
mins. Carefully remove supernatant and recentrifuge for 5 mins.
Remove the remaining supernatant with a sequencing tip.
Resuspend in 20 p.1 of MQ water and mix with 5 ill of loading buffer.
Load and run on a TAE gel. When the linearized DNA band has been
resolved from the linkers, cut a hole in the agarose below the band and
replace with low-melt agarose (see above).245
Appendix 22: Gene Clean DNA Fragments
Glassmilk powder Concentration = 0.5 mg glass/Ill
Binding capacity: 1 mg glass binds - 21.ig DNA
Method:
1. Bring the volume of DNA in solution up to 200 1.11 with H2O.
For gel purification, excise the band from the gel.
2. Add 2-3 volumes of Nal solution and MIX.
For gel purification, place the eppendorf tube at 550 C to melt the
agarose (app. 5-10 min.)
3. Add 5 IA of GLASS, VORTEX.
4. Place on ice for 5 mins.
5. Burst spin for 5 sec
6. Discard the NaI solution
7. Resuspend 3x with "NEW" Buffer
Add 400 1.11 of NEW buffer each time and vortex briefly
Burst spin and remove the NEW buffer
8. After the last spin, burst the tube again to remove residual buffer
9. Elute the DNA from the glass
Add Xj.t1 of H2O or 0.1x TE (XL 5111) MIX
Incubate at 550 C for =5 minutes
10. Burst spin
11. Remove supernatant containing the DNA. Be sure not to get any
glassmilk with the supernatant.
12. If desired, the elution from the glass may be repeated.
NaI Solution
Saturated solution of NaI (Refractive index of 1.5000) with sodium sulfite
added as an antioxidant.
In a 700 C waterbath
Add 2 g Na2SO3 (sodium sulfite) to 100 ml MQ H2O and dissolve.
Add 180 g Nal to the 100 ml
Add -1/4 the amount of NaI at a time until all is dissolved (note: the
last bit may not go completely into solutionthe solution may
remain cloudy)
Let sit overnight at room temperature wrapped in foil.
Filter through 0.45 µ nitrocellulose to remove undissolved NaI
Store @ 40 C in the DARK
Glass powder:
1 g of glass powder in 2 ml of H2O for stock (0.5 mg/ml)
see Vogelstein and Gillespie for preparation of glass or246
BIO 101 Inc.,P.O. Box 2284, La Jolla, CA 92038-2284
1-800-424-6101
Product = "GENECLEAN"
NEW Buffer
NEW buffer = 50% (20 mM Tris-HC1 [7.2], 0.2 M NaC1, 2 mM EDTA)
50% EtOH
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